data_1w4i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1w4i _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.622 0.249 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.73 162.09 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.337 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.402 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 7.4 mtp -86.97 150.16 49.39 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.962 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -50.57 -52.02 9.88 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.168 1.912 . . . . 0.0 112.504 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.417 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -63.98 -34.96 79.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 110.61 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.404 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -60.65 -52.9 63.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.79 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -56.0 -33.76 65.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.623 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -53.1 56.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.53 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.84 -25.4 68.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.783 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.542 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -73.88 -36.89 64.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.984 0.421 . . . . 0.0 110.352 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -76.34 -29.36 57.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.301 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -82.04 -49.04 10.67 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.148 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.511 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.59 -10.21 52.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.71 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 33.23 55.46 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.956 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 17.3 mm -87.81 142.88 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.93 0.395 . . . . 0.0 111.522 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.445 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -94.84 100.79 12.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.433 HD22 HG23 ' A' ' 144' ' ' ILE . 5.1 mt -65.12 -18.67 65.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.286 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -17.27 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.86 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -110.86 5.66 20.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.602 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.485 HG22 HD13 ' A' ' 158' ' ' ILE . 61.5 t -87.72 148.27 4.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.087 0.47 . . . . 0.0 111.198 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.95 109.92 5.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.349 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.82 122.2 8.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.919 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.45 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -139.32 33.68 2.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.349 0.595 . . . . 0.0 110.661 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.51 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -126.96 -165.53 11.95 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.1 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -31.93 98.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.821 3.014 . . . . 0.0 114.285 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.2 -16.89 11.08 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.443 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.58 43.45 0.24 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.5 p -99.68 144.2 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.135 0.493 . . . . 0.0 111.729 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.502 ' N ' HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -71.6 127.78 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.369 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 31.0 p -102.86 167.94 9.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.797 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.417 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 99.0 t -54.77 -31.61 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 110.873 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.22 -39.39 94.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.432 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 4.8 m-20 -69.89 -44.25 70.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.397 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.45 HG23 ' CD1' ' A' ' 158' ' ' ILE . 83.4 t -63.41 -54.64 30.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.292 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -57.65 -34.41 69.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.731 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -72.7 -49.54 30.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.438 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.462 ' HD2' HG22 ' A' ' 144' ' ' ILE . 14.9 t80 -65.99 -47.97 72.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.798 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.453 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -56.59 -42.01 77.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.403 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 6.9 pt-20 -72.13 -33.08 67.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.048 0.452 . . . . 0.0 110.454 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 23.0 tt0 -77.99 -24.07 48.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.5 t -89.35 -38.24 14.29 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.648 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.213 179.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.674 0.274 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.525 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.52 161.99 33.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 35.9 mmm -84.53 155.42 62.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.922 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.92 -52.07 5.78 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.246 1.964 . . . . 0.0 112.247 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.438 ' CB ' HG23 ' A' ' 160' ' ' VAL . . . -62.95 -32.54 73.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.986 0.422 . . . . 0.0 110.624 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -61.13 -49.86 75.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.72 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.1 mtt85 -58.44 -33.4 69.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.511 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -63.6 -52.7 59.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.226 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.48 -24.2 67.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.816 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.557 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.73 -35.74 62.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.92 0.391 . . . . 0.0 110.378 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -76.39 -29.38 57.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.186 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -82.37 -48.94 10.55 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.161 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.486 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.97 -9.95 51.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.746 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.52 32.41 54.77 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.047 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.557 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 15.1 mm -88.35 148.61 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.132 0.491 . . . . 0.0 111.712 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -106.99 100.89 10.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.486 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.414 ' HA ' ' CG2' ' A' ' 149' ' ' VAL . 1.7 mp -62.56 -19.53 63.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.336 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.7 m -62.19 -21.05 64.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.924 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -106.32 -4.76 19.69 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.55 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 162' ' ' ASP . 58.0 t -79.01 147.36 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -70.98 113.0 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.203 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.93 122.68 7.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.126 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.45 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -139.77 33.25 2.0 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.317 0.579 . . . . 0.0 110.661 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.512 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -123.45 -165.29 12.27 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.801 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -31.09 95.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.776 2.984 . . . . 0.0 114.197 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.76 -20.41 12.17 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.188 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 131.04 44.73 0.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.3 p -100.62 142.97 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.252 0.548 . . . . 0.0 111.956 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.579 HD13 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.26 124.61 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.03 179.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 158' ' ' ILE . 1.4 p -107.34 165.7 11.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.231 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.438 HG23 ' CB ' ' A' ' 134' ' ' ALA . 30.0 t -50.16 -26.02 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.593 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -45.58 88.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.578 ' HB2' HD11 ' A' ' 158' ' ' ILE . 6.6 m-20 -74.83 -33.64 62.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.494 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.579 HG22 HD13 ' A' ' 158' ' ' ILE . 8.7 t -65.1 -54.53 28.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.6 tptp -61.31 -37.31 82.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.546 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.36 -42.96 74.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.307 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -71.45 -50.52 30.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.642 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.484 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -55.89 -39.41 71.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.254 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 22.6 pt-20 -75.63 -45.72 35.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.155 0.502 . . . . 0.0 109.866 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.2 tp10 -64.4 -21.93 66.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.487 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.443 HG21 ' N ' ' A' ' 171' ' ' ALA . 1.1 t -93.71 -33.16 13.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.443 ' N ' HG21 ' A' ' 170' ' ' THR . . . . . . . . 0 CA--C 1.528 0.104 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.634 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.707 0.289 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.54 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.47 162.02 33.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 10.4 mtp -80.75 146.91 61.24 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.808 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.22 -40.11 21.49 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.249 1.966 . . . . 0.0 112.324 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.452 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -77.85 -27.87 49.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.478 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -63.37 -52.56 61.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.617 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.542 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 18.6 mtp-105 -56.25 -35.01 66.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.463 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -62.76 -51.56 66.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.25 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -23.2 67.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.582 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -72.03 -41.47 67.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.581 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -76.52 -29.03 56.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.569 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.27 -43.62 17.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.652 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.511 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -100.65 -2.28 33.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.178 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.08 39.18 92.83 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.643 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 66.8 mt -87.54 141.8 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.054 0.454 . . . . 0.0 111.8 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.434 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -94.28 100.58 12.61 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.729 ' HG ' HD12 ' A' ' 158' ' ' ILE . 0.4 OUTLIER -68.29 -22.6 64.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.217 -178.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.5 m -65.19 -13.96 59.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.193 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -114.29 0.02 14.02 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.48 ' CG1' HD13 ' A' ' 158' ' ' ILE . 60.2 t -81.6 149.98 4.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.801 0.334 . . . . 0.0 110.959 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -70.96 108.79 4.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.314 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.67 119.99 7.93 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.808 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.444 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -136.88 34.48 2.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.231 0.538 . . . . 0.0 110.895 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.528 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -130.29 -166.25 11.76 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.3 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -32.53 100.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.864 3.043 . . . . 0.0 114.315 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.2 -16.38 9.5 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.474 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 126.75 42.25 0.29 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.54 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.7 p -97.65 144.4 11.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.197 -0.502 . . . . 0.0 111.35 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.729 HD12 ' HG ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -74.0 129.29 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.791 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.0 p -100.86 168.0 9.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.174 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.452 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 50.4 t -55.64 -31.7 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.337 . . . . 0.0 111.139 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -38.88 84.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.119 0.485 . . . . 0.0 109.909 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.443 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 10.0 m-20 -74.94 -38.67 61.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.725 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 158' ' ' ILE . 45.6 t -64.67 -54.71 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.042 0.449 . . . . 0.0 110.362 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -60.4 -40.7 91.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.794 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -69.04 -40.3 78.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.454 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.505 ' CD2' HG22 ' A' ' 144' ' ' ILE . 6.5 t80 -72.13 -52.15 18.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' HB1' HG12 ' A' ' 144' ' ' ILE . . . -57.63 -38.47 75.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.538 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.69 -34.69 69.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.237 0.542 . . . . 0.0 110.481 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -21.94 50.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.087 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 t -92.61 -35.13 13.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.652 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.641 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.404 ' O ' HG21 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.57 0.224 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.472 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.72 162.21 32.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.311 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.409 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 4.7 mmm -86.26 150.3 51.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.172 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.59 -51.94 9.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.202 1.934 . . . . 0.0 112.149 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.411 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -59.75 -34.52 73.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.021 0.438 . . . . 0.0 110.637 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.402 ' CB ' HG23 ' A' ' 163' ' ' VAL . . . -59.98 -51.22 70.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.57 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 84.5 mtt-85 -55.11 -36.41 65.68 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.447 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.3 mtm-85 -61.48 -51.19 69.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.99 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.85 -24.84 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.581 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -70.91 -41.54 71.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.731 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -76.38 -29.05 56.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.768 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -82.16 -43.79 17.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.575 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.552 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -100.67 -1.83 34.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.08 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.31 39.15 94.23 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.645 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.581 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 58.5 mt -87.55 144.99 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 112.002 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.425 ' N ' HG21 ' A' ' 144' ' ' ILE . 1.2 m-20 -97.8 100.64 12.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.518 ' HG ' ' CD1' ' A' ' 158' ' ' ILE . 2.5 mp -74.39 -20.74 59.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.229 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 t -61.93 -17.03 55.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.715 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -109.16 -9.78 15.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.63 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HB ' ' CD1' ' A' ' 158' ' ' ILE . 57.8 t -70.66 146.09 12.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.063 0.459 . . . . 0.0 111.191 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.7 121.15 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.433 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -77.77 123.24 6.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.065 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -143.46 38.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.29 0.567 . . . . 0.0 110.857 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -129.68 -162.65 10.91 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.102 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -31.75 96.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.775 2.983 . . . . 0.0 114.176 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.12 -18.15 14.62 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.277 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.37 44.4 0.19 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.479 HG21 ' N ' ' A' ' 158' ' ' ILE . 1.5 p -103.74 141.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.352 0.596 . . . . 0.0 112.01 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.518 ' CD1' ' HG ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -67.42 127.93 29.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.5 p -108.07 172.82 6.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.102 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.411 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 53.7 t -54.67 -29.8 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -63.65 -40.78 97.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.417 ' CB ' ' CG1' ' A' ' 149' ' ' VAL . 2.0 m-20 -71.81 -42.56 66.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.602 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 158' ' ' ILE . 80.7 t -64.49 -54.53 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.381 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -58.67 -37.38 75.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -70.81 -46.4 62.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.153 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.474 ' CE2' HG22 ' A' ' 144' ' ' ILE . 16.8 t80 -65.52 -50.55 64.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.451 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.461 ' CB ' ' CD1' ' A' ' 144' ' ' ILE . . . -56.54 -44.61 81.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.547 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -71.98 -34.91 69.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.298 0.571 . . . . 0.0 110.405 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -77.42 -21.87 52.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.859 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 167' ' ' ALA . 1.4 t -91.32 -41.14 11.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.866 0.365 . . . . 0.0 110.896 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.218 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.406 ' O ' HG21 ' A' ' 157' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.73 0.3 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.524 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.56 162.1 32.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.276 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.25 153.77 66.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.41 -52.01 8.69 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.297 1.998 . . . . 0.0 112.344 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.419 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -64.79 -32.11 73.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.415 ' CB ' HG23 ' A' ' 163' ' ' VAL . . . -61.33 -52.97 62.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.885 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -55.65 -36.53 67.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.453 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -61.45 -50.91 70.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.45 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.05 -24.67 67.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.89 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.541 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.64 -34.73 62.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.965 0.412 . . . . 0.0 110.537 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -33.63 59.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.362 0.601 . . . . 0.0 109.997 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -79.61 -47.99 14.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.073 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.537 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.23 -10.45 52.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.779 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.22 34.76 57.67 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.832 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 16.2 mm -90.81 141.83 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.015 0.436 . . . . 0.0 111.695 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.443 ' N ' HG21 ' A' ' 144' ' ' ILE . 2.7 m-20 -94.19 100.78 12.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.43 HD22 HG23 ' A' ' 144' ' ' ILE . 5.5 mt -63.5 -20.62 65.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.229 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 79.7 p -64.13 -16.83 62.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.106 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -108.57 -3.77 17.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.726 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' A' ' 158' ' ' ILE . 59.8 t -79.94 149.88 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.076 0.465 . . . . 0.0 111.04 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.1 OUTLIER -72.32 121.68 19.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.364 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.07 119.14 4.78 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.003 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.452 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -137.92 34.23 2.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.413 0.625 . . . . 0.0 110.678 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.511 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -126.77 -166.3 12.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.095 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -31.64 98.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.867 3.045 . . . . 0.0 114.269 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.77 -18.11 13.34 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.399 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.38 44.53 0.21 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.524 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.3 p -101.08 144.87 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.162 0.506 . . . . 0.0 111.685 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.506 ' N ' HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -71.1 126.31 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.137 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.3 p -102.36 167.13 10.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.62 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.419 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 95.4 t -54.78 -36.3 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.384 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 2.5 pt-20 -58.49 -37.05 74.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.564 ' HA ' ' HG2' ' A' ' 165' ' ' ARG . 34.5 m-20 -72.68 -46.89 51.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.355 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 158' ' ' ILE . 71.1 t -56.92 -52.8 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 109.858 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -60.35 -37.67 81.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.234 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -72.29 -36.22 68.91 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.617 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.531 ' N ' ' HG3' ' A' ' 165' ' ' ARG . 14.9 t80 -77.12 -50.09 13.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.038 0.447 . . . . 0.0 110.194 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.498 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -57.52 -36.37 71.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.378 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.02 -34.74 61.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.061 0.458 . . . . 0.0 110.443 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -78.05 -22.07 49.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.219 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.41 HG21 ' O ' ' A' ' 167' ' ' ALA . 3.0 t -88.45 -33.42 17.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.805 0.336 . . . . 0.0 111.049 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.401 ' N ' HG21 ' A' ' 170' ' ' THR . . . . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.793 0.33 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' A' ' 158' ' ' ILE . . . -133.3 162.14 32.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.641 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.89 151.43 54.91 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.011 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.83 -52.14 9.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.306 2.004 . . . . 0.0 112.511 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.426 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -61.75 -36.05 79.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.008 0.432 . . . . 0.0 110.819 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.406 ' CB ' HG23 ' A' ' 163' ' ' VAL . . . -60.61 -52.81 63.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.912 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -56.27 -34.76 66.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.749 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -63.02 -52.0 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.252 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.66 -23.71 67.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.841 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.543 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.44 -36.8 63.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.016 0.436 . . . . 0.0 110.376 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -76.28 -29.3 57.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.144 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.12 -49.03 10.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.094 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.516 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.41 -10.13 52.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.804 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.12 32.64 55.95 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.946 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 17.8 mm -87.77 140.07 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.918 0.39 . . . . 0.0 111.437 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.422 ' N ' HG21 ' A' ' 144' ' ' ILE . 3.7 m-20 -93.48 100.78 13.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.406 HD22 HG23 ' A' ' 144' ' ' ILE . 5.5 mt -64.22 -17.72 63.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.208 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t -65.38 -15.62 62.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.199 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -114.03 5.61 16.14 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.73 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.441 HG22 HD13 ' A' ' 158' ' ' ILE . 57.4 t -87.62 145.63 7.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.941 0.401 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 111.88 7.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.629 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -75.45 118.28 5.47 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.72 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.484 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -126.83 29.37 5.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.109 0.481 . . . . 0.0 111.295 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.765 ' HA2' HG13 ' A' ' 157' ' ' VAL . . . -130.4 -156.6 8.71 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.242 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.569 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 40.5 Cg_exo -38.11 108.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.111 2.541 . . . . 0.0 114.07 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.82 5.81 27.06 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.494 -0.776 . . . . 0.0 113.519 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.5 40.69 1.86 Allowed Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.765 HG13 ' HA2' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -86.73 140.44 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.039 -0.581 . . . . 0.0 111.617 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.441 HD13 HG22 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -79.01 131.35 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.5 p -108.95 167.65 9.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.719 0.295 . . . . 0.0 110.842 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.426 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 47.4 t -54.2 -24.58 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 3.3 tt0 -65.79 -42.95 90.13 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.405 ' OD1' ' CG2' ' A' ' 152' ' ' THR . 11.9 m-20 -74.21 -35.94 63.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.503 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.422 HG21 ' CD1' ' A' ' 158' ' ' ILE . 58.2 t -66.16 -53.69 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.955 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -62.82 -35.71 80.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.715 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 0.6 OUTLIER -71.78 -44.3 64.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.134 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.477 ' HD2' HG22 ' A' ' 144' ' ' ILE . 15.2 t80 -70.11 -47.66 60.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.983 0.42 . . . . 0.0 110.317 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 170' ' ' THR . . . -58.15 -39.0 77.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.548 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 14.2 pt-20 -75.27 -45.48 39.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.029 0.442 . . . . 0.0 110.429 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.1 tm-20 -65.19 -23.81 67.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.439 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 167' ' ' ALA . 1.1 t -90.54 -37.36 13.91 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.684 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.439 179.88 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.413 ' CB ' ' HB ' ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.823 0.345 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.539 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.4 162.05 32.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.5 OUTLIER -93.35 145.71 30.51 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.197 179.299 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.72 -52.04 9.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.406 2.071 . . . . 0.0 112.692 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.39 78.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.976 0.417 . . . . 0.0 110.917 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.406 ' CB ' HG23 ' A' ' 163' ' ' VAL . . . -60.2 -52.84 63.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.027 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -56.86 -33.78 67.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.653 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -63.46 -50.9 67.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -23.97 66.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.837 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.54 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.21 -37.05 63.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.013 0.435 . . . . 0.0 110.466 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -76.3 -29.28 57.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.251 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -82.13 -48.44 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.149 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.494 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.95 -10.7 49.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.735 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.5 36.03 45.24 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.842 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 23.3 mm -92.44 139.83 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.995 0.426 . . . . 0.0 111.583 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.427 ' N ' HG21 ' A' ' 144' ' ' ILE . 2.2 m-20 -93.2 100.75 13.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.41 HD22 HG23 ' A' ' 144' ' ' ILE . 6.1 mt -64.88 -16.73 63.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.368 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -15.65 62.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.061 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -112.27 2.71 16.69 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.643 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.441 ' HB ' ' CD1' ' A' ' 158' ' ' ILE . 47.7 t -86.91 142.23 13.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.094 0.474 . . . . 0.0 111.073 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -70.91 127.7 33.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.979 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.0 118.57 4.97 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.912 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.498 HG21 ' OD2' ' A' ' 162' ' ' ASP . 0.4 OUTLIER -128.8 22.57 5.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.12 0.485 . . . . 0.0 110.827 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.507 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -113.78 -164.34 15.39 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.936 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -31.15 97.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.827 3.018 . . . . 0.0 114.258 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.14 -17.7 16.6 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.408 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.84 45.22 0.21 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.539 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.1 p -100.4 145.66 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.228 0.537 . . . . 0.0 111.781 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.514 ' N ' HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -72.94 124.85 30.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.155 179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.1 p -108.01 170.35 8.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.61 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.4 t -52.57 -25.7 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -66.21 -43.11 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.498 ' OD2' HG21 ' A' ' 152' ' ' THR . 3.3 m-20 -73.08 -40.06 65.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.565 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.413 HG21 ' CD1' ' A' ' 158' ' ' ILE . 44.8 t -65.01 -53.52 40.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.073 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -61.82 -34.9 76.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.016 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -72.86 -47.29 47.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.792 0.33 . . . . 0.0 111.344 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.484 ' HD2' HG22 ' A' ' 144' ' ' ILE . 14.9 t80 -68.87 -41.13 78.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.309 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.463 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -63.71 -38.64 91.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.323 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -77.13 -36.94 54.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.136 0.493 . . . . 0.0 110.471 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.35 -24.51 59.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.935 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 167' ' ' ALA . 3.0 t -83.35 -39.64 20.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.67 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.379 179.86 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.461 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.31 162.11 32.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.567 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.27 159.13 54.18 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.793 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.61 -52.07 3.48 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.122 1.882 . . . . 0.0 112.313 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.42 -35.72 74.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.087 0.47 . . . . 0.0 110.545 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.419 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -60.8 -51.22 70.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.587 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -57.11 -34.13 68.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.675 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.11 -51.77 65.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.189 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.69 -24.22 67.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.765 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.55 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.75 -35.54 62.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.392 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -76.37 -29.44 57.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.125 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -82.18 -49.03 10.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.134 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.474 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -87.92 -9.12 54.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.758 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.15 34.76 54.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.148 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.55 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 13.1 mm -90.81 150.13 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.132 0.492 . . . . 0.0 111.711 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -107.91 100.98 10.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.473 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.42 ' HG ' HG12 ' A' ' 158' ' ' ILE . 1.4 mp -63.4 -17.65 62.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.422 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -18.74 62.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.917 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -110.43 -3.04 16.29 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.601 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.417 ' CG1' ' CB ' ' A' ' 162' ' ' ASP . 75.1 t -80.36 143.27 12.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.003 0.43 . . . . 0.0 111.07 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -71.25 112.74 7.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.206 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -76.29 123.52 6.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.282 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -127.09 15.97 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 0.0 111.367 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.701 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -115.02 -154.3 10.65 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.423 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.577 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 31.1 Cg_exo -36.01 106.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.426 2.751 . . . . 0.0 114.243 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.31 25.14 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.62 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.31 40.11 1.84 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.701 HG11 ' HA2' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -86.68 142.3 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.086 -0.557 . . . . 0.0 111.241 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -81.14 123.63 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.419 ' O ' HD13 ' A' ' 158' ' ' ILE . 1.2 p -106.66 166.12 10.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.343 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.1 t -50.33 -25.4 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.448 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.66 -45.86 84.96 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.582 ' HB2' HD11 ' A' ' 158' ' ' ILE . 4.9 m-20 -74.97 -33.78 61.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.439 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.578 HG22 HD13 ' A' ' 158' ' ' ILE . 6.1 t -65.12 -54.57 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -61.91 -35.9 79.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.59 -42.56 74.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -71.91 -51.27 23.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.552 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.478 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -56.82 -37.69 71.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.587 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 9.5 pt-20 -76.84 -42.5 39.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.264 0.554 . . . . 0.0 110.336 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.405 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.9 tp10 -70.07 -21.93 63.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.826 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 167' ' ' ALA . 1.4 t -89.34 -41.01 12.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.048 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.87 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.407 ' O ' HG21 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.68 0.276 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.544 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.5 162.11 32.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.408 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -89.06 150.04 44.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.089 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.59 -51.95 9.97 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.198 1.932 . . . . 0.0 112.443 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.42 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -60.2 -37.02 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.03 0.443 . . . . 0.0 110.713 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.417 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -59.62 -48.75 80.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.692 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.404 ' HA ' HD23 ' A' ' 146' ' ' LEU . 74.2 mtm180 -59.57 -34.77 73.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.641 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -50.03 72.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.283 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.2 -25.23 66.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.919 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.559 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.97 -32.34 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.034 0.445 . . . . 0.0 110.413 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -35.11 58.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.873 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -80.35 -47.5 14.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.207 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.479 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.02 -12.13 48.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.705 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.21 31.44 54.99 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.009 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 13.3 mm -88.46 147.85 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.449 . . . . 0.0 111.602 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.36 100.99 10.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.774 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.43 ' HA ' ' CG2' ' A' ' 149' ' ' VAL . 0.9 OUTLIER -63.19 -17.8 62.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.549 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.5 m -63.31 -17.75 62.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.009 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -111.36 -1.09 16.11 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.584 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.43 ' CG2' ' HA ' ' A' ' 146' ' ' LEU . 63.6 t -81.01 148.62 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.004 0.43 . . . . 0.0 110.969 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 111.21 6.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.358 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.09 122.62 9.04 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.074 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -142.46 32.94 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.334 0.588 . . . . 0.0 110.569 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.77 -165.43 12.4 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.819 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -31.04 95.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.831 3.021 . . . . 0.0 114.197 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.56 -18.85 17.12 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.248 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.71 45.19 0.18 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.544 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.3 p -102.35 142.25 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.327 0.584 . . . . 0.0 111.997 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -68.66 124.68 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.868 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.416 ' O ' HD13 ' A' ' 158' ' ' ILE . 20.1 p -106.08 163.65 12.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.207 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.42 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 61.5 t -50.35 -33.28 10.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.467 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -59.16 -41.62 88.81 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.661 ' HB2' HD11 ' A' ' 158' ' ' ILE . 12.2 m-20 -74.97 -35.92 62.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.409 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.562 HG22 HD13 ' A' ' 158' ' ' ILE . 19.2 t -63.08 -54.7 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -37.62 84.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.458 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -65.99 -44.68 84.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.057 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -72.4 -46.89 53.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.731 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.433 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -57.82 -41.28 81.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.605 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.65 -37.23 70.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.288 0.566 . . . . 0.0 110.063 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -76.02 -21.9 56.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.832 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.5 t -94.64 -32.25 13.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.257 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.153 0 CA-C-O 120.784 0.326 . . . . 0.0 111.737 -179.772 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.443 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.445 ' CA ' HG21 ' A' ' 157' ' ' VAL . . . -133.28 162.04 32.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.417 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.54 151.25 55.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.838 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.16 -50.12 14.92 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.069 1.846 . . . . 0.0 112.31 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.412 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -66.18 -32.89 74.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.845 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.461 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -61.35 -52.97 62.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.767 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.435 ' HA ' ' CD1' ' A' ' 146' ' ' LEU . 50.1 mtp180 -56.38 -35.54 67.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.39 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -61.63 -49.51 76.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.176 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -25.52 67.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.504 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.577 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -69.98 -41.93 73.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.021 0.439 . . . . 0.0 110.684 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.5 -29.15 56.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.86 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -82.17 -43.2 18.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.651 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.553 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -101.16 -2.36 31.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.971 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.95 39.03 93.21 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.648 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.577 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 65.5 mt -87.81 141.0 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 111.635 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.0 100.45 13.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 136' ' ' ARG . 5.9 mt -71.4 -18.19 62.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -15.9 63.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -113.24 1.52 15.24 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.712 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.446 HG22 HD13 ' A' ' 158' ' ' ILE . 58.2 t -82.72 144.59 9.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.993 0.425 . . . . 0.0 110.799 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -70.88 117.73 12.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.625 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.81 114.79 3.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.755 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.471 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -117.33 20.32 13.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.673 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -129.1 -153.86 8.07 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.754 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.53 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 21.2 Cg_exo -32.66 106.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.783 2.989 . . . . 0.0 114.617 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.5 10.58 8.09 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.876 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.49 41.73 1.57 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.673 HG11 ' HA2' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -86.33 145.01 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.033 -0.583 . . . . 0.0 111.157 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.446 HD13 HG22 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -83.73 136.05 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 36.1 p -112.16 166.9 10.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.318 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.412 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 24.3 t -55.18 -29.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.1 -40.12 94.12 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.81 -39.12 61.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.389 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.461 HG22 ' CB ' ' A' ' 135' ' ' ALA . 60.1 t -65.26 -54.66 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.316 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -59.26 -42.5 91.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.837 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -67.65 -43.31 80.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.237 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.487 ' CD2' HG22 ' A' ' 144' ' ' ILE . 9.8 t80 -67.1 -54.41 21.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.491 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.438 ' HB3' ' CD1' ' A' ' 144' ' ' ILE . . . -53.01 -41.99 65.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.618 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.56 -33.03 72.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.97 -24.98 47.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.869 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.2 t -93.15 -37.99 11.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.752 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.313 179.833 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.728 0.299 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.529 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.54 162.14 32.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.169 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.0 mtp -86.48 148.63 47.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.091 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.35 -52.04 9.9 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.357 2.038 . . . . 0.0 112.375 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.418 ' CB ' HG23 ' A' ' 160' ' ' VAL . . . -63.09 -34.72 78.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.912 0.386 . . . . 0.0 110.711 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.413 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -60.0 -50.57 73.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.776 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -58.48 -34.5 70.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.608 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -62.47 -50.0 73.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.284 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.01 -25.07 66.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.905 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.561 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.9 -32.6 61.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.005 0.431 . . . . 0.0 110.38 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 -34.97 59.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.394 0.616 . . . . 0.0 109.944 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.07 -47.58 14.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.196 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.487 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.08 -11.81 49.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.713 -179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.54 31.84 55.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.885 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.561 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 11.0 mm -87.83 148.7 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.542 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -106.19 100.96 10.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.697 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.425 ' HG ' HG12 ' A' ' 158' ' ' ILE . 1.8 mp -63.65 -20.0 65.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.495 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -19.96 63.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.965 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -107.19 -6.21 17.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.514 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.441 ' CG1' ' CB ' ' A' ' 162' ' ' ASP . 58.0 t -77.47 146.92 7.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.054 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 111.77 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.362 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.78 122.48 8.34 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.051 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.455 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -138.85 32.69 2.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.291 0.567 . . . . 0.0 110.673 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.524 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -124.13 -164.79 12.06 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.865 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -31.69 97.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.781 2.988 . . . . 0.0 114.192 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.36 -18.1 15.79 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.344 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.75 44.43 0.2 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.529 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.4 p -100.32 142.4 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 111.99 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -71.43 124.81 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.306 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.451 ' O ' HD13 ' A' ' 158' ' ' ILE . 1.3 p -107.05 165.14 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.162 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.418 HG23 ' CB ' ' A' ' 134' ' ' ALA . 21.9 t -50.14 -25.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.676 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.39 -45.68 86.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.565 ' HB2' HD11 ' A' ' 158' ' ' ILE . 5.7 m-20 -74.86 -33.07 62.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.484 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.564 HG22 HD13 ' A' ' 158' ' ' ILE . 7.0 t -66.02 -54.6 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -61.6 -36.24 80.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.588 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -70.86 -42.11 70.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.28 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -71.62 -49.89 35.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.651 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.465 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -56.94 -39.76 75.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.496 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.61 -35.32 67.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 110.217 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -77.93 -24.49 48.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.955 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.8 t -89.75 -33.99 16.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.775 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.218 179.874 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.743 0.306 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.522 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.51 162.15 32.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.184 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.402 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -86.27 149.18 49.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.055 179.037 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.9 -52.07 9.84 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.366 2.044 . . . . 0.0 112.516 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.422 ' CB ' HG23 ' A' ' 160' ' ' VAL . . . -64.04 -35.13 79.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.957 0.408 . . . . 0.0 110.817 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.403 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -59.78 -52.82 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.995 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.415 ' HA ' ' CD1' ' A' ' 146' ' ' LEU . 4.5 mtt-85 -56.17 -34.98 66.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -61.79 -51.34 68.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.047 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.05 -24.19 67.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.77 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.547 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.81 -33.68 62.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.416 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.26 -34.16 59.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.962 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -80.59 -47.57 13.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.225 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.51 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.71 -10.91 49.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.822 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.17 36.17 56.5 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.929 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.547 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 11.5 mm -90.69 142.12 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.933 0.397 . . . . 0.0 111.659 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.45 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -93.87 100.78 12.89 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.415 ' CD1' ' HA ' ' A' ' 136' ' ' ARG . 3.9 mt -63.05 -22.13 66.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.349 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.2 p -66.75 -14.96 63.2 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -111.2 5.65 20.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.667 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' A' ' 158' ' ' ILE . 87.9 t -90.34 148.1 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.031 0.444 . . . . 0.0 110.97 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -70.87 108.56 4.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.457 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.06 123.5 10.64 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.974 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -141.7 34.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.309 0.576 . . . . 0.0 110.746 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.518 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -125.34 -164.64 11.9 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.955 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -31.69 96.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.809 3.006 . . . . 0.0 114.264 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.88 -17.07 17.71 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.389 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.26 43.97 0.22 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.522 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.5 p -100.8 143.08 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.208 0.528 . . . . 0.0 111.84 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.486 ' N ' HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -70.42 127.28 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.141 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.3 p -106.43 167.05 10.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.422 HG23 ' CB ' ' A' ' 134' ' ' ALA . 44.8 t -52.84 -26.87 11.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.125 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -64.77 -44.03 91.35 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.408 ' CB ' ' CG1' ' A' ' 149' ' ' VAL . 13.9 m-20 -71.62 -37.35 70.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.653 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.432 HG21 ' CD1' ' A' ' 158' ' ' ILE . 55.2 t -66.87 -54.56 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.406 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -60.87 -33.75 73.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.565 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -43.73 56.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.336 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -70.81 -46.75 62.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.465 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.483 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -62.02 -35.58 78.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.629 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.09 -36.29 55.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.088 0.47 . . . . 0.0 110.773 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.25 -21.91 55.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.025 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 167' ' ' ALA . 2.5 t -87.23 -40.52 14.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 110.797 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.168 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.459 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.56 0.219 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.421 ' HA ' HG22 ' A' ' 158' ' ' ILE . . . -133.24 162.1 32.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.949 0.404 . . . . 0.0 111.735 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.0 mtp -84.47 152.06 60.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.651 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.34 -41.9 49.59 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.119 1.88 . . . . 0.0 112.441 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.422 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -74.88 -30.37 61.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.89 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.95 -50.94 71.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.616 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.604 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 56.2 mtm180 -57.03 -34.28 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.304 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.22 -49.01 75.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.264 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -24.31 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.299 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.12 -36.28 64.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.64 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -76.5 -30.18 57.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.278 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -82.3 -48.99 10.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.33 -7.39 48.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.063 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.32 38.97 58.26 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.087 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 12.0 mm -92.22 142.47 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.095 0.474 . . . . 0.0 111.793 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.437 ' N ' HG21 ' A' ' 144' ' ' ILE . 1.5 t70 -98.38 100.73 12.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.604 ' CD2' ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -57.88 -25.1 60.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.342 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -14.7 62.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.177 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -112.5 4.93 17.71 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.478 HG21 ' CD2' ' A' ' 166' ' ' TYR . 93.6 t -92.69 150.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.875 0.369 . . . . 0.0 111.021 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -70.89 105.92 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.396 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -73.04 116.84 5.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.841 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.477 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -126.58 31.48 5.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.087 0.47 . . . . 0.0 111.089 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.757 ' HA2' HG13 ' A' ' 157' ' ' VAL . . . -132.14 -156.87 8.44 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.363 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.572 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 39.0 Cg_exo -38.18 109.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.235 2.623 . . . . 0.0 114.142 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.66 5.66 25.24 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.592 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.59 39.08 2.11 Favored Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.757 HG13 ' HA2' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -84.63 143.78 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.999 -0.601 . . . . 0.0 111.469 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.502 HD12 ' HG ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -81.16 136.31 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.5 p -112.12 165.55 12.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.87 0.367 . . . . 0.0 111.04 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.422 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 39.3 t -52.45 -31.1 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.022 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.02 -39.45 93.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -74.88 -40.14 61.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.542 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 158' ' ' ILE . 26.9 t -64.65 -54.75 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.021 0.438 . . . . 0.0 110.263 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -41.51 97.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.414 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 161' ' ' GLU . 73.3 mtt-85 -62.65 -47.65 82.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.317 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.478 ' CD2' HG21 ' A' ' 149' ' ' VAL . 0.6 OUTLIER -62.87 -54.65 35.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.021 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.421 ' HA ' HD13 ' A' ' 144' ' ' ILE . . . -59.65 -41.85 91.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.841 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -72.91 -31.74 64.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 110.655 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 1.2 tm-20 -77.95 -21.98 50.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.303 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.07 -27.95 13.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.881 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.921 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.403 ' CB ' ' HB ' ' A' ' 157' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.047 0 CA-C-O 120.821 0.343 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.4 162.06 32.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.84 147.28 37.11 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.151 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.78 -51.99 9.75 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.282 1.988 . . . . 0.0 112.371 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.422 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -63.13 -33.69 75.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 110.629 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.405 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -62.06 -52.9 62.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.673 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -54.65 -38.24 66.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 110.501 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -60.72 -49.66 76.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.129 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 1.1 mp -64.15 -24.18 67.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.57 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.554 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.83 -36.16 62.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.943 0.401 . . . . 0.0 110.493 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -76.34 -33.04 58.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.315 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -82.01 -44.74 16.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.092 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.516 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -85.0 -13.3 51.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.294 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.09 39.12 54.31 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.257 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.554 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 25.5 mm -100.81 146.36 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.412 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.4 OUTLIER -99.88 100.79 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.436 HD22 HG23 ' A' ' 144' ' ' ILE . 4.3 mt -61.4 -21.54 64.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.621 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -61.97 -17.67 57.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.001 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -107.66 -8.56 16.08 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.677 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 158' ' ' ILE . 59.0 t -76.28 146.21 9.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.052 0.454 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -71.46 118.74 14.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.444 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.24 119.28 5.14 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.822 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -135.71 34.27 2.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.343 0.592 . . . . 0.0 110.747 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.522 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -127.24 -164.75 11.75 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.989 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -31.66 97.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.911 3.074 . . . . 0.0 114.233 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.52 -17.04 15.7 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.425 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.78 44.32 0.22 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.5 p -100.8 144.31 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.12 0.485 . . . . 0.0 111.77 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.507 ' N ' HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -71.78 127.73 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.346 179.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 p -104.3 164.22 11.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.322 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.422 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 83.3 t -51.33 -27.63 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.804 0.335 . . . . 0.0 110.999 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -63.05 -42.83 99.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.002 0.429 . . . . 0.0 109.865 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.402 ' CB ' ' CG1' ' A' ' 149' ' ' VAL . 14.3 m-20 -72.69 -36.64 67.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.868 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.425 HG23 ' CD1' ' A' ' 158' ' ' ILE . 79.1 t -66.67 -54.63 23.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.906 0.384 . . . . 0.0 110.143 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -61.0 -36.02 78.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.785 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -71.9 -46.02 59.2 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.542 ' HD2' HG22 ' A' ' 144' ' ' ILE . 18.7 t80 -66.42 -51.1 60.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.52 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.504 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -56.73 -42.48 79.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.517 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.8 -36.34 70.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.345 0.593 . . . . 0.0 110.24 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -75.63 -21.95 57.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.79 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.449 HG21 ' N ' ' A' ' 171' ' ' ALA . 1.3 t -93.92 -34.76 12.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.115 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.449 ' N ' HG21 ' A' ' 170' ' ' THR . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.886 0.374 . . . . 0.0 111.506 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.511 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.42 162.0 33.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.032 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 36.1 mmm -87.35 152.98 53.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.103 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.12 -52.03 6.59 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.283 1.988 . . . . 0.0 112.026 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.422 ' CB ' HG23 ' A' ' 160' ' ' VAL . . . -61.86 -30.06 70.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.66 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.94 -52.8 58.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HA ' ' CD1' ' A' ' 146' ' ' LEU . 80.6 mtt180 -55.99 -36.16 67.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -62.39 -50.06 73.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.208 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -23.79 67.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.751 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.586 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.46 -38.43 62.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.881 0.372 . . . . 0.0 110.539 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -76.31 -29.41 57.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.292 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -82.37 -45.04 15.38 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.55 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.447 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -97.29 -2.8 41.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.118 -178.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.28 38.91 91.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.712 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.586 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 64.9 mt -87.62 142.71 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.401 . . . . 0.0 111.444 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -94.17 100.46 12.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.44 ' CD1' ' HA ' ' A' ' 136' ' ' ARG . 5.7 mt -72.07 -21.91 61.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.254 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.94 -15.89 62.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -111.72 0.25 16.22 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.464 ' HB ' ' CD1' ' A' ' 158' ' ' ILE . 57.2 t -81.98 148.82 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.139 0.495 . . . . 0.0 111.185 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.5 OUTLIER -77.27 124.53 27.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.199 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.57 121.69 5.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.175 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -137.49 34.22 2.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -124.19 -164.71 12.03 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.709 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -30.92 95.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.798 2.999 . . . . 0.0 114.301 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.84 -17.62 20.44 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.453 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.77 45.04 0.19 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.511 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.4 p -102.13 144.21 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.162 0.506 . . . . 0.0 111.822 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.492 ' N ' HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -71.89 126.72 32.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.021 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.6 p -109.37 167.85 9.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.409 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.422 HG23 ' CB ' ' A' ' 134' ' ' ALA . 21.9 t -52.42 -26.37 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.753 0.311 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 4.1 mt-10 -65.43 -43.2 91.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.85 -43.68 57.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.827 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' A' ' 158' ' ' ILE . 20.0 t -57.22 -54.24 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.054 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.511 ' HA ' ' CE ' ' A' ' 164' ' ' LYS . 0.2 OUTLIER -65.29 -46.84 78.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 12.6 mtp180 -52.96 -41.71 64.81 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.053 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.454 ' CE2' HG22 ' A' ' 144' ' ' ILE . 12.3 t80 -73.7 -46.66 44.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.267 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.441 ' CB ' ' CD1' ' A' ' 144' ' ' ILE . . . -59.88 -49.1 79.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.458 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.91 -34.08 76.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.32 0.581 . . . . 0.0 109.981 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.7 OUTLIER -78.13 -30.13 49.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.674 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 167' ' ' ALA . 0.6 OUTLIER -82.12 -37.06 26.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.632 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.4 179.861 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.705 0.288 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.563 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.45 161.03 35.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.8 mtp -81.5 153.01 70.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.78 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.21 -41.45 75.87 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.203 1.935 . . . . 0.0 111.985 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.445 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -75.1 -27.39 59.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.652 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -65.21 -50.85 64.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.679 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.585 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 3.3 mtt-85 -55.94 -42.68 76.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.124 0.487 . . . . 0.0 110.261 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -57.94 -47.46 82.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.799 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -65.37 -22.96 66.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.148 178.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.577 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -73.29 -37.88 66.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.536 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -76.38 -30.69 57.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.313 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.32 -44.65 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.565 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.543 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -95.6 -3.95 45.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.743 -179.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.46 37.66 92.86 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.478 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.577 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 45.1 mt -89.41 138.52 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.45 ' N ' HG21 ' A' ' 144' ' ' ILE . 1.4 m-20 -96.39 100.55 12.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.619 ' HG ' HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -61.63 -23.0 65.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.539 -178.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 t -66.65 -12.19 57.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.305 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -115.6 4.44 14.15 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.43 ' CG1' HD13 ' A' ' 158' ' ' ILE . 67.3 t -89.2 152.02 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.778 0.323 . . . . 0.0 110.921 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.81 106.48 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.349 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.95 120.41 9.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.914 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.439 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -137.82 32.2 2.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 110.796 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.541 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -126.98 -166.38 12.14 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.129 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -32.26 99.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.86 3.04 . . . . 0.0 114.307 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.26 -17.16 10.48 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.435 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.46 43.19 0.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.563 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.5 p -98.51 143.88 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.129 0.49 . . . . 0.0 111.523 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.619 HD12 ' HG ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -72.31 127.61 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.69 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.4 p -100.67 165.83 11.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.207 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.445 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 67.9 t -54.96 -30.53 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.701 0.286 . . . . 0.0 111.142 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -61.77 -39.77 92.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.009 0.433 . . . . 0.0 109.85 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.85 -37.61 62.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.416 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.509 HG21 ' CD1' ' A' ' 158' ' ' ILE . 42.1 t -64.12 -54.84 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.591 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -61.64 -42.44 98.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.618 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -64.57 -45.2 88.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 111.054 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.449 ' CD2' HG22 ' A' ' 144' ' ' ILE . 3.7 t80 -67.21 -49.46 64.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.46 ' HB3' ' CD1' ' A' ' 144' ' ' ILE . . . -63.38 -34.5 77.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.958 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.28 -38.03 63.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.0 110.562 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.72 -21.91 57.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.984 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 167' ' ' ALA . 1.6 t -91.93 -36.7 13.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.247 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 0.0 111.591 -179.835 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.454 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.762 0.315 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.458 ' CA ' HG21 ' A' ' 157' ' ' VAL . . . -133.23 162.03 32.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.639 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -88.24 157.65 50.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.718 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.64 -52.02 7.03 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.157 1.904 . . . . 0.0 112.224 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.417 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.05 -32.71 74.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.943 0.402 . . . . 0.0 110.601 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.42 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -63.45 -52.83 59.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HA ' ' CD1' ' A' ' 146' ' ' LEU . 1.1 mtm105 -56.44 -34.41 66.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.135 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -62.25 -50.99 69.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.964 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.96 -24.03 67.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.382 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.589 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -71.33 -40.76 70.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 110.617 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -76.32 -29.2 57.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.701 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -82.2 -44.17 16.72 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.576 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.549 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -99.61 -2.22 36.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.061 -178.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.53 39.13 93.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.588 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.589 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 67.2 mt -87.63 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.971 0.415 . . . . 0.0 111.712 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.408 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.7 OUTLIER -93.26 100.48 12.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.429 ' CD1' ' HA ' ' A' ' 136' ' ' ARG . 5.6 mt -70.52 -18.83 62.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.278 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.57 -15.0 62.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.994 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -114.58 3.17 14.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.708 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.466 HG22 HD13 ' A' ' 158' ' ' ILE . 84.3 t -83.96 144.45 9.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.947 0.403 . . . . 0.0 110.809 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 111.45 6.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.413 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.44 120.22 5.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.979 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.459 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -122.83 18.96 10.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 0.0 111.235 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.7 ' HA2' HG13 ' A' ' 157' ' ' VAL . . . -123.86 -154.21 8.87 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.587 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 26.6 Cg_exo -34.73 109.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.553 2.835 . . . . 0.0 114.467 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.27 8.53 6.71 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.518 -0.764 . . . . 0.0 113.806 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.95 41.37 1.7 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.7 HG13 ' HA2' ' A' ' 153' ' ' GLY . 0.5 OUTLIER -85.54 145.03 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.054 -0.573 . . . . 0.0 111.433 -178.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.466 HD13 HG22 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -83.87 132.47 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.3 p -112.07 166.82 10.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.932 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.417 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 19.2 t -53.27 -27.74 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.293 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 4.4 pt-20 -64.12 -42.97 96.64 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -75.09 -38.12 61.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 158' ' ' ILE . 58.3 t -62.59 -54.54 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.907 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -60.73 -41.38 95.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.022 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -68.79 -37.52 79.33 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.689 0.28 . . . . 0.0 111.491 -179.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.489 ' CE2' HG22 ' A' ' 144' ' ' ILE . 7.2 t80 -74.01 -54.1 8.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.438 ' CB ' ' CD1' ' A' ' 144' ' ' ILE . . . -52.7 -41.08 63.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.551 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 10.4 pt-20 -71.12 -39.39 72.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.153 0.502 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.424 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 6.9 tt0 -70.1 -21.96 63.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.501 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.8 -34.27 10.94 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.114 -179.883 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.719 0.295 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.38 162.05 32.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.2 mtp -82.61 146.33 53.02 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.87 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.45 -39.21 22.02 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.19 1.926 . . . . 0.0 112.349 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.456 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -77.71 -28.18 50.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.504 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -64.01 -50.89 66.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.66 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.557 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 73.6 mtt180 -58.3 -35.51 71.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.334 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -62.25 -50.39 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.124 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -23.05 66.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.561 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.572 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -73.21 -38.62 66.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.646 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -32.24 58.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.482 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -82.11 -42.71 18.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.616 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.529 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -99.47 -2.9 34.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.962 -178.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.82 39.21 95.01 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.197 -1.002 . . . . 0.0 111.618 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.572 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 68.6 mt -87.55 143.34 11.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.031 0.443 . . . . 0.0 111.811 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.44 ' N ' HG21 ' A' ' 144' ' ' ILE . 2.5 t0 -95.38 100.61 12.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.696 ' HG ' HD12 ' A' ' 158' ' ' ILE . 0.4 OUTLIER -68.46 -24.1 64.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.088 -178.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -65.44 -14.77 61.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.038 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -110.92 -2.2 16.12 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.761 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 62.1 t -82.49 148.48 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.966 0.412 . . . . 0.0 111.109 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.99 110.3 5.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.487 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.63 120.4 7.49 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.907 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.461 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -135.7 32.94 2.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.344 0.593 . . . . 0.0 110.726 -179.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.523 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -127.73 -165.73 11.92 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.189 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -32.22 99.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.82 3.014 . . . . 0.0 114.33 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.73 -16.64 10.64 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.46 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.09 43.01 0.26 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.6 p -98.47 144.46 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.314 -0.443 . . . . 0.0 111.536 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.696 HD12 ' HG ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -73.75 128.33 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 110.924 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 p -101.02 168.6 9.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.144 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.456 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 46.5 t -56.21 -30.22 29.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.712 0.291 . . . . 0.0 110.991 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.75 -39.04 90.18 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.465 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 12.1 m-20 -75.05 -38.32 61.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.615 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.504 HG22 ' CB ' ' A' ' 135' ' ' ALA . 52.5 t -64.47 -54.74 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.097 0.475 . . . . 0.0 110.313 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -60.51 -41.36 94.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.792 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -68.23 -40.15 82.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.425 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.5 ' CE2' HG22 ' A' ' 144' ' ' ILE . 6.8 t80 -72.29 -52.67 15.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.921 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.44 ' HB1' HG12 ' A' ' 144' ' ' ILE . . . -55.66 -39.73 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.381 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 8.8 pt-20 -72.21 -38.15 69.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.35 0.595 . . . . 0.0 110.04 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 1.7 tp10 -73.13 -21.97 60.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.733 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 t -96.58 -41.06 8.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.903 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.428 179.966 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.697 0.284 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.527 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.47 162.01 33.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.233 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.404 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 5.7 mmm -85.05 152.48 58.85 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.988 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.29 -52.06 9.14 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.324 2.016 . . . . 0.0 112.092 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 137' ' ' ARG . . . -62.07 -39.81 93.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 110.531 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -54.18 -46.05 72.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.695 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -62.22 -33.93 75.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.573 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.616 ' HG3' HD11 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -59.5 -54.35 47.61 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 110.195 179.629 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.616 HD11 ' HG3' ' A' ' 137' ' ' ARG . 4.7 mp -68.06 -24.2 65.05 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.547 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.583 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.64 -39.09 62.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.034 0.445 . . . . 0.0 109.947 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -76.44 -30.26 57.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.378 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -82.35 -49.25 10.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.094 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.443 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -85.08 -12.91 51.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.472 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.51 29.5 48.65 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.178 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 14.5 mm -87.73 147.91 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 111.476 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.96 100.93 10.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.678 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 139' ' ' ALA . 2.0 mp -63.59 -20.08 65.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.255 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 m -63.02 -19.79 64.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.85 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -107.08 -3.91 19.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.495 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.444 ' CG1' ' CB ' ' A' ' 162' ' ' ASP . 58.3 t -79.92 147.47 6.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.081 0.467 . . . . 0.0 111.025 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 110.75 5.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.261 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.64 123.64 10.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.194 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.436 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -142.73 33.8 1.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.357 0.599 . . . . 0.0 110.649 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.57 -165.17 12.36 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.777 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -31.46 96.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.73 2.953 . . . . 0.0 114.157 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.26 -18.51 17.44 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.309 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.07 46.52 0.17 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.2 p -104.54 142.29 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 112.082 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -69.15 123.35 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.036 179.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.444 ' O ' HD13 ' A' ' 158' ' ' ILE . 1.3 p -106.74 165.95 10.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.163 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.418 HG23 ' CB ' ' A' ' 134' ' ' ALA . 21.6 t -50.21 -25.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.603 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.5 -45.57 86.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.583 ' HB2' HD11 ' A' ' 158' ' ' ILE . 8.1 m-20 -74.91 -33.3 61.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.493 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.569 HG22 HD13 ' A' ' 158' ' ' ILE . 9.8 t -66.02 -54.59 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -61.72 -35.69 78.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.514 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -43.31 68.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.324 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -72.29 -46.51 55.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.818 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.47 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -59.74 -39.77 85.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.602 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -73.25 -36.97 66.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.13 0.491 . . . . 0.0 110.307 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -21.9 50.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.989 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.7 t -91.34 -35.08 14.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.095 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.294 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.468 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.72 0.295 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 158' ' ' ILE . . . -133.32 162.13 32.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.962 0.41 . . . . 0.0 111.658 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.39 149.08 41.97 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.927 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.42 -51.99 9.24 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.27 1.98 . . . . 0.0 112.704 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.93 81.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 111.012 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.4 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -61.1 -52.92 62.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.124 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HA ' ' CD1' ' A' ' 146' ' ' LEU . 1.3 mtt180 -55.6 -37.43 68.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.76 -52.33 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.57 -23.15 67.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.86 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.548 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.71 -36.92 62.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.96 0.41 . . . . 0.0 110.434 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -76.38 -29.39 57.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.125 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.2 -48.56 11.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.2 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.479 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -88.97 -8.96 53.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.825 -179.273 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.4 35.78 55.83 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.102 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 14.0 mm -90.17 140.68 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.972 0.415 . . . . 0.0 111.522 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.44 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -93.23 100.78 13.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 136' ' ' ARG . 4.9 mt -64.51 -19.64 65.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.334 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.2 p -66.12 -15.36 63.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.196 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -113.45 6.82 17.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.651 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.425 HG23 HD13 ' A' ' 158' ' ' ILE . 87.5 t -90.69 144.13 9.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.888 0.375 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -70.98 113.52 8.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.347 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -77.56 120.55 5.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.921 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.49 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -123.53 24.89 8.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.026 0.441 . . . . 0.0 111.325 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.702 ' HA2' HG13 ' A' ' 157' ' ' VAL . . . -129.7 -154.92 8.27 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.592 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.563 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 30.6 Cg_exo -35.53 108.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.436 2.758 . . . . 0.0 114.445 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.98 8.0 14.89 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.616 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.84 40.71 1.81 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.702 HG13 ' HA2' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -85.74 142.4 13.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.99 -0.605 . . . . 0.0 111.401 -178.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' A' ' 131' ' ' ALA . 0.1 OUTLIER -82.55 131.01 34.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 p -110.66 170.98 7.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.217 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.2 t -54.92 -23.89 13.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.088 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.44 -41.49 76.2 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.406 ' CB ' ' CG1' ' A' ' 149' ' ' VAL . 0.7 OUTLIER -73.64 -38.72 64.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.306 179.227 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.429 HG21 ' CD1' ' A' ' 158' ' ' ILE . 48.5 t -68.53 -51.96 41.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.259 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -62.09 -34.11 75.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.439 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -75.43 -42.17 54.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.367 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.425 ' HD2' HG22 ' A' ' 144' ' ' ILE . 10.8 t80 -71.95 -48.37 45.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.069 0.462 . . . . 0.0 110.436 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.429 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -59.57 -38.83 82.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.325 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.77 -38.77 62.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.296 0.569 . . . . 0.0 110.367 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -73.04 -22.01 60.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.77 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 167' ' ' ALA . 1.3 t -92.12 -41.06 10.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.948 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.473 -179.9 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.3 p -80.79 90.29 5.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 110.981 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -105.38 -168.54 1.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -99.36 164.37 12.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.034 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 130' ' ' ALA . 1.7 p 44.94 -168.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.468 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.468 ' N ' HG11 ' A' ' 129' ' ' VAL . . . -123.18 143.06 50.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.73 162.09 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.337 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.402 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 7.4 mtp -86.97 150.16 49.39 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.962 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -50.57 -52.02 9.88 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.168 1.912 . . . . 0.0 112.504 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.417 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -63.98 -34.96 79.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 110.61 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.404 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -60.65 -52.9 63.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.79 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -56.0 -33.76 65.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.623 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -53.1 56.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.53 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.84 -25.4 68.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.783 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.542 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -73.88 -36.89 64.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.984 0.421 . . . . 0.0 110.352 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -76.34 -29.36 57.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.301 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -82.04 -49.04 10.67 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.148 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.511 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.59 -10.21 52.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.71 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 33.23 55.46 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.956 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 17.3 mm -87.81 142.88 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.93 0.395 . . . . 0.0 111.522 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.445 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -94.84 100.79 12.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.433 HD22 HG23 ' A' ' 144' ' ' ILE . 5.1 mt -65.12 -18.67 65.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.286 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -17.27 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.86 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -110.86 5.66 20.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.602 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.485 HG22 HD13 ' A' ' 158' ' ' ILE . 61.5 t -87.72 148.27 4.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.087 0.47 . . . . 0.0 111.198 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.95 109.92 5.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.349 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.82 122.2 8.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.919 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.45 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -139.32 33.68 2.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.349 0.595 . . . . 0.0 110.661 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.51 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -126.96 -165.53 11.95 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.1 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -31.93 98.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.821 3.014 . . . . 0.0 114.285 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.2 -16.89 11.08 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.443 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.58 43.45 0.24 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.5 p -99.68 144.2 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.135 0.493 . . . . 0.0 111.729 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.502 ' N ' HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -71.6 127.78 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.369 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 31.0 p -102.86 167.94 9.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.797 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 99.0 t -54.77 -31.61 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 110.873 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.22 -39.39 94.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.432 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 4.8 m-20 -69.89 -44.25 70.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.397 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.45 HG23 ' CD1' ' A' ' 158' ' ' ILE . 83.4 t -63.41 -54.64 30.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.292 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -57.65 -34.41 69.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.731 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -72.7 -49.54 30.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.438 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.462 ' HD2' HG22 ' A' ' 144' ' ' ILE . 14.9 t80 -65.99 -47.97 72.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.798 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.453 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -56.59 -42.01 77.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.403 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.444 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 6.9 pt-20 -72.13 -33.08 67.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.048 0.452 . . . . 0.0 110.454 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 23.0 tt0 -77.99 -24.07 48.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.5 t -89.35 -38.24 14.29 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.648 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -168.02 93.03 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 9.9 ttpt -109.78 -41.32 4.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.755 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -156.66 75.59 0.85 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.008 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.11 48.13 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.976 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.417 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . . . -177.02 -62.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.122 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 175' ' ' ALA . 57.2 Cg_endo -71.09 108.96 2.44 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.552 2.168 . . . . 0.0 112.323 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 178' ' ' PRO . . . -88.23 -52.97 0.38 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 177' ' ' ALA . 50.7 Cg_exo -53.32 115.74 2.49 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.474 2.116 . . . . 0.0 112.24 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -135.73 87.91 24.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.173 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.42 170.49 16.05 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.513 2.142 . . . . 0.0 112.25 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.1 -64.81 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -72.58 139.07 47.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.062 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.42 95.41 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -128.28 -57.28 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -72.64 157.17 38.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.076 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.2 p -76.21 -14.9 60.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.525 0.202 . . . . 0.0 111.289 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.98 42.78 6.64 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.504 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -82.37 147.22 28.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.2 t -151.52 159.6 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.169 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.91 120.43 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.909 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.525 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.52 161.99 33.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 35.9 mmm -84.53 155.42 62.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.922 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.92 -52.07 5.78 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.246 1.964 . . . . 0.0 112.247 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.438 ' CB ' HG23 ' A' ' 160' ' ' VAL . . . -62.95 -32.54 73.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.986 0.422 . . . . 0.0 110.624 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -61.13 -49.86 75.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.72 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.1 mtt85 -58.44 -33.4 69.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.511 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -63.6 -52.7 59.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.226 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.48 -24.2 67.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.816 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.557 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.73 -35.74 62.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.92 0.391 . . . . 0.0 110.378 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -76.39 -29.38 57.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.186 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -82.37 -48.94 10.55 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.161 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.486 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.97 -9.95 51.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.746 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.52 32.41 54.77 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.047 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.557 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 15.1 mm -88.35 148.61 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.132 0.491 . . . . 0.0 111.712 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -106.99 100.89 10.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.486 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.414 ' HA ' ' CG2' ' A' ' 149' ' ' VAL . 1.7 mp -62.56 -19.53 63.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.336 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.7 m -62.19 -21.05 64.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.924 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -106.32 -4.76 19.69 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.55 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 162' ' ' ASP . 58.0 t -79.01 147.36 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -70.98 113.0 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.203 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.93 122.68 7.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.126 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.45 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -139.77 33.25 2.0 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.317 0.579 . . . . 0.0 110.661 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.512 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -123.45 -165.29 12.27 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.801 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -31.09 95.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.776 2.984 . . . . 0.0 114.197 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.76 -20.41 12.17 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.188 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 131.04 44.73 0.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.3 p -100.62 142.97 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.252 0.548 . . . . 0.0 111.956 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.579 HD13 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.26 124.61 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.03 179.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 158' ' ' ILE . 1.4 p -107.34 165.7 11.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.231 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.438 HG23 ' CB ' ' A' ' 134' ' ' ALA . 30.0 t -50.16 -26.02 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.593 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -45.58 88.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.578 ' HB2' HD11 ' A' ' 158' ' ' ILE . 6.6 m-20 -74.83 -33.64 62.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.494 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.579 HG22 HD13 ' A' ' 158' ' ' ILE . 8.7 t -65.1 -54.53 28.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.6 tptp -61.31 -37.31 82.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.546 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.36 -42.96 74.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.307 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -71.45 -50.52 30.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.642 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.484 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -55.89 -39.41 71.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.254 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 22.6 pt-20 -75.63 -45.72 35.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.155 0.502 . . . . 0.0 109.866 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.2 tp10 -64.4 -21.93 66.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.487 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.443 HG21 ' N ' ' A' ' 171' ' ' ALA . 1.1 t -93.71 -33.16 13.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.443 ' N ' HG21 ' A' ' 170' ' ' THR . . . -177.81 96.21 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.634 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -115.49 -177.62 3.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.545 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.62 102.78 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.006 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.19 -39.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.997 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 73.52 149.55 0.13 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.44 160.08 50.67 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.55 2.167 . . . . 0.0 112.4 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 61.46 74.33 0.51 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.078 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.63 -170.35 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.584 2.189 . . . . 0.0 112.224 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -169.97 85.84 0.57 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.21 -35.78 8.12 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.523 2.149 . . . . 0.0 112.297 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.05 152.88 0.94 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.804 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -138.13 131.66 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.17 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.45 -60.89 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.29 158.54 43.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 33.4 2.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.07 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -77.85 152.01 33.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.36 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -60.63 149.41 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.957 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.4 t 57.31 162.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.258 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -125.32 131.18 53.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.54 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.47 162.02 33.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 10.4 mtp -80.75 146.91 61.24 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.808 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.22 -40.11 21.49 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.249 1.966 . . . . 0.0 112.324 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.452 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -77.85 -27.87 49.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.478 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -63.37 -52.56 61.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.617 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.542 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 18.6 mtp-105 -56.25 -35.01 66.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.463 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -62.76 -51.56 66.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.25 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -23.2 67.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.582 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -72.03 -41.47 67.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.581 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -76.52 -29.03 56.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.569 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.27 -43.62 17.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.652 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.511 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -100.65 -2.28 33.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.178 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.08 39.18 92.83 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.643 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 66.8 mt -87.54 141.8 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.054 0.454 . . . . 0.0 111.8 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.434 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -94.28 100.58 12.61 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.729 ' HG ' HD12 ' A' ' 158' ' ' ILE . 0.4 OUTLIER -68.29 -22.6 64.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.217 -178.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.5 m -65.19 -13.96 59.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.193 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -114.29 0.02 14.02 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.48 ' CG1' HD13 ' A' ' 158' ' ' ILE . 60.2 t -81.6 149.98 4.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.801 0.334 . . . . 0.0 110.959 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -70.96 108.79 4.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.314 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.67 119.99 7.93 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.808 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.444 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -136.88 34.48 2.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.231 0.538 . . . . 0.0 110.895 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.528 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -130.29 -166.25 11.76 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.3 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -32.53 100.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.864 3.043 . . . . 0.0 114.315 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.2 -16.38 9.5 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.474 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 126.75 42.25 0.29 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.54 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.7 p -97.65 144.4 11.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.197 -0.502 . . . . 0.0 111.35 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.729 HD12 ' HG ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -74.0 129.29 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.791 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.0 p -100.86 168.0 9.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.174 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.452 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 50.4 t -55.64 -31.7 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.337 . . . . 0.0 111.139 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -38.88 84.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.119 0.485 . . . . 0.0 109.909 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.443 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 10.0 m-20 -74.94 -38.67 61.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.725 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 158' ' ' ILE . 45.6 t -64.67 -54.71 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.042 0.449 . . . . 0.0 110.362 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -60.4 -40.7 91.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.794 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -69.04 -40.3 78.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.454 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.505 ' CD2' HG22 ' A' ' 144' ' ' ILE . 6.5 t80 -72.13 -52.15 18.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' HB1' HG12 ' A' ' 144' ' ' ILE . . . -57.63 -38.47 75.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.538 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 8.8 pt-20 -71.69 -34.69 69.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.237 0.542 . . . . 0.0 110.481 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -21.94 50.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.087 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 t -92.61 -35.13 13.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.652 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 172' ' ' LYS . . . -146.15 -63.61 0.31 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.641 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 21.2 tttp 74.95 -18.23 0.45 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.897 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -167.86 -43.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 111.115 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.1 p -157.3 -78.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -169.89 153.85 5.01 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.149 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.53 66.17 2.94 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.607 2.205 . . . . 0.0 112.227 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -95.48 139.92 22.15 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.128 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.53 151.5 24.04 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.458 2.105 . . . . 0.0 112.241 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -90.25 160.73 39.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.062 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.02 -171.51 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.544 2.163 . . . . 0.0 112.226 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.42 ' HA ' ' CE ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -59.68 161.61 6.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -107.23 178.35 4.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.042 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.2 p -76.62 -40.05 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.74 -75.7 0.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt 60.91 159.65 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.825 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.113 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.551 -0.22 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -82.01 132.96 35.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.74 -44.5 32.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.49 -177.17 3.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.6 t -131.36 158.03 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.404 ' O ' HG21 ' A' ' 157' ' ' VAL . . . -113.46 127.0 55.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.639 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.472 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.72 162.21 32.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.311 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.409 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 4.7 mmm -86.26 150.3 51.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.172 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.59 -51.94 9.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.202 1.934 . . . . 0.0 112.149 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.411 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -59.75 -34.52 73.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.021 0.438 . . . . 0.0 110.637 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.402 ' CB ' HG23 ' A' ' 163' ' ' VAL . . . -59.98 -51.22 70.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.57 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 84.5 mtt-85 -55.11 -36.41 65.68 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.447 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.3 mtm-85 -61.48 -51.19 69.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.99 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.85 -24.84 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.581 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -70.91 -41.54 71.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.731 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -76.38 -29.05 56.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.768 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -82.16 -43.79 17.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.575 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.552 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -100.67 -1.83 34.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.08 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.31 39.15 94.23 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.645 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.581 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 58.5 mt -87.55 144.99 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 112.002 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.425 ' N ' HG21 ' A' ' 144' ' ' ILE . 1.2 m-20 -97.8 100.64 12.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.518 ' HG ' ' CD1' ' A' ' 158' ' ' ILE . 2.5 mp -74.39 -20.74 59.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.229 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 t -61.93 -17.03 55.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.715 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -109.16 -9.78 15.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.63 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HB ' ' CD1' ' A' ' 158' ' ' ILE . 57.8 t -70.66 146.09 12.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.063 0.459 . . . . 0.0 111.191 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.7 121.15 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.433 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -77.77 123.24 6.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.065 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -143.46 38.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.29 0.567 . . . . 0.0 110.857 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -129.68 -162.65 10.91 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.102 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -31.75 96.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.775 2.983 . . . . 0.0 114.176 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.12 -18.15 14.62 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.277 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.37 44.4 0.19 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.479 HG21 ' N ' ' A' ' 158' ' ' ILE . 1.5 p -103.74 141.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.352 0.596 . . . . 0.0 112.01 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.518 ' CD1' ' HG ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -67.42 127.93 29.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.5 p -108.07 172.82 6.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.102 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.411 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 53.7 t -54.67 -29.8 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -63.65 -40.78 97.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.417 ' CB ' ' CG1' ' A' ' 149' ' ' VAL . 2.0 m-20 -71.81 -42.56 66.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.602 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 158' ' ' ILE . 80.7 t -64.49 -54.53 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.381 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -58.67 -37.38 75.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -70.81 -46.4 62.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.153 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.474 ' CE2' HG22 ' A' ' 144' ' ' ILE . 16.8 t80 -65.52 -50.55 64.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.451 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.461 ' CB ' ' CD1' ' A' ' 144' ' ' ILE . . . -56.54 -44.61 81.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.547 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 14.4 pt-20 -71.98 -34.91 69.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.298 0.571 . . . . 0.0 110.405 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -77.42 -21.87 52.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.859 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 167' ' ' ALA . 1.4 t -91.32 -41.14 11.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.866 0.365 . . . . 0.0 110.896 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.79 98.56 2.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.218 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 3.6 tttp -155.44 -175.32 5.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.07 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -153.68 -169.09 3.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.962 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.3 p 56.1 36.31 27.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.995 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -101.94 143.45 26.61 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.127 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.91 118.18 4.51 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.48 2.12 . . . . 0.0 112.142 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -147.09 91.66 5.09 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.036 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.33 -36.45 68.55 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.587 2.192 . . . . 0.0 112.339 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -113.73 98.88 48.67 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.135 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.99 170.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.475 2.117 . . . . 0.0 112.36 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 159.29 15.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -125.54 77.61 1.66 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.005 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.02 110.53 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 60.49 -178.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.721 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -116.85 39.16 3.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.031 -179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.8 p -127.78 100.27 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 110.982 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -131.24 32.76 4.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -77.58 -31.45 53.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.94 159.56 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.204 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.406 ' O ' HG21 ' A' ' 157' ' ' VAL . . . -117.61 131.03 56.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.98 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.524 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.56 162.1 32.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.276 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.25 153.77 66.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.41 -52.01 8.69 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.297 1.998 . . . . 0.0 112.344 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.419 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -64.79 -32.11 73.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.415 ' CB ' HG23 ' A' ' 163' ' ' VAL . . . -61.33 -52.97 62.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.885 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -55.65 -36.53 67.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.453 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -61.45 -50.91 70.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.45 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.05 -24.67 67.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.89 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.541 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.64 -34.73 62.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.965 0.412 . . . . 0.0 110.537 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -33.63 59.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.362 0.601 . . . . 0.0 109.997 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -79.61 -47.99 14.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.073 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.537 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.23 -10.45 52.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.779 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.22 34.76 57.67 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.832 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 16.2 mm -90.81 141.83 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.015 0.436 . . . . 0.0 111.695 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.443 ' N ' HG21 ' A' ' 144' ' ' ILE . 2.7 m-20 -94.19 100.78 12.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.43 HD22 HG23 ' A' ' 144' ' ' ILE . 5.5 mt -63.5 -20.62 65.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.229 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 79.7 p -64.13 -16.83 62.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.106 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -108.57 -3.77 17.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.726 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' A' ' 158' ' ' ILE . 59.8 t -79.94 149.88 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.076 0.465 . . . . 0.0 111.04 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.1 OUTLIER -72.32 121.68 19.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.364 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.07 119.14 4.78 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.003 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.452 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -137.92 34.23 2.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.413 0.625 . . . . 0.0 110.678 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.511 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -126.77 -166.3 12.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.095 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -31.64 98.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.867 3.045 . . . . 0.0 114.269 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.77 -18.11 13.34 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.399 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.38 44.53 0.21 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.524 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.3 p -101.08 144.87 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.162 0.506 . . . . 0.0 111.685 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.506 ' N ' HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -71.1 126.31 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.137 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.3 p -102.36 167.13 10.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.62 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.419 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 95.4 t -54.78 -36.3 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.384 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 2.5 pt-20 -58.49 -37.05 74.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.564 ' HA ' ' HG2' ' A' ' 165' ' ' ARG . 34.5 m-20 -72.68 -46.89 51.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.355 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 158' ' ' ILE . 71.1 t -56.92 -52.8 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 109.858 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -60.35 -37.67 81.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.234 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -72.29 -36.22 68.91 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.617 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.531 ' N ' ' HG3' ' A' ' 165' ' ' ARG . 14.9 t80 -77.12 -50.09 13.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.038 0.447 . . . . 0.0 110.194 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.498 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -57.52 -36.37 71.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.378 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.545 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 9.9 pt-20 -75.02 -34.74 61.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.061 0.458 . . . . 0.0 110.443 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -78.05 -22.07 49.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.219 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.41 HG21 ' O ' ' A' ' 167' ' ' ALA . 3.0 t -88.45 -33.42 17.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.805 0.336 . . . . 0.0 111.049 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.401 ' N ' HG21 ' A' ' 170' ' ' THR . . . -160.31 92.37 0.98 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 0.3 OUTLIER -161.96 161.39 28.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -170.54 100.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.3 p -127.2 74.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.009 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 62.85 127.09 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.201 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.06 106.52 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.412 2.075 . . . . 0.0 112.262 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -160.93 147.82 11.88 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.084 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.53 -28.59 14.31 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.602 2.201 . . . . 0.0 112.396 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -168.96 76.05 0.75 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.134 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.95 -167.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.641 2.227 . . . . 0.0 112.299 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.27 -46.7 8.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 58.23 179.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.41 43.67 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.057 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -58.01 164.42 2.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.031 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.02 120.23 12.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.146 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.84 165.2 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 127.68 54.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.17 159.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.9 -58.9 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . 65.63 120.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' A' ' 158' ' ' ILE . . . -133.3 162.14 32.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.641 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.89 151.43 54.91 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.011 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.83 -52.14 9.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.306 2.004 . . . . 0.0 112.511 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.426 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -61.75 -36.05 79.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.008 0.432 . . . . 0.0 110.819 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.406 ' CB ' HG23 ' A' ' 163' ' ' VAL . . . -60.61 -52.81 63.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.912 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -56.27 -34.76 66.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.749 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -63.02 -52.0 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.252 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.66 -23.71 67.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.841 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.543 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.44 -36.8 63.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.016 0.436 . . . . 0.0 110.376 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -76.28 -29.3 57.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.144 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.12 -49.03 10.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.094 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.516 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.41 -10.13 52.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.804 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.12 32.64 55.95 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.946 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 17.8 mm -87.77 140.07 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.918 0.39 . . . . 0.0 111.437 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.422 ' N ' HG21 ' A' ' 144' ' ' ILE . 3.7 m-20 -93.48 100.78 13.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.406 HD22 HG23 ' A' ' 144' ' ' ILE . 5.5 mt -64.22 -17.72 63.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.208 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t -65.38 -15.62 62.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.199 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -114.03 5.61 16.14 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.73 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.441 HG22 HD13 ' A' ' 158' ' ' ILE . 57.4 t -87.62 145.63 7.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.941 0.401 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 111.88 7.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.629 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -75.45 118.28 5.47 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.72 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.484 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -126.83 29.37 5.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.109 0.481 . . . . 0.0 111.295 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.765 ' HA2' HG13 ' A' ' 157' ' ' VAL . . . -130.4 -156.6 8.71 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.242 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.569 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 40.5 Cg_exo -38.11 108.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.111 2.541 . . . . 0.0 114.07 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.82 5.81 27.06 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.494 -0.776 . . . . 0.0 113.519 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.5 40.69 1.86 Allowed Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.765 HG13 ' HA2' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -86.73 140.44 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.039 -0.581 . . . . 0.0 111.617 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.441 HD13 HG22 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -79.01 131.35 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.5 p -108.95 167.65 9.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.719 0.295 . . . . 0.0 110.842 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.426 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 47.4 t -54.2 -24.58 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 3.3 tt0 -65.79 -42.95 90.13 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.405 ' OD1' ' CG2' ' A' ' 152' ' ' THR . 11.9 m-20 -74.21 -35.94 63.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.503 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.422 HG21 ' CD1' ' A' ' 158' ' ' ILE . 58.2 t -66.16 -53.69 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.955 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -62.82 -35.71 80.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.715 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 0.6 OUTLIER -71.78 -44.3 64.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.134 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.477 ' HD2' HG22 ' A' ' 144' ' ' ILE . 15.2 t80 -70.11 -47.66 60.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.983 0.42 . . . . 0.0 110.317 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 170' ' ' THR . . . -58.15 -39.0 77.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.548 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 14.2 pt-20 -75.27 -45.48 39.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.029 0.442 . . . . 0.0 110.429 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.1 tm-20 -65.19 -23.81 67.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.439 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 167' ' ' ALA . 1.1 t -90.54 -37.36 13.91 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.684 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -175.22 94.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.439 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 168' ' ' GLU . 0.3 OUTLIER -107.21 146.66 31.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.619 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -166.79 52.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.23 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 69.3 p -74.04 -31.22 62.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -90.41 166.08 20.98 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.027 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.03 103.63 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.505 2.137 . . . . 0.0 112.297 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -95.19 148.73 35.13 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.65 177.24 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.502 2.135 . . . . 0.0 112.311 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 58.97 86.12 0.17 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.21 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.44 -35.62 7.95 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.519 2.146 . . . . 0.0 112.33 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -172.36 2.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.045 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -99.7 30.3 3.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.9 105.21 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.116 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.33 -75.52 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.04 164.68 32.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.074 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.576 -0.21 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.44 136.6 36.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.804 0.335 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -109.19 107.95 18.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.37 167.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 130' ' ' ALA . 2.1 p -164.94 -46.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.479 ' N ' ' CG1' ' A' ' 129' ' ' VAL . . . 62.97 118.11 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.095 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.539 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.4 162.05 32.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.5 OUTLIER -93.35 145.71 30.51 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.197 179.299 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.72 -52.04 9.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.406 2.071 . . . . 0.0 112.692 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.39 78.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.976 0.417 . . . . 0.0 110.917 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.406 ' CB ' HG23 ' A' ' 163' ' ' VAL . . . -60.2 -52.84 63.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.027 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.4 mtm105 -56.86 -33.78 67.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.653 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -63.46 -50.9 67.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -23.97 66.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.837 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.54 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.21 -37.05 63.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.013 0.435 . . . . 0.0 110.466 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -76.3 -29.28 57.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.251 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -82.13 -48.44 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.149 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.494 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.95 -10.7 49.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.735 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.5 36.03 45.24 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.842 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 23.3 mm -92.44 139.83 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.995 0.426 . . . . 0.0 111.583 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.427 ' N ' HG21 ' A' ' 144' ' ' ILE . 2.2 m-20 -93.2 100.75 13.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.41 HD22 HG23 ' A' ' 144' ' ' ILE . 6.1 mt -64.88 -16.73 63.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.368 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -15.65 62.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.061 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -112.27 2.71 16.69 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.643 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.441 ' HB ' ' CD1' ' A' ' 158' ' ' ILE . 47.7 t -86.91 142.23 13.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.094 0.474 . . . . 0.0 111.073 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -70.91 127.7 33.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.979 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.0 118.57 4.97 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.912 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.498 HG21 ' OD2' ' A' ' 162' ' ' ASP . 0.4 OUTLIER -128.8 22.57 5.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.12 0.485 . . . . 0.0 110.827 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.507 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -113.78 -164.34 15.39 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.936 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -31.15 97.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.827 3.018 . . . . 0.0 114.258 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.14 -17.7 16.6 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.408 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.84 45.22 0.21 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.539 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.1 p -100.4 145.66 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.228 0.537 . . . . 0.0 111.781 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.514 ' N ' HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -72.94 124.85 30.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.155 179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.1 p -108.01 170.35 8.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.61 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.4 t -52.57 -25.7 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -66.21 -43.11 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.498 ' OD2' HG21 ' A' ' 152' ' ' THR . 3.3 m-20 -73.08 -40.06 65.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.565 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.413 HG21 ' CD1' ' A' ' 158' ' ' ILE . 44.8 t -65.01 -53.52 40.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.073 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -61.82 -34.9 76.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.016 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -72.86 -47.29 47.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.792 0.33 . . . . 0.0 111.344 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.484 ' HD2' HG22 ' A' ' 144' ' ' ILE . 14.9 t80 -68.87 -41.13 78.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.309 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.463 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -63.71 -38.64 91.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.323 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.441 ' HA ' ' CB ' ' A' ' 172' ' ' LYS . 14.7 pt-20 -77.13 -36.94 54.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.136 0.493 . . . . 0.0 110.471 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.35 -24.51 59.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.935 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 167' ' ' ALA . 3.0 t -83.35 -39.64 20.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.67 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -161.51 94.7 0.98 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.379 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.441 ' CB ' ' HA ' ' A' ' 168' ' ' GLU . 5.5 tmtt? -177.3 -42.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.005 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -157.59 179.51 9.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.22 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.3 p -150.35 -46.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.961 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -139.47 159.73 64.55 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.061 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.26 175.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.539 2.159 . . . . 0.0 112.345 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -174.57 78.6 0.34 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.25 -168.47 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.597 2.198 . . . . 0.0 112.305 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -123.86 86.76 53.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.37 162.78 41.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.524 2.149 . . . . 0.0 112.339 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -99.39 -39.43 8.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -65.0 -27.35 68.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.242 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t 66.67 85.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.081 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -132.54 168.74 17.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.945 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt 60.76 53.2 4.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.071 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.0 p -99.37 150.78 21.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.805 0.336 . . . . 0.0 110.945 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.85 129.6 12.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.74 169.17 17.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -60.97 -67.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.155 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.461 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . 66.12 122.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.673 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.31 162.11 32.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.567 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.27 159.13 54.18 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.793 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.61 -52.07 3.48 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.122 1.882 . . . . 0.0 112.313 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.42 -35.72 74.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.087 0.47 . . . . 0.0 110.545 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.419 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -60.8 -51.22 70.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.587 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -57.11 -34.13 68.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.675 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.11 -51.77 65.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.189 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.69 -24.22 67.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.765 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.55 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.75 -35.54 62.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.392 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -76.37 -29.44 57.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.125 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -82.18 -49.03 10.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.134 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.474 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -87.92 -9.12 54.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.758 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.15 34.76 54.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.148 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.55 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 13.1 mm -90.81 150.13 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.132 0.492 . . . . 0.0 111.711 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -107.91 100.98 10.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.473 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.42 ' HG ' HG12 ' A' ' 158' ' ' ILE . 1.4 mp -63.4 -17.65 62.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.422 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -18.74 62.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.917 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -110.43 -3.04 16.29 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.601 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.417 ' CG1' ' CB ' ' A' ' 162' ' ' ASP . 75.1 t -80.36 143.27 12.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.003 0.43 . . . . 0.0 111.07 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -71.25 112.74 7.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.206 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -76.29 123.52 6.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.282 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -127.09 15.97 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 0.0 111.367 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.701 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -115.02 -154.3 10.65 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.423 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.577 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 31.1 Cg_exo -36.01 106.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.426 2.751 . . . . 0.0 114.243 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.31 25.14 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.62 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.31 40.11 1.84 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.701 HG11 ' HA2' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -86.68 142.3 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.086 -0.557 . . . . 0.0 111.241 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -81.14 123.63 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.419 ' O ' HD13 ' A' ' 158' ' ' ILE . 1.2 p -106.66 166.12 10.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.343 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.1 t -50.33 -25.4 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.448 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.66 -45.86 84.96 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.582 ' HB2' HD11 ' A' ' 158' ' ' ILE . 4.9 m-20 -74.97 -33.78 61.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.439 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.578 HG22 HD13 ' A' ' 158' ' ' ILE . 6.1 t -65.12 -54.57 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -61.91 -35.9 79.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.59 -42.56 74.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -71.91 -51.27 23.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.552 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.478 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -56.82 -37.69 71.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.587 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 9.5 pt-20 -76.84 -42.5 39.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.264 0.554 . . . . 0.0 110.336 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.405 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.9 tp10 -70.07 -21.93 63.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.826 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 167' ' ' ALA . 1.4 t -89.34 -41.01 12.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.048 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -146.5 -55.72 0.26 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 33.7 tttp 65.34 168.01 0.19 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.534 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.07 58.02 1.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.996 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.23 -31.49 9.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.409 ' CB ' ' HD3' ' A' ' 176' ' ' PRO . . . -178.88 -55.1 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 175' ' ' ALA . 52.0 Cg_exo -53.19 179.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.463 2.109 . . . . 0.0 112.229 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -172.2 78.11 0.46 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.71 -176.75 2.16 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.621 2.214 . . . . 0.0 112.412 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.454 ' CB ' ' CD ' ' A' ' 180' ' ' PRO . . . -170.99 -64.73 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.021 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 179' ' ' ALA . 17.8 Cg_endo -61.07 -73.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.398 2.065 . . . . 0.0 112.274 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.462 ' HE3' ' HA ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER 179.53 -39.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 62.76 124.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.18 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.4 m -98.28 29.98 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 -43.83 23.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.29 100.94 5.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.095 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -161.31 160.43 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 -122.58 137.81 54.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.57 -179.7 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.0 t -133.63 159.52 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.407 ' O ' HG21 ' A' ' 157' ' ' VAL . . . -133.62 132.44 40.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.544 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.5 162.11 32.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.408 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -89.06 150.04 44.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.089 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.59 -51.95 9.97 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.198 1.932 . . . . 0.0 112.443 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.42 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -60.2 -37.02 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.03 0.443 . . . . 0.0 110.713 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.417 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -59.62 -48.75 80.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.692 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.404 ' HA ' HD23 ' A' ' 146' ' ' LEU . 74.2 mtm180 -59.57 -34.77 73.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.641 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -50.03 72.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.283 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.2 -25.23 66.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.919 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.559 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.97 -32.34 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.034 0.445 . . . . 0.0 110.413 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -35.11 58.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.873 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -80.35 -47.5 14.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.207 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.479 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.02 -12.13 48.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.705 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.21 31.44 54.99 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.009 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 13.3 mm -88.46 147.85 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.449 . . . . 0.0 111.602 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.36 100.99 10.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.774 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.43 ' HA ' ' CG2' ' A' ' 149' ' ' VAL . 0.9 OUTLIER -63.19 -17.8 62.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.549 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.5 m -63.31 -17.75 62.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.009 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -111.36 -1.09 16.11 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.584 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.43 ' CG2' ' HA ' ' A' ' 146' ' ' LEU . 63.6 t -81.01 148.62 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.004 0.43 . . . . 0.0 110.969 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 111.21 6.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.358 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.09 122.62 9.04 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.074 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -142.46 32.94 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.334 0.588 . . . . 0.0 110.569 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.77 -165.43 12.4 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.819 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -31.04 95.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.831 3.021 . . . . 0.0 114.197 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.56 -18.85 17.12 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.248 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.71 45.19 0.18 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.544 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.3 p -102.35 142.25 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.327 0.584 . . . . 0.0 111.997 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -68.66 124.68 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.868 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.416 ' O ' HD13 ' A' ' 158' ' ' ILE . 20.1 p -106.08 163.65 12.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.207 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.42 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 61.5 t -50.35 -33.28 10.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.467 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -59.16 -41.62 88.81 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.661 ' HB2' HD11 ' A' ' 158' ' ' ILE . 12.2 m-20 -74.97 -35.92 62.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.409 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.562 HG22 HD13 ' A' ' 158' ' ' ILE . 19.2 t -63.08 -54.7 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -37.62 84.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.458 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -65.99 -44.68 84.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.057 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -72.4 -46.89 53.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.731 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.433 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -57.82 -41.28 81.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.605 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 9.1 pt-20 -71.65 -37.23 70.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.288 0.566 . . . . 0.0 110.063 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -76.02 -21.9 56.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.832 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.5 t -94.64 -32.25 13.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.257 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -148.0 -61.58 0.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.784 0.326 . . . . 0.0 111.737 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 15.4 tttt 67.6 -71.89 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.815 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -121.71 66.68 0.9 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.019 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.03 33.39 2.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.905 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.81 106.36 22.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.079 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.69 161.22 44.66 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.384 2.056 . . . . 0.0 112.35 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.409 ' CB ' ' CD ' ' A' ' 178' ' ' PRO . . . -65.65 -61.42 5.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.145 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 177' ' ' ALA . 50.5 Cg_endo -69.34 140.92 45.52 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.493 2.129 . . . . 0.0 112.276 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.52 164.35 50.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.52 -175.89 1.24 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.488 2.126 . . . . 0.0 112.333 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.54 161.24 15.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -84.23 118.65 24.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.044 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.8 t -103.66 31.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -142.37 161.15 38.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.878 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -72.04 -33.06 67.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.13 179.936 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.0 p -107.36 75.31 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.909 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -128.21 31.61 5.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.971 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -143.47 165.92 26.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.93 -61.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.443 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . 66.61 120.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.948 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.445 ' CA ' HG21 ' A' ' 157' ' ' VAL . . . -133.28 162.04 32.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.417 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.54 151.25 55.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.838 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.16 -50.12 14.92 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.069 1.846 . . . . 0.0 112.31 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.412 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -66.18 -32.89 74.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.845 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.461 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -61.35 -52.97 62.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.767 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.435 ' HA ' ' CD1' ' A' ' 146' ' ' LEU . 50.1 mtp180 -56.38 -35.54 67.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.39 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -61.63 -49.51 76.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.176 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -25.52 67.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.504 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.577 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -69.98 -41.93 73.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.021 0.439 . . . . 0.0 110.684 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.5 -29.15 56.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.86 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -82.17 -43.2 18.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.651 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.553 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -101.16 -2.36 31.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.971 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.95 39.03 93.21 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.648 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.577 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 65.5 mt -87.81 141.0 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 111.635 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.0 100.45 13.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 136' ' ' ARG . 5.9 mt -71.4 -18.19 62.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -15.9 63.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -113.24 1.52 15.24 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.712 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.446 HG22 HD13 ' A' ' 158' ' ' ILE . 58.2 t -82.72 144.59 9.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.993 0.425 . . . . 0.0 110.799 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -70.88 117.73 12.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.625 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.81 114.79 3.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.755 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.471 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -117.33 20.32 13.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.673 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -129.1 -153.86 8.07 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.754 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.53 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 21.2 Cg_exo -32.66 106.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.783 2.989 . . . . 0.0 114.617 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.5 10.58 8.09 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.876 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.49 41.73 1.57 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.673 HG11 ' HA2' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -86.33 145.01 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.033 -0.583 . . . . 0.0 111.157 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.446 HD13 HG22 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -83.73 136.05 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 36.1 p -112.16 166.9 10.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.318 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.412 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 24.3 t -55.18 -29.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.1 -40.12 94.12 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.81 -39.12 61.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.389 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.461 HG22 ' CB ' ' A' ' 135' ' ' ALA . 60.1 t -65.26 -54.66 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.316 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -59.26 -42.5 91.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.837 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -67.65 -43.31 80.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.237 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.487 ' CD2' HG22 ' A' ' 144' ' ' ILE . 9.8 t80 -67.1 -54.41 21.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.491 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.438 ' HB3' ' CD1' ' A' ' 144' ' ' ILE . . . -53.01 -41.99 65.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.618 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 7.5 pt-20 -69.56 -33.03 72.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 0.0 110.263 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.97 -24.98 47.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.869 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.2 t -93.15 -37.99 11.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.752 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.96 79.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.313 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 9.9 tttm -78.26 -37.15 45.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -174.72 41.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.98 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.4 t -56.78 95.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.983 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -163.61 93.99 1.08 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.87 -26.16 52.21 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.478 2.119 . . . . 0.0 112.261 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -143.08 124.6 8.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.039 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.75 -61.42 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.413 2.075 . . . . 0.0 112.31 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -168.39 119.63 0.67 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.988 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.51 160.74 48.62 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.382 2.055 . . . . 0.0 112.247 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.74 -56.26 3.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.943 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.09 129.55 38.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.087 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.8 p -176.49 -40.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -86.92 -56.43 3.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.76 30.4 1.87 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.224 -0.894 . . . . 0.0 111.073 179.944 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.18 61.21 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.9 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.4 84.78 2.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -142.74 140.48 31.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 130' ' ' ALA . 1.9 p -120.79 -47.81 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 0.0 111.09 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.483 ' N ' ' CG1' ' A' ' 129' ' ' VAL . . . 62.24 133.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.019 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.529 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.54 162.14 32.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.169 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.0 mtp -86.48 148.63 47.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.091 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.35 -52.04 9.9 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.357 2.038 . . . . 0.0 112.375 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.418 ' CB ' HG23 ' A' ' 160' ' ' VAL . . . -63.09 -34.72 78.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.912 0.386 . . . . 0.0 110.711 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.413 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -60.0 -50.57 73.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.776 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -58.48 -34.5 70.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.608 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -62.47 -50.0 73.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.284 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.01 -25.07 66.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.905 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.561 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.9 -32.6 61.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.005 0.431 . . . . 0.0 110.38 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 -34.97 59.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.394 0.616 . . . . 0.0 109.944 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.07 -47.58 14.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.196 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.487 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.08 -11.81 49.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.713 -179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.54 31.84 55.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.885 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.561 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 11.0 mm -87.83 148.7 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.542 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -106.19 100.96 10.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.697 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.425 ' HG ' HG12 ' A' ' 158' ' ' ILE . 1.8 mp -63.65 -20.0 65.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.495 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -19.96 63.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.965 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -107.19 -6.21 17.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.514 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.441 ' CG1' ' CB ' ' A' ' 162' ' ' ASP . 58.0 t -77.47 146.92 7.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.054 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 111.77 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.362 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.78 122.48 8.34 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.051 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.455 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -138.85 32.69 2.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.291 0.567 . . . . 0.0 110.673 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.524 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -124.13 -164.79 12.06 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.865 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -31.69 97.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.781 2.988 . . . . 0.0 114.192 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.36 -18.1 15.79 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.344 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.75 44.43 0.2 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.529 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.4 p -100.32 142.4 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 111.99 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -71.43 124.81 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.306 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.451 ' O ' HD13 ' A' ' 158' ' ' ILE . 1.3 p -107.05 165.14 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.162 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.418 HG23 ' CB ' ' A' ' 134' ' ' ALA . 21.9 t -50.14 -25.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.676 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.39 -45.68 86.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.565 ' HB2' HD11 ' A' ' 158' ' ' ILE . 5.7 m-20 -74.86 -33.07 62.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.484 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.564 HG22 HD13 ' A' ' 158' ' ' ILE . 7.0 t -66.02 -54.6 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -61.6 -36.24 80.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.588 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -70.86 -42.11 70.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.28 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -71.62 -49.89 35.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.651 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.465 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -56.94 -39.76 75.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.496 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 11.1 pt-20 -72.61 -35.32 67.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 110.217 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -77.93 -24.49 48.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.955 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.8 t -89.75 -33.99 16.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.775 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -173.94 90.93 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.218 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 11.5 tttt -103.85 -33.63 8.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.841 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.9 134.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 53.0 p -112.08 -34.65 5.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.971 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.42 138.42 91.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.86 112.07 3.45 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.436 2.091 . . . . 0.0 112.292 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -131.9 106.4 13.94 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.123 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.5 -26.85 33.84 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.445 2.096 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -159.14 89.71 2.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -51.34 143.78 33.15 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.49 2.126 . . . . 0.0 112.399 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -117.74 -43.01 2.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.949 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -72.62 169.55 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.094 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.99 -43.78 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.55 157.08 18.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.16 -45.31 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.17 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 p -126.95 -45.01 1.6 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.883 0.373 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -111.41 111.0 21.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.44 149.73 45.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER -168.43 -164.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.943 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.436 ' N ' ' CG1' ' A' ' 129' ' ' VAL . . . -126.95 139.72 52.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.066 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.522 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.51 162.15 32.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.184 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.402 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -86.27 149.18 49.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.055 179.037 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.9 -52.07 9.84 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.366 2.044 . . . . 0.0 112.516 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.422 ' CB ' HG23 ' A' ' 160' ' ' VAL . . . -64.04 -35.13 79.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.957 0.408 . . . . 0.0 110.817 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.403 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -59.78 -52.82 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.995 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' HA ' ' CD1' ' A' ' 146' ' ' LEU . 4.5 mtt-85 -56.17 -34.98 66.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -61.79 -51.34 68.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.047 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.05 -24.19 67.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.77 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.547 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.81 -33.68 62.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.416 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.26 -34.16 59.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.962 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -80.59 -47.57 13.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.225 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.51 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.71 -10.91 49.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.822 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.17 36.17 56.5 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.929 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.547 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 11.5 mm -90.69 142.12 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.933 0.397 . . . . 0.0 111.659 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.45 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -93.87 100.78 12.89 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.415 ' CD1' ' HA ' ' A' ' 136' ' ' ARG . 3.9 mt -63.05 -22.13 66.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.349 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.2 p -66.75 -14.96 63.2 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -111.2 5.65 20.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.667 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' A' ' 158' ' ' ILE . 87.9 t -90.34 148.1 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.031 0.444 . . . . 0.0 110.97 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -70.87 108.56 4.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.457 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.06 123.5 10.64 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.974 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -141.7 34.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.309 0.576 . . . . 0.0 110.746 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.518 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -125.34 -164.64 11.9 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.955 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -31.69 96.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.809 3.006 . . . . 0.0 114.264 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.88 -17.07 17.71 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.389 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.26 43.97 0.22 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.522 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.5 p -100.8 143.08 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.208 0.528 . . . . 0.0 111.84 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.486 ' N ' HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -70.42 127.28 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.141 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.3 p -106.43 167.05 10.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.422 HG23 ' CB ' ' A' ' 134' ' ' ALA . 44.8 t -52.84 -26.87 11.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.125 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -64.77 -44.03 91.35 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.408 ' CB ' ' CG1' ' A' ' 149' ' ' VAL . 13.9 m-20 -71.62 -37.35 70.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.653 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.432 HG21 ' CD1' ' A' ' 158' ' ' ILE . 55.2 t -66.87 -54.56 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.406 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -60.87 -33.75 73.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.565 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -43.73 56.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.336 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -70.81 -46.75 62.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.465 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.483 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -62.02 -35.58 78.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.629 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 11.1 pt-20 -77.09 -36.29 55.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.088 0.47 . . . . 0.0 110.773 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.25 -21.91 55.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.025 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 167' ' ' ALA . 2.5 t -87.23 -40.52 14.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 110.797 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.74 95.11 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.168 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 4.7 tttm -163.51 163.7 24.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.99 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.02 95.41 4.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.054 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 69.3 p -77.89 -34.32 51.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.965 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 58.77 78.58 0.35 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.63 82.79 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.662 2.241 . . . . 0.0 112.304 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 59.23 89.79 0.1 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.132 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.59 98.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.617 2.212 . . . . 0.0 112.3 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -137.24 96.21 11.32 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.27 141.56 52.3 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.509 2.139 . . . . 0.0 112.226 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -100.43 -51.78 3.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.0 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -114.48 126.61 55.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.093 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.52 30.74 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -106.08 158.96 16.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -128.03 -71.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.108 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.4 p -109.15 -42.61 4.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 60.65 176.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.952 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.99 148.15 40.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -141.12 -165.48 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.923 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.459 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -149.06 129.97 14.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.429 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.421 ' HA ' HG22 ' A' ' 158' ' ' ILE . . . -133.24 162.1 32.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.949 0.404 . . . . 0.0 111.735 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.0 mtp -84.47 152.06 60.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.651 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.34 -41.9 49.59 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.119 1.88 . . . . 0.0 112.441 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.422 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -74.88 -30.37 61.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.89 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.95 -50.94 71.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.616 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.604 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 56.2 mtm180 -57.03 -34.28 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.304 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.22 -49.01 75.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.264 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -24.31 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.299 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.12 -36.28 64.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.64 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -76.5 -30.18 57.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.278 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -82.3 -48.99 10.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.33 -7.39 48.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.063 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.32 38.97 58.26 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.087 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 12.0 mm -92.22 142.47 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.095 0.474 . . . . 0.0 111.793 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.437 ' N ' HG21 ' A' ' 144' ' ' ILE . 1.5 t70 -98.38 100.73 12.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.604 ' CD2' ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -57.88 -25.1 60.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.342 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -14.7 62.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.177 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -112.5 4.93 17.71 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.478 HG21 ' CD2' ' A' ' 166' ' ' TYR . 93.6 t -92.69 150.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.875 0.369 . . . . 0.0 111.021 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -70.89 105.92 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.396 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -73.04 116.84 5.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.841 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.477 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -126.58 31.48 5.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.087 0.47 . . . . 0.0 111.089 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.757 ' HA2' HG13 ' A' ' 157' ' ' VAL . . . -132.14 -156.87 8.44 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.363 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.572 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 39.0 Cg_exo -38.18 109.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.235 2.623 . . . . 0.0 114.142 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.66 5.66 25.24 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.592 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.59 39.08 2.11 Favored Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.757 HG13 ' HA2' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -84.63 143.78 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.999 -0.601 . . . . 0.0 111.469 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.502 HD12 ' HG ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -81.16 136.31 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.5 p -112.12 165.55 12.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.87 0.367 . . . . 0.0 111.04 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.422 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 39.3 t -52.45 -31.1 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.022 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.02 -39.45 93.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -74.88 -40.14 61.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.542 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 158' ' ' ILE . 26.9 t -64.65 -54.75 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.021 0.438 . . . . 0.0 110.263 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -41.51 97.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.414 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 161' ' ' GLU . 73.3 mtt-85 -62.65 -47.65 82.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.317 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.478 ' CD2' HG21 ' A' ' 149' ' ' VAL . 0.6 OUTLIER -62.87 -54.65 35.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.021 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.421 ' HA ' HD13 ' A' ' 144' ' ' ILE . . . -59.65 -41.85 91.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.841 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.618 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 0.0 OUTLIER -72.91 -31.74 64.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 110.655 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 1.2 tm-20 -77.95 -21.98 50.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.303 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.07 -27.95 13.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.881 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 175.53 90.48 0.01 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.921 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.618 ' HB3' ' HA ' ' A' ' 168' ' ' GLU . 1.5 ptmm? -95.17 141.45 28.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.65 110.39 14.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.8 p -115.72 32.04 6.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.4 59.43 6.84 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.064 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.95 173.08 11.67 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.801 2.334 . . . . 0.0 112.279 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.436 ' CB ' ' HD3' ' A' ' 178' ' ' PRO . . . -176.85 -53.73 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.111 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 177' ' ' ALA . 33.3 Cg_exo -61.11 101.25 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.477 2.118 . . . . 0.0 112.027 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 62.17 92.69 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.945 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.73 148.2 86.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.578 2.185 . . . . 0.0 112.304 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 169.04 18.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -69.49 171.6 8.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.02 -42.46 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -136.32 -49.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -137.58 -48.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.976 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.054 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.2 m -115.38 49.22 1.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -173.19 -41.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -56.96 -178.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.011 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.3 t -60.03 -72.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.012 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.403 ' CB ' ' HB ' ' A' ' 157' ' ' VAL . . . 61.96 126.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.2 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.4 162.06 32.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.84 147.28 37.11 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.151 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.78 -51.99 9.75 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.282 1.988 . . . . 0.0 112.371 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.422 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -63.13 -33.69 75.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 110.629 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.405 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -62.06 -52.9 62.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.673 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -54.65 -38.24 66.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 110.501 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -60.72 -49.66 76.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.129 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 1.1 mp -64.15 -24.18 67.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.57 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.554 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.83 -36.16 62.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.943 0.401 . . . . 0.0 110.493 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -76.34 -33.04 58.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.315 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -82.01 -44.74 16.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.092 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.516 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -85.0 -13.3 51.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.294 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.09 39.12 54.31 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.257 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.554 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 25.5 mm -100.81 146.36 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.412 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.4 OUTLIER -99.88 100.79 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.436 HD22 HG23 ' A' ' 144' ' ' ILE . 4.3 mt -61.4 -21.54 64.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.621 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -61.97 -17.67 57.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.001 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -107.66 -8.56 16.08 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.677 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 158' ' ' ILE . 59.0 t -76.28 146.21 9.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.052 0.454 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -71.46 118.74 14.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.444 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.24 119.28 5.14 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.822 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -135.71 34.27 2.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.343 0.592 . . . . 0.0 110.747 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.522 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -127.24 -164.75 11.75 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.989 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -31.66 97.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.911 3.074 . . . . 0.0 114.233 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.52 -17.04 15.7 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.425 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.78 44.32 0.22 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.5 p -100.8 144.31 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.12 0.485 . . . . 0.0 111.77 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.507 ' N ' HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -71.78 127.73 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.346 179.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 p -104.3 164.22 11.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.322 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.422 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 83.3 t -51.33 -27.63 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.804 0.335 . . . . 0.0 110.999 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -63.05 -42.83 99.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.002 0.429 . . . . 0.0 109.865 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.402 ' CB ' ' CG1' ' A' ' 149' ' ' VAL . 14.3 m-20 -72.69 -36.64 67.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.868 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.425 HG23 ' CD1' ' A' ' 158' ' ' ILE . 79.1 t -66.67 -54.63 23.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.906 0.384 . . . . 0.0 110.143 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -61.0 -36.02 78.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.785 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -71.9 -46.02 59.2 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.542 ' HD2' HG22 ' A' ' 144' ' ' ILE . 18.7 t80 -66.42 -51.1 60.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.52 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.504 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -56.73 -42.48 79.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.517 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.571 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 12.5 pt-20 -71.8 -36.34 70.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.345 0.593 . . . . 0.0 110.24 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -75.63 -21.95 57.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.79 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.449 HG21 ' N ' ' A' ' 171' ' ' ALA . 1.3 t -93.92 -34.76 12.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.115 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.449 ' N ' HG21 ' A' ' 170' ' ' THR . . . -161.71 96.27 1.03 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.886 0.374 . . . . 0.0 111.506 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -142.73 -170.2 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.642 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.69 120.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.19 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.06 119.81 32.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 62.77 119.25 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.043 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.25 -27.38 34.86 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.384 2.056 . . . . 0.0 112.33 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -171.62 164.59 4.54 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.066 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.91 62.48 3.18 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.534 2.156 . . . . 0.0 112.327 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -107.87 152.96 41.85 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.089 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.14 -73.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.6 2.2 . . . . 0.0 112.293 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.73 -175.39 3.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.94 108.41 3.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.8 m -84.45 -31.27 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.101 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.24 -47.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.818 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -106.9 93.05 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.095 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.29 145.69 24.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.89 97.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.69 172.11 4.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 30.5 m -59.77 -177.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.289 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.51 118.85 16.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.022 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.511 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.42 162.0 33.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.032 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 36.1 mmm -87.35 152.98 53.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.103 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.12 -52.03 6.59 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.283 1.988 . . . . 0.0 112.026 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.422 ' CB ' HG23 ' A' ' 160' ' ' VAL . . . -61.86 -30.06 70.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.66 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.94 -52.8 58.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HA ' ' CD1' ' A' ' 146' ' ' LEU . 80.6 mtt180 -55.99 -36.16 67.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -62.39 -50.06 73.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.208 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -23.79 67.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.751 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.586 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.46 -38.43 62.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.881 0.372 . . . . 0.0 110.539 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -76.31 -29.41 57.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.292 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -82.37 -45.04 15.38 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.55 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.447 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -97.29 -2.8 41.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.118 -178.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.28 38.91 91.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.712 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.586 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 64.9 mt -87.62 142.71 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.401 . . . . 0.0 111.444 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -94.17 100.46 12.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.44 ' CD1' ' HA ' ' A' ' 136' ' ' ARG . 5.7 mt -72.07 -21.91 61.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.254 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.94 -15.89 62.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -111.72 0.25 16.22 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.464 ' HB ' ' CD1' ' A' ' 158' ' ' ILE . 57.2 t -81.98 148.82 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.139 0.495 . . . . 0.0 111.185 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.5 OUTLIER -77.27 124.53 27.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.199 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.57 121.69 5.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.175 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -137.49 34.22 2.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -124.19 -164.71 12.03 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.709 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -30.92 95.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.798 2.999 . . . . 0.0 114.301 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.84 -17.62 20.44 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.453 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.77 45.04 0.19 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.511 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.4 p -102.13 144.21 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.162 0.506 . . . . 0.0 111.822 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.492 ' N ' HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -71.89 126.72 32.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.021 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.6 p -109.37 167.85 9.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.409 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.422 HG23 ' CB ' ' A' ' 134' ' ' ALA . 21.9 t -52.42 -26.37 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.753 0.311 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 4.1 mt-10 -65.43 -43.2 91.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.85 -43.68 57.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.827 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' A' ' 158' ' ' ILE . 20.0 t -57.22 -54.24 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.054 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.511 ' HA ' ' CE ' ' A' ' 164' ' ' LYS . 0.2 OUTLIER -65.29 -46.84 78.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 12.6 mtp180 -52.96 -41.71 64.81 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.053 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.454 ' CE2' HG22 ' A' ' 144' ' ' ILE . 12.3 t80 -73.7 -46.66 44.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.267 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.441 ' CB ' ' CD1' ' A' ' 144' ' ' ILE . . . -59.88 -49.1 79.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.458 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 9.7 pt-20 -62.91 -34.08 76.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.32 0.581 . . . . 0.0 109.981 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.7 OUTLIER -78.13 -30.13 49.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.674 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 167' ' ' ALA . 0.6 OUTLIER -82.12 -37.06 26.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.632 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -176.59 94.94 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.4 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 0.1 OUTLIER -100.81 -162.07 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.432 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -132.94 111.89 11.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 111.139 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 16.9 p -104.16 34.19 3.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -157.15 77.47 3.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.081 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.85 -43.48 48.93 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.638 2.225 . . . . 0.0 112.471 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.449 ' CB ' ' CD ' ' A' ' 178' ' ' PRO . . . -85.4 -65.15 0.21 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.647 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 177' ' ' ALA . 44.6 Cg_endo -68.91 158.95 55.85 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.281 1.987 . . . . 0.0 112.567 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -146.93 87.9 6.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.049 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -51.69 -27.13 25.21 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.686 2.257 . . . . 0.0 112.474 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.56 -31.45 8.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 59.91 76.23 0.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.999 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.3 -30.96 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.221 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.37 161.15 16.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.09 -45.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.089 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.3 m -111.95 -38.17 4.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.46 -56.49 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -127.71 150.17 49.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -122.44 -164.39 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.448 ' N ' ' CG1' ' A' ' 129' ' ' VAL . . . -98.69 123.82 43.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.098 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.563 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.45 161.03 35.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.8 mtp -81.5 153.01 70.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.78 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.21 -41.45 75.87 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.203 1.935 . . . . 0.0 111.985 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.445 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -75.1 -27.39 59.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.652 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -65.21 -50.85 64.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.679 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.585 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 3.3 mtt-85 -55.94 -42.68 76.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.124 0.487 . . . . 0.0 110.261 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -57.94 -47.46 82.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.799 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -65.37 -22.96 66.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.148 178.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.577 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -73.29 -37.88 66.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.536 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -76.38 -30.69 57.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.313 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.32 -44.65 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.565 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.543 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -95.6 -3.95 45.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.743 -179.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.46 37.66 92.86 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.478 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.577 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 45.1 mt -89.41 138.52 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.45 ' N ' HG21 ' A' ' 144' ' ' ILE . 1.4 m-20 -96.39 100.55 12.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.619 ' HG ' HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -61.63 -23.0 65.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.539 -178.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 t -66.65 -12.19 57.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.305 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -115.6 4.44 14.15 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.43 ' CG1' HD13 ' A' ' 158' ' ' ILE . 67.3 t -89.2 152.02 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.778 0.323 . . . . 0.0 110.921 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.81 106.48 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.349 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.95 120.41 9.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.914 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.439 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -137.82 32.2 2.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 110.796 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.541 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -126.98 -166.38 12.14 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.129 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -32.26 99.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.86 3.04 . . . . 0.0 114.307 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.26 -17.16 10.48 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.435 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.46 43.19 0.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.563 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.5 p -98.51 143.88 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.129 0.49 . . . . 0.0 111.523 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.619 HD12 ' HG ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -72.31 127.61 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.69 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.4 p -100.67 165.83 11.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.207 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.445 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 67.9 t -54.96 -30.53 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.701 0.286 . . . . 0.0 111.142 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -61.77 -39.77 92.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.009 0.433 . . . . 0.0 109.85 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.85 -37.61 62.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.416 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.509 HG21 ' CD1' ' A' ' 158' ' ' ILE . 42.1 t -64.12 -54.84 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.591 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -61.64 -42.44 98.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.618 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -64.57 -45.2 88.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 111.054 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.449 ' CD2' HG22 ' A' ' 144' ' ' ILE . 3.7 t80 -67.21 -49.46 64.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.46 ' HB3' ' CD1' ' A' ' 144' ' ' ILE . . . -63.38 -34.5 77.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.958 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 6.3 pt-20 -74.28 -38.03 63.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.0 110.562 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.72 -21.91 57.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.984 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 167' ' ' ALA . 1.6 t -91.93 -36.7 13.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.247 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -161.33 96.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 0.0 111.591 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.516 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 0.8 OUTLIER -166.82 -69.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.961 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -171.68 -174.22 1.32 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.173 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.38 132.8 4.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -133.65 120.22 15.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.065 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.62 -39.05 84.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.324 2.016 . . . . 0.0 112.227 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 56.65 86.33 0.17 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.202 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.36 174.29 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.556 2.171 . . . . 0.0 112.288 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.415 ' CB ' ' HD3' ' A' ' 180' ' ' PRO . . . -179.55 -55.55 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.241 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.415 ' HD3' ' CB ' ' A' ' 179' ' ' ALA . 58.1 Cg_exo -51.68 140.38 46.38 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.437 2.091 . . . . 0.0 112.405 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.447 ' HA ' ' CE ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -164.76 -171.55 2.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.835 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -65.18 -37.98 89.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.0 m 42.39 32.24 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.699 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.18 -60.38 1.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.79 139.74 32.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.016 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.066 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.6 m -142.66 97.96 3.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.839 0.352 . . . . 0.0 110.85 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.62 -32.31 8.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -135.7 -45.78 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 t -109.55 160.25 8.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.027 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.454 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -127.47 128.17 45.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.458 ' CA ' HG21 ' A' ' 157' ' ' VAL . . . -133.23 162.03 32.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.639 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -88.24 157.65 50.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.718 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.64 -52.02 7.03 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.157 1.904 . . . . 0.0 112.224 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.417 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.05 -32.71 74.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.943 0.402 . . . . 0.0 110.601 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.42 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -63.45 -52.83 59.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HA ' ' CD1' ' A' ' 146' ' ' LEU . 1.1 mtm105 -56.44 -34.41 66.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.135 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -62.25 -50.99 69.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.964 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.96 -24.03 67.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.382 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.589 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -71.33 -40.76 70.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 110.617 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -76.32 -29.2 57.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.701 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -82.2 -44.17 16.72 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.576 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.549 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -99.61 -2.22 36.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.061 -178.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.53 39.13 93.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.588 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.589 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 67.2 mt -87.63 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.971 0.415 . . . . 0.0 111.712 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.408 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.7 OUTLIER -93.26 100.48 12.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.429 ' CD1' ' HA ' ' A' ' 136' ' ' ARG . 5.6 mt -70.52 -18.83 62.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.278 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.57 -15.0 62.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.994 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -114.58 3.17 14.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.708 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.466 HG22 HD13 ' A' ' 158' ' ' ILE . 84.3 t -83.96 144.45 9.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.947 0.403 . . . . 0.0 110.809 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 111.45 6.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.413 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.44 120.22 5.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.979 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.459 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -122.83 18.96 10.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 0.0 111.235 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.7 ' HA2' HG13 ' A' ' 157' ' ' VAL . . . -123.86 -154.21 8.87 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.587 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 26.6 Cg_exo -34.73 109.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.553 2.835 . . . . 0.0 114.467 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.27 8.53 6.71 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.518 -0.764 . . . . 0.0 113.806 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.95 41.37 1.7 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.7 HG13 ' HA2' ' A' ' 153' ' ' GLY . 0.5 OUTLIER -85.54 145.03 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.054 -0.573 . . . . 0.0 111.433 -178.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.466 HD13 HG22 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -83.87 132.47 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.3 p -112.07 166.82 10.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.932 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 19.2 t -53.27 -27.74 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.293 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 4.4 pt-20 -64.12 -42.97 96.64 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -75.09 -38.12 61.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 158' ' ' ILE . 58.3 t -62.59 -54.54 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.907 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -60.73 -41.38 95.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.022 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -68.79 -37.52 79.33 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.689 0.28 . . . . 0.0 111.491 -179.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.489 ' CE2' HG22 ' A' ' 144' ' ' ILE . 7.2 t80 -74.01 -54.1 8.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.438 ' CB ' ' CD1' ' A' ' 144' ' ' ILE . . . -52.7 -41.08 63.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.551 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.625 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 10.4 pt-20 -71.12 -39.39 72.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.153 0.502 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.424 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 6.9 tt0 -70.1 -21.96 63.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.501 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.8 -34.27 10.94 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -176.66 93.69 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.114 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.625 ' HB3' ' HA ' ' A' ' 168' ' ' GLU . 6.1 pttt -102.21 138.95 38.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.47 -33.97 10.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.3 p -140.07 -62.12 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.716 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 57.27 167.04 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.214 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.81 165.92 29.39 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.555 2.17 . . . . 0.0 112.307 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.417 ' CB ' ' CD ' ' A' ' 178' ' ' PRO . . . -178.26 -62.11 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 177' ' ' ALA . 57.7 Cg_endo -71.31 138.58 33.3 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.47 2.113 . . . . 0.0 112.267 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -104.45 88.53 2.18 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.217 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.79 -172.97 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.553 2.169 . . . . 0.0 112.23 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.97 173.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 59.1 77.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.092 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -58.59 113.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.46 162.8 24.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.91 177.61 9.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.064 179.975 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.3 m -117.57 73.85 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.862 0.363 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 -160.83 101.72 1.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -137.7 -48.22 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.478 HG11 ' N ' ' A' ' 130' ' ' ALA . 1.7 p 44.41 -167.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.478 ' N ' HG11 ' A' ' 129' ' ' VAL . . . -122.66 141.85 51.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.072 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.38 162.05 32.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.2 mtp -82.61 146.33 53.02 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.87 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.45 -39.21 22.02 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.19 1.926 . . . . 0.0 112.349 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.456 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . . . -77.71 -28.18 50.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.504 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -64.01 -50.89 66.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.66 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.557 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 73.6 mtt180 -58.3 -35.51 71.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.334 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -62.25 -50.39 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.124 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -23.05 66.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.561 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.572 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -73.21 -38.62 66.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.646 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -32.24 58.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.482 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -82.11 -42.71 18.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.616 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.529 ' HB3' HG13 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -99.47 -2.9 34.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.962 -178.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.82 39.21 95.01 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.197 -1.002 . . . . 0.0 111.618 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.572 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 68.6 mt -87.55 143.34 11.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.031 0.443 . . . . 0.0 111.811 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.44 ' N ' HG21 ' A' ' 144' ' ' ILE . 2.5 t0 -95.38 100.61 12.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.696 ' HG ' HD12 ' A' ' 158' ' ' ILE . 0.4 OUTLIER -68.46 -24.1 64.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.088 -178.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -65.44 -14.77 61.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.038 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -110.92 -2.2 16.12 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.761 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 62.1 t -82.49 148.48 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.966 0.412 . . . . 0.0 111.109 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.99 110.3 5.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.487 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.63 120.4 7.49 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.907 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.461 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -135.7 32.94 2.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.344 0.593 . . . . 0.0 110.726 -179.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.523 ' HA2' HG11 ' A' ' 157' ' ' VAL . . . -127.73 -165.73 11.92 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.189 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -32.22 99.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.82 3.014 . . . . 0.0 114.33 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.73 -16.64 10.64 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.46 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.09 43.01 0.26 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.6 p -98.47 144.46 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.314 -0.443 . . . . 0.0 111.536 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.696 HD12 ' HG ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -73.75 128.33 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 110.924 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 p -101.02 168.6 9.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.144 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.456 ' CG2' ' CB ' ' A' ' 134' ' ' ALA . 46.5 t -56.21 -30.22 29.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.712 0.291 . . . . 0.0 110.991 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.75 -39.04 90.18 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.465 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 12.1 m-20 -75.05 -38.32 61.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.615 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.504 HG22 ' CB ' ' A' ' 135' ' ' ALA . 52.5 t -64.47 -54.74 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.097 0.475 . . . . 0.0 110.313 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -60.51 -41.36 94.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.792 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -68.23 -40.15 82.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.425 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.5 ' CE2' HG22 ' A' ' 144' ' ' ILE . 6.8 t80 -72.29 -52.67 15.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.921 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.44 ' HB1' HG12 ' A' ' 144' ' ' ILE . . . -55.66 -39.73 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.381 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 8.8 pt-20 -72.21 -38.15 69.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.35 0.595 . . . . 0.0 110.04 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 1.7 tp10 -73.13 -21.97 60.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.733 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 t -96.58 -41.06 8.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.903 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -164.44 88.15 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.428 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 4.0 tttm -101.74 161.51 13.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.551 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.53 -18.05 61.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.395 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.5 t -54.01 -32.13 53.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.848 0.356 . . . . 0.0 111.071 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -129.07 116.07 18.88 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.12 -78.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.329 2.019 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 178.74 91.37 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.04 157.09 63.32 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.445 2.097 . . . . 0.0 112.31 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.445 ' CB ' ' HD3' ' A' ' 180' ' ' PRO . . . -173.5 -57.35 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.23 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' A' ' 179' ' ' ALA . 52.6 Cg_exo -52.61 152.44 16.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.306 2.004 . . . . 0.0 112.251 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -108.53 147.97 30.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -146.2 29.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.998 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.7 t -107.23 32.07 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.138 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -91.86 167.53 12.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -43.62 64.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.038 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.555 -0.218 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -84.51 126.18 33.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.814 0.34 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.48 29.97 7.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -131.4 156.96 44.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.679 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.1 t -150.51 159.46 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.271 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -137.73 136.47 37.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.715 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.527 ' HA ' HG21 ' A' ' 157' ' ' VAL . . . -133.47 162.01 33.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.233 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.404 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 5.7 mmm -85.05 152.48 58.85 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.988 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.29 -52.06 9.14 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.324 2.016 . . . . 0.0 112.092 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 137' ' ' ARG . . . -62.07 -39.81 93.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 110.531 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -54.18 -46.05 72.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.695 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -62.22 -33.93 75.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.573 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.616 ' HG3' HD11 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -59.5 -54.35 47.61 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 110.195 179.629 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.616 HD11 ' HG3' ' A' ' 137' ' ' ARG . 4.7 mp -68.06 -24.2 65.05 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.547 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.583 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.64 -39.09 62.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.034 0.445 . . . . 0.0 109.947 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -76.44 -30.26 57.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.378 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -82.35 -49.25 10.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.094 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.443 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -85.08 -12.91 51.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.472 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.51 29.5 48.65 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.178 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 14.5 mm -87.73 147.91 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 111.476 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.96 100.93 10.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.678 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 139' ' ' ALA . 2.0 mp -63.59 -20.08 65.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.255 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 m -63.02 -19.79 64.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.85 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -107.08 -3.91 19.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.495 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.444 ' CG1' ' CB ' ' A' ' 162' ' ' ASP . 58.3 t -79.92 147.47 6.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.081 0.467 . . . . 0.0 111.025 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 110.75 5.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.261 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.64 123.64 10.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.194 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.436 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -142.73 33.8 1.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.357 0.599 . . . . 0.0 110.649 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.57 -165.17 12.36 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.777 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -31.46 96.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.73 2.953 . . . . 0.0 114.157 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.26 -18.51 17.44 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.309 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.07 46.52 0.17 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 131' ' ' ALA . 1.2 p -104.54 142.29 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 112.082 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -69.15 123.35 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.036 179.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.444 ' O ' HD13 ' A' ' 158' ' ' ILE . 1.3 p -106.74 165.95 10.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.163 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.418 HG23 ' CB ' ' A' ' 134' ' ' ALA . 21.6 t -50.21 -25.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.603 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.5 -45.57 86.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.583 ' HB2' HD11 ' A' ' 158' ' ' ILE . 8.1 m-20 -74.91 -33.3 61.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.493 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.569 HG22 HD13 ' A' ' 158' ' ' ILE . 9.8 t -66.02 -54.59 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -61.72 -35.69 78.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.514 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -43.31 68.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.324 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -72.29 -46.51 55.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.818 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.47 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -59.74 -39.77 85.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.602 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 172' ' ' LYS . 13.8 pt-20 -73.25 -36.97 66.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.13 0.491 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -21.9 50.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.989 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.7 t -91.34 -35.08 14.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.095 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.89 86.31 1.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.294 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -176.68 -73.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.738 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 174' ' ' THR . . . 61.64 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.72 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 173' ' ' ALA . 5.2 t 48.35 27.53 1.39 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.472 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -140.26 148.64 54.97 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.189 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.0 153.16 63.33 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.609 2.206 . . . . 0.0 112.312 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 178' ' ' PRO . . . -72.24 -61.15 1.93 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.197 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 177' ' ' ALA . 56.2 Cg_endo -70.34 129.83 17.64 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.488 2.125 . . . . 0.0 112.377 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.87 109.86 2.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.24 162.36 40.72 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.366 2.044 . . . . 0.0 112.33 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -96.97 -50.04 4.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.47 109.49 11.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.014 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.1 m -118.5 32.16 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.15 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -94.84 -50.52 5.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.12 174.63 11.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.132 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.14 132.27 11.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.885 0.374 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.68 119.2 38.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.23 -30.96 71.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.7 t -106.14 159.93 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.201 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.468 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -134.55 130.12 36.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 158' ' ' ILE . . . -133.32 162.13 32.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.962 0.41 . . . . 0.0 111.658 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.39 149.08 41.97 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.927 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.42 -51.99 9.24 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.27 1.98 . . . . 0.0 112.704 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.93 81.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 111.012 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.4 ' CB ' HG22 ' A' ' 163' ' ' VAL . . . -61.1 -52.92 62.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.124 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HA ' ' CD1' ' A' ' 146' ' ' LEU . 1.3 mtt180 -55.6 -37.43 68.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.76 -52.33 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.57 -23.15 67.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.86 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.548 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -74.71 -36.92 62.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.96 0.41 . . . . 0.0 110.434 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -76.38 -29.39 57.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.125 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.2 -48.56 11.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.2 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.479 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -88.97 -8.96 53.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.825 -179.273 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.4 35.78 55.83 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.102 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 139' ' ' ALA . 14.0 mm -90.17 140.68 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.972 0.415 . . . . 0.0 111.522 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.44 ' N ' HG21 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -93.23 100.78 13.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 136' ' ' ARG . 4.9 mt -64.51 -19.64 65.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.334 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.2 p -66.12 -15.36 63.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.196 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -113.45 6.82 17.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.651 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.425 HG23 HD13 ' A' ' 158' ' ' ILE . 87.5 t -90.69 144.13 9.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.888 0.375 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -70.98 113.52 8.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.347 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -77.56 120.55 5.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.921 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.49 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -123.53 24.89 8.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.026 0.441 . . . . 0.0 111.325 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.702 ' HA2' HG13 ' A' ' 157' ' ' VAL . . . -129.7 -154.92 8.27 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.592 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.563 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 30.6 Cg_exo -35.53 108.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.436 2.758 . . . . 0.0 114.445 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.98 8.0 14.89 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.616 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.84 40.71 1.81 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.702 HG13 ' HA2' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -85.74 142.4 13.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.99 -0.605 . . . . 0.0 111.401 -178.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' A' ' 131' ' ' ALA . 0.1 OUTLIER -82.55 131.01 34.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 p -110.66 170.98 7.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.217 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.2 t -54.92 -23.89 13.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.088 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.44 -41.49 76.2 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.406 ' CB ' ' CG1' ' A' ' 149' ' ' VAL . 0.7 OUTLIER -73.64 -38.72 64.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.306 179.227 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.429 HG21 ' CD1' ' A' ' 158' ' ' ILE . 48.5 t -68.53 -51.96 41.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.259 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -62.09 -34.11 75.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.439 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -75.43 -42.17 54.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.367 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.425 ' HD2' HG22 ' A' ' 144' ' ' ILE . 10.8 t80 -71.95 -48.37 45.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.069 0.462 . . . . 0.0 110.436 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.429 ' CB ' HG13 ' A' ' 144' ' ' ILE . . . -59.57 -38.83 82.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.325 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 11.6 pt-20 -74.77 -38.77 62.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.296 0.569 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -73.04 -22.01 60.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.77 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 167' ' ' ALA . 1.3 t -92.12 -41.06 10.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.948 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -158.95 99.2 1.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.473 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 0.1 OUTLIER -142.04 -167.91 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.737 179.684 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.0 78.73 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.0 p -115.62 33.62 5.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.827 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.28 115.58 20.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.066 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -86.9 26.48 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.805 2.337 . . . . 0.0 112.936 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 61.81 158.79 0.11 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.174 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.33 115.74 4.18 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.636 2.224 . . . . 0.0 112.305 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -97.71 112.53 61.72 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.151 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -50.98 170.45 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.498 2.132 . . . . 0.0 112.337 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -44.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.869 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -74.48 163.87 27.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.02 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.1 m -132.34 112.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.31 169.26 12.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -96.78 122.18 39.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.142 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.855 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.622 0.249 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.696 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.73 162.09 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.337 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.418 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 7.4 mtp -86.97 150.16 49.39 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.962 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -50.57 -52.02 9.88 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.168 1.912 . . . . 0.0 112.504 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.712 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.98 -34.96 79.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 110.61 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.654 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.65 -52.9 63.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.79 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.599 ' HA ' HD11 ' A' ' 146' ' ' LEU . 87.6 mtt-85 -56.0 -33.76 65.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.623 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -53.1 56.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.53 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -62.84 -25.4 68.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.783 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.077 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -73.88 -36.89 64.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.984 0.421 . . . . 0.0 110.352 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -76.34 -29.36 57.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.301 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -82.04 -49.04 10.67 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.148 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.541 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.59 -10.21 52.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.71 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 33.23 55.46 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.956 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.865 HG13 ' HB2' ' A' ' 167' ' ' ALA . 17.3 mm -87.81 142.88 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.93 0.395 . . . . 0.0 111.522 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.84 100.79 12.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 1.077 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.1 mt -65.12 -18.67 65.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.286 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -17.27 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.86 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -110.86 5.66 20.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.602 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.814 ' CB ' HD12 ' A' ' 158' ' ' ILE . 61.5 t -87.72 148.27 4.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.087 0.47 . . . . 0.0 111.198 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.95 109.92 5.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.349 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.82 122.2 8.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.919 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.49 HG22 ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -139.32 33.68 2.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.349 0.595 . . . . 0.0 110.661 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -126.96 -165.53 11.95 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.1 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -31.93 98.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.821 3.014 . . . . 0.0 114.285 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.2 -16.89 11.08 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.443 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.58 43.45 0.24 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.855 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -99.68 144.2 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.135 0.493 . . . . 0.0 111.729 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.924 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.6 127.78 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.369 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 31.0 p -102.86 167.94 9.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.797 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.712 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 99.0 t -54.77 -31.61 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 110.873 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.22 -39.39 94.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.49 ' OD2' HG22 ' A' ' 152' ' ' THR . 4.8 m-20 -69.89 -44.25 70.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.397 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.924 HG22 HD11 ' A' ' 158' ' ' ILE . 83.4 t -63.41 -54.64 30.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.292 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -57.65 -34.41 69.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.731 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -72.7 -49.54 30.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.438 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.706 ' CE2' HG23 ' A' ' 144' ' ' ILE . 14.9 t80 -65.99 -47.97 72.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.798 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.865 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.59 -42.01 77.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.403 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 6.9 pt-20 -72.13 -33.08 67.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.048 0.452 . . . . 0.0 110.454 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.418 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 23.0 tt0 -77.99 -24.07 48.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.5 t -89.35 -38.24 14.29 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.648 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.213 179.912 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.823 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.674 0.274 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.739 ' HB1' HD23 ' A' ' 146' ' ' LEU . . . -133.52 161.99 33.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.42 ' HG3' ' HB ' ' A' ' 159' ' ' THR . 35.9 mmm -84.53 155.42 62.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.922 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.92 -52.07 5.78 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.246 1.964 . . . . 0.0 112.247 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.624 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -62.95 -32.54 73.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.986 0.422 . . . . 0.0 110.624 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.809 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.13 -49.86 75.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.72 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.1 mtt85 -58.44 -33.4 69.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.511 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -63.6 -52.7 59.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.226 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -64.48 -24.2 67.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.816 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.73 -35.74 62.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.92 0.391 . . . . 0.0 110.378 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -76.39 -29.38 57.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.186 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -82.37 -48.94 10.55 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.161 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.84 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.97 -9.95 51.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.746 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.52 32.41 54.77 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.047 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.922 HG13 ' HB2' ' A' ' 167' ' ' ALA . 15.1 mm -88.35 148.61 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.132 0.491 . . . . 0.0 111.712 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -106.99 100.89 10.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.486 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.739 HD23 ' HB1' ' A' ' 131' ' ' ALA . 1.7 mp -62.56 -19.53 63.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.336 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.7 m -62.19 -21.05 64.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.924 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -106.32 -4.76 19.69 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.55 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.995 HG11 HD13 ' A' ' 158' ' ' ILE . 58.0 t -79.01 147.36 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -70.98 113.0 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.203 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.93 122.68 7.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.126 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -139.77 33.25 2.0 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.317 0.579 . . . . 0.0 110.661 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.45 -165.29 12.27 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.801 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -31.09 95.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.776 2.984 . . . . 0.0 114.197 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.76 -20.41 12.17 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.188 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 131.04 44.73 0.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.3 p -100.62 142.97 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.252 0.548 . . . . 0.0 111.956 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.995 HD13 HG11 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -71.26 124.61 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.03 179.415 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.83 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.4 p -107.34 165.7 11.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.231 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.624 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 30.0 t -50.16 -26.02 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.593 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -45.58 88.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.669 ' HB2' HD13 ' A' ' 158' ' ' ILE . 6.6 m-20 -74.83 -33.64 62.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.494 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.933 ' CG2' HD11 ' A' ' 158' ' ' ILE . 8.7 t -65.1 -54.53 28.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.6 tptp -61.31 -37.31 82.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.546 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.36 -42.96 74.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.307 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.56 ' CE2' HG23 ' A' ' 144' ' ' ILE . 23.3 t80 -71.45 -50.52 30.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.642 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.922 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -55.89 -39.41 71.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.254 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 22.6 pt-20 -75.63 -45.72 35.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.155 0.502 . . . . 0.0 109.866 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.2 tp10 -64.4 -21.93 66.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.487 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.1 t -93.71 -33.16 13.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.104 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.634 179.766 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.849 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.707 0.289 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.704 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.47 162.02 33.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 10.4 mtp -80.75 146.91 61.24 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.808 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.22 -40.11 21.49 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.249 1.966 . . . . 0.0 112.324 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -77.85 -27.87 49.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.603 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -63.37 -52.56 61.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.617 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.712 ' HA ' HD21 ' A' ' 146' ' ' LEU . 18.6 mtp-105 -56.25 -35.01 66.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.463 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -62.76 -51.56 66.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.25 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -64.21 -23.2 67.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.693 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -72.03 -41.47 67.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.581 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -76.52 -29.03 56.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.569 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.27 -43.62 17.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.652 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.845 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -100.65 -2.28 33.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.178 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.08 39.18 92.83 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.643 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.739 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 66.8 mt -87.54 141.8 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.054 0.454 . . . . 0.0 111.8 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.28 100.58 12.61 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.712 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER -68.29 -22.6 64.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.217 -178.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.5 m -65.19 -13.96 59.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.193 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -114.29 0.02 14.02 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.897 ' CB ' HD12 ' A' ' 158' ' ' ILE . 60.2 t -81.6 149.98 4.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.801 0.334 . . . . 0.0 110.959 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -70.96 108.79 4.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.314 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.67 119.99 7.93 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.808 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -136.88 34.48 2.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.231 0.538 . . . . 0.0 110.895 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.492 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -130.29 -166.25 11.76 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.3 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.426 ' N ' HG12 ' A' ' 157' ' ' VAL . 36.2 Cg_exo -32.53 100.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.864 3.043 . . . . 0.0 114.315 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.2 -16.38 9.5 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.474 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 126.75 42.25 0.29 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.849 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.7 p -97.65 144.4 11.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.197 -0.502 . . . . 0.0 111.35 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.0 129.29 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.791 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.0 p -100.86 168.0 9.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.174 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.765 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 50.4 t -55.64 -31.7 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.337 . . . . 0.0 111.139 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -38.88 84.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.119 0.485 . . . . 0.0 109.909 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.473 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 10.0 m-20 -74.94 -38.67 61.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.725 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.01 HG22 HD11 ' A' ' 158' ' ' ILE . 45.6 t -64.67 -54.71 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.042 0.449 . . . . 0.0 110.362 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -60.4 -40.7 91.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.794 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -69.04 -40.3 78.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.454 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.689 ' CE2' HG23 ' A' ' 144' ' ' ILE . 6.5 t80 -72.13 -52.15 18.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.845 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -57.63 -38.47 75.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.538 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.69 -34.69 69.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.237 0.542 . . . . 0.0 110.481 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -21.94 50.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.087 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.4 t -92.61 -35.13 13.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.652 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.641 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.869 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.57 0.224 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.672 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.72 162.21 32.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.311 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 4.7 mmm -86.26 150.3 51.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.172 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.59 -51.94 9.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.202 1.934 . . . . 0.0 112.149 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.756 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -59.75 -34.52 73.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.021 0.438 . . . . 0.0 110.637 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 1.011 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -59.98 -51.22 70.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.57 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.415 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 84.5 mtt-85 -55.11 -36.41 65.68 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.447 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.3 mtm-85 -61.48 -51.19 69.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.99 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 138' ' ' LEU . 0.9 OUTLIER -62.85 -24.84 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.762 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . . . -70.91 -41.54 71.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.731 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -76.38 -29.05 56.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.768 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -82.16 -43.79 17.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.575 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.618 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -100.67 -1.83 34.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.08 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.31 39.15 94.23 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.645 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.781 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 58.5 mt -87.55 144.99 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 112.002 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.8 100.64 12.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.85 ' HG ' HD11 ' A' ' 158' ' ' ILE . 2.5 mp -74.39 -20.74 59.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.229 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 t -61.93 -17.03 55.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.715 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -109.16 -9.78 15.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.63 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.972 ' HB ' HD12 ' A' ' 158' ' ' ILE . 57.8 t -70.66 146.09 12.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.063 0.459 . . . . 0.0 111.191 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.7 121.15 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.433 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -77.77 123.24 6.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.065 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.431 HG22 ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -143.46 38.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.29 0.567 . . . . 0.0 110.857 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -129.68 -162.65 10.91 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.102 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -31.75 96.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.775 2.983 . . . . 0.0 114.176 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.12 -18.15 14.62 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.277 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.37 44.4 0.19 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.869 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -103.74 141.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.352 0.596 . . . . 0.0 112.01 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.972 HD12 ' HB ' ' A' ' 149' ' ' VAL . 0.1 OUTLIER -67.42 127.93 29.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.5 p -108.07 172.82 6.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.102 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.756 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 53.7 t -54.67 -29.8 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -63.65 -40.78 97.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' OD2' HG22 ' A' ' 152' ' ' THR . 2.0 m-20 -71.81 -42.56 66.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.602 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.011 HG21 ' HB1' ' A' ' 135' ' ' ALA . 80.7 t -64.49 -54.53 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.381 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -58.67 -37.38 75.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -70.81 -46.4 62.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.153 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.576 ' CE2' HG23 ' A' ' 144' ' ' ILE . 16.8 t80 -65.52 -50.55 64.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.451 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.781 ' HB2' ' CD1' ' A' ' 144' ' ' ILE . . . -56.54 -44.61 81.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.547 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -71.98 -34.91 69.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.298 0.571 . . . . 0.0 110.405 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -77.42 -21.87 52.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.859 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.4 t -91.32 -41.14 11.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.866 0.365 . . . . 0.0 110.896 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.218 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.837 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.73 0.3 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.662 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.56 162.1 32.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.276 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.1 OUTLIER -83.25 153.77 66.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.41 -52.01 8.69 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.297 1.998 . . . . 0.0 112.344 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.813 ' HB3' HG21 ' A' ' 160' ' ' VAL . . . -64.79 -32.11 73.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.809 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.33 -52.97 62.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.885 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.654 ' HA ' HD11 ' A' ' 146' ' ' LEU . 9.1 mtt-85 -55.65 -36.53 67.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.453 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -61.45 -50.91 70.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.45 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -65.05 -24.67 67.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.89 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.037 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.64 -34.73 62.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.965 0.412 . . . . 0.0 110.537 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -33.63 59.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.362 0.601 . . . . 0.0 109.997 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -79.61 -47.99 14.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.073 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.817 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.23 -10.45 52.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.779 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.22 34.76 57.67 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.832 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.89 HG13 ' HB2' ' A' ' 167' ' ' ALA . 16.2 mm -90.81 141.83 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.015 0.436 . . . . 0.0 111.695 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.19 100.78 12.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 1.037 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.5 mt -63.5 -20.62 65.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.229 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 79.7 p -64.13 -16.83 62.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.106 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -108.57 -3.77 17.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.726 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.81 ' CB ' HD12 ' A' ' 158' ' ' ILE . 59.8 t -79.94 149.88 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.076 0.465 . . . . 0.0 111.04 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.1 OUTLIER -72.32 121.68 19.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.364 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.07 119.14 4.78 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.003 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -137.92 34.23 2.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.413 0.625 . . . . 0.0 110.678 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.485 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -126.77 -166.3 12.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.095 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -31.64 98.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.867 3.045 . . . . 0.0 114.269 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.77 -18.11 13.34 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.399 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.38 44.53 0.21 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.837 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.3 p -101.08 144.87 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.162 0.506 . . . . 0.0 111.685 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.829 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.1 126.31 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.137 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 23.3 p -102.36 167.13 10.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.62 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.813 HG21 ' HB3' ' A' ' 134' ' ' ALA . 95.4 t -54.78 -36.3 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.384 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 2.5 pt-20 -58.49 -37.05 74.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.606 ' HA ' ' HG2' ' A' ' 165' ' ' ARG . 34.5 m-20 -72.68 -46.89 51.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.355 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.829 HG22 HD11 ' A' ' 158' ' ' ILE . 71.1 t -56.92 -52.8 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 109.858 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -60.35 -37.67 81.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.234 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.606 ' HG2' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -72.29 -36.22 68.91 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.617 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.681 ' HE2' HG23 ' A' ' 144' ' ' ILE . 14.9 t80 -77.12 -50.09 13.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.038 0.447 . . . . 0.0 110.194 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.89 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -57.52 -36.37 71.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.378 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.02 -34.74 61.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.061 0.458 . . . . 0.0 110.443 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -78.05 -22.07 49.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.219 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 167' ' ' ALA . 3.0 t -88.45 -33.42 17.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.805 0.336 . . . . 0.0 111.049 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 -179.809 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.793 0.33 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.461 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.3 162.14 32.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.641 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.89 151.43 54.91 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.011 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.83 -52.14 9.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.306 2.004 . . . . 0.0 112.511 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.68 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -61.75 -36.05 79.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.008 0.432 . . . . 0.0 110.819 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.94 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.61 -52.81 63.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.912 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.669 ' HA ' HD11 ' A' ' 146' ' ' LEU . 76.8 mtt180 -56.27 -34.76 66.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.749 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -63.02 -52.0 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.252 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -64.66 -23.71 67.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.841 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.032 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.44 -36.8 63.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.016 0.436 . . . . 0.0 110.376 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -76.28 -29.3 57.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.144 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.12 -49.03 10.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.094 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.756 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.41 -10.13 52.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.804 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.12 32.64 55.95 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.946 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.854 HG13 ' HB2' ' A' ' 167' ' ' ALA . 17.8 mm -87.77 140.07 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.918 0.39 . . . . 0.0 111.437 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.48 100.78 13.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.5 mt -64.22 -17.72 63.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.208 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t -65.38 -15.62 62.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.199 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -114.03 5.61 16.14 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.73 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.803 ' CB ' HD12 ' A' ' 158' ' ' ILE . 57.4 t -87.62 145.63 7.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.941 0.401 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 111.88 7.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.629 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -75.45 118.28 5.47 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.72 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.459 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -126.83 29.37 5.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.109 0.481 . . . . 0.0 111.295 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.781 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -130.4 -156.6 8.71 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.242 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.564 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 40.5 Cg_exo -38.11 108.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.111 2.541 . . . . 0.0 114.07 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.82 5.81 27.06 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.494 -0.776 . . . . 0.0 113.519 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.5 40.69 1.86 Allowed Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -86.73 140.44 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.039 -0.581 . . . . 0.0 111.617 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.823 HD13 ' HB3' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -79.01 131.35 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.506 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.5 p -108.95 167.65 9.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.719 0.295 . . . . 0.0 110.842 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.68 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 47.4 t -54.2 -24.58 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 3.3 tt0 -65.79 -42.95 90.13 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.409 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 11.9 m-20 -74.21 -35.94 63.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.503 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.94 HG21 ' HB1' ' A' ' 135' ' ' ALA . 58.2 t -66.16 -53.69 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.955 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -62.82 -35.71 80.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.715 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 0.6 OUTLIER -71.78 -44.3 64.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.134 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.726 ' CE2' HG23 ' A' ' 144' ' ' ILE . 15.2 t80 -70.11 -47.66 60.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.983 0.42 . . . . 0.0 110.317 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.854 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -58.15 -39.0 77.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.548 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 14.2 pt-20 -75.27 -45.48 39.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.029 0.442 . . . . 0.0 110.429 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.1 tm-20 -65.19 -23.81 67.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.439 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.1 t -90.54 -37.36 13.91 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.684 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.439 179.88 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.777 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.823 0.345 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.66 ' CA ' HG23 ' A' ' 157' ' ' VAL . . . -133.4 162.05 32.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.446 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.5 OUTLIER -93.35 145.71 30.51 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.197 179.299 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.72 -52.04 9.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.406 2.071 . . . . 0.0 112.692 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.637 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -59.74 -37.39 78.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.976 0.417 . . . . 0.0 110.917 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.912 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.2 -52.84 63.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.027 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.624 ' HA ' HD11 ' A' ' 146' ' ' LEU . 14.4 mtm105 -56.86 -33.78 67.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.653 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -63.46 -50.9 67.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -65.77 -23.97 66.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.837 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.993 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.21 -37.05 63.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.013 0.435 . . . . 0.0 110.466 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -76.3 -29.28 57.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.251 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -82.13 -48.44 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.149 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.66 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.95 -10.7 49.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.735 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.5 36.03 45.24 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.842 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.762 HG13 ' HB2' ' A' ' 167' ' ' ALA . 23.3 mm -92.44 139.83 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.995 0.426 . . . . 0.0 111.583 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -93.2 100.75 13.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.993 HD21 ' HB2' ' A' ' 139' ' ' ALA . 6.1 mt -64.88 -16.73 63.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.368 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -15.65 62.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.061 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -112.27 2.71 16.69 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.643 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.781 ' CB ' HD12 ' A' ' 158' ' ' ILE . 47.7 t -86.91 142.23 13.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.094 0.474 . . . . 0.0 111.073 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -70.91 127.7 33.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.979 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.0 118.57 4.97 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.912 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -128.8 22.57 5.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.12 0.485 . . . . 0.0 110.827 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -113.78 -164.34 15.39 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.936 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -31.15 97.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.827 3.018 . . . . 0.0 114.258 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.14 -17.7 16.6 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.408 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.84 45.22 0.21 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.777 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.1 p -100.4 145.66 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.228 0.537 . . . . 0.0 111.781 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.829 HD13 ' HB3' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -72.94 124.85 30.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.155 179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.1 p -108.01 170.35 8.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.61 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.637 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 24.4 t -52.57 -25.7 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -66.21 -43.11 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 152' ' ' THR . 3.3 m-20 -73.08 -40.06 65.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.565 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.912 HG21 ' HB1' ' A' ' 135' ' ' ALA . 44.8 t -65.01 -53.52 40.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.073 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -61.82 -34.9 76.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.016 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -72.86 -47.29 47.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.792 0.33 . . . . 0.0 111.344 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.739 ' HE2' HG23 ' A' ' 144' ' ' ILE . 14.9 t80 -68.87 -41.13 78.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.309 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.762 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -63.71 -38.64 91.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.323 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -77.13 -36.94 54.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.136 0.493 . . . . 0.0 110.471 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.35 -24.51 59.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.935 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 167' ' ' ALA . 3.0 t -83.35 -39.64 20.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.67 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.379 179.86 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.827 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . . . -133.31 162.11 32.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.567 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.27 159.13 54.18 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.793 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.61 -52.07 3.48 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.122 1.882 . . . . 0.0 112.313 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.527 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -59.42 -35.72 74.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.087 0.47 . . . . 0.0 110.545 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.8 -51.22 70.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.587 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.827 ' CZ ' ' HB3' ' A' ' 131' ' ' ALA . 4.1 mtt85 -57.11 -34.13 68.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.675 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.11 -51.77 65.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.189 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.525 HD22 HG13 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -64.69 -24.22 67.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.765 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.75 -35.54 62.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.392 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -76.37 -29.44 57.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.125 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -82.18 -49.03 10.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.134 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.923 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -87.92 -9.12 54.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.758 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.15 34.76 54.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.148 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.957 HG13 ' HB2' ' A' ' 167' ' ' ALA . 13.1 mm -90.81 150.13 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.132 0.492 . . . . 0.0 111.711 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -107.91 100.98 10.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.473 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.654 HD23 ' HB1' ' A' ' 131' ' ' ALA . 1.4 mp -63.4 -17.65 62.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.422 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -18.74 62.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.917 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -110.43 -3.04 16.29 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.601 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 1.058 HG11 HD13 ' A' ' 158' ' ' ILE . 75.1 t -80.36 143.27 12.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.003 0.43 . . . . 0.0 111.07 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -71.25 112.74 7.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.206 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -76.29 123.52 6.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.282 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -127.09 15.97 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 0.0 111.367 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.72 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -115.02 -154.3 10.65 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.423 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.571 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 31.1 Cg_exo -36.01 106.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.426 2.751 . . . . 0.0 114.243 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.31 25.14 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.62 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.31 40.11 1.84 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.3 OUTLIER -86.68 142.3 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.086 -0.557 . . . . 0.0 111.241 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.058 HD13 HG11 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -81.14 123.63 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.823 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.2 p -106.66 166.12 10.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.343 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 21.1 t -50.33 -25.4 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.448 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.66 -45.86 84.96 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.724 ' HB2' HD13 ' A' ' 158' ' ' ILE . 4.9 m-20 -74.97 -33.78 61.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.439 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.945 ' CG2' HD11 ' A' ' 158' ' ' ILE . 6.1 t -65.12 -54.57 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -61.91 -35.9 79.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.59 -42.56 74.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.548 ' CE2' HG23 ' A' ' 144' ' ' ILE . 26.8 t80 -71.91 -51.27 23.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.552 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.957 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.82 -37.69 71.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.587 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 9.5 pt-20 -76.84 -42.5 39.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.264 0.554 . . . . 0.0 110.336 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.9 tp10 -70.07 -21.93 63.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.826 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.4 t -89.34 -41.01 12.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.048 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.87 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.842 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.68 0.276 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.678 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.5 162.11 32.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.437 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -89.06 150.04 44.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.089 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.59 -51.95 9.97 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.198 1.932 . . . . 0.0 112.443 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.658 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -60.2 -37.02 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.03 0.443 . . . . 0.0 110.713 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.821 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -59.62 -48.75 80.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.692 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -59.57 -34.77 73.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.641 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -50.03 72.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.283 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -67.2 -25.23 66.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.919 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.764 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.97 -32.34 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.034 0.445 . . . . 0.0 110.413 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -35.11 58.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.873 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -80.35 -47.5 14.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.207 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.769 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.02 -12.13 48.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.705 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.21 31.44 54.99 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.009 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.857 HG13 ' HB2' ' A' ' 167' ' ' ALA . 13.3 mm -88.46 147.85 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.449 . . . . 0.0 111.602 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.36 100.99 10.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.774 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.637 HD23 ' HB1' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -63.19 -17.8 62.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.549 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.5 m -63.31 -17.75 62.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.009 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -111.36 -1.09 16.11 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.584 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 1.08 HG11 HD13 ' A' ' 158' ' ' ILE . 63.6 t -81.01 148.62 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.004 0.43 . . . . 0.0 110.969 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 111.21 6.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.358 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.09 122.62 9.04 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.074 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -142.46 32.94 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.334 0.588 . . . . 0.0 110.569 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.77 -165.43 12.4 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.819 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -31.04 95.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.831 3.021 . . . . 0.0 114.197 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.56 -18.85 17.12 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.248 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.71 45.19 0.18 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.842 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.3 p -102.35 142.25 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.327 0.584 . . . . 0.0 111.997 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.08 HD13 HG11 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -68.66 124.68 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.868 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.812 ' N ' HD12 ' A' ' 158' ' ' ILE . 20.1 p -106.08 163.65 12.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.207 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.658 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 61.5 t -50.35 -33.28 10.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.467 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -59.16 -41.62 88.81 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.534 ' HB2' HD13 ' A' ' 158' ' ' ILE . 12.2 m-20 -74.97 -35.92 62.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.409 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.916 ' CG2' HD11 ' A' ' 158' ' ' ILE . 19.2 t -63.08 -54.7 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -37.62 84.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.458 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -65.99 -44.68 84.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.057 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.526 ' CE2' HG23 ' A' ' 144' ' ' ILE . 15.5 t80 -72.4 -46.89 53.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.731 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.857 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -57.82 -41.28 81.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.605 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.65 -37.23 70.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.288 0.566 . . . . 0.0 110.063 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -76.02 -21.9 56.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.832 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.5 t -94.64 -32.25 13.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.257 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.153 0 CA-C-O 120.784 0.326 . . . . 0.0 111.737 -179.772 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.766 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.476 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.28 162.04 32.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.417 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.445 ' HG3' HG22 ' A' ' 159' ' ' THR . 0.0 OUTLIER -85.54 151.25 55.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.838 178.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.16 -50.12 14.92 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.069 1.846 . . . . 0.0 112.31 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.638 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -66.18 -32.89 74.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.845 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.665 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.35 -52.97 62.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.767 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.618 ' HA ' HD11 ' A' ' 146' ' ' LEU . 50.1 mtp180 -56.38 -35.54 67.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.39 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -61.63 -49.51 76.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.176 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.64 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -64.7 -25.52 67.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.504 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.758 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -69.98 -41.93 73.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.021 0.439 . . . . 0.0 110.684 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.5 -29.15 56.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.86 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -82.17 -43.2 18.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.651 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.759 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -101.16 -2.36 31.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.971 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.95 39.03 93.21 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.648 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.764 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 65.5 mt -87.81 141.0 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 111.635 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.0 100.45 13.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.765 ' HB3' HD13 ' A' ' 158' ' ' ILE . 5.9 mt -71.4 -18.19 62.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -15.9 63.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -113.24 1.52 15.24 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.712 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.818 ' CB ' HD12 ' A' ' 158' ' ' ILE . 58.2 t -82.72 144.59 9.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.993 0.425 . . . . 0.0 110.799 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -70.88 117.73 12.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.625 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 156' ' ' GLY . . . -80.81 114.79 3.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.755 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.47 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -117.33 20.32 13.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.692 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -129.1 -153.86 8.07 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.754 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.52 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 21.2 Cg_exo -32.66 106.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.783 2.989 . . . . 0.0 114.617 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.5 10.58 8.09 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.876 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.412 ' O ' ' HA3' ' A' ' 151' ' ' GLY . . . 107.49 41.73 1.57 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -86.33 145.01 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.033 -0.583 . . . . 0.0 111.157 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.048 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -83.73 136.05 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 163' ' ' VAL . 36.1 p -112.16 166.9 10.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.318 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.64 HG13 HD22 ' A' ' 138' ' ' LEU . 24.3 t -55.18 -29.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.1 -40.12 94.12 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 14.1 m-20 -74.81 -39.12 61.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.389 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.048 HG22 HD11 ' A' ' 158' ' ' ILE . 60.1 t -65.26 -54.66 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.316 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -59.26 -42.5 91.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.837 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -67.65 -43.31 80.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.237 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.654 ' CE2' HG23 ' A' ' 144' ' ' ILE . 9.8 t80 -67.1 -54.41 21.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.491 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.764 ' HB2' ' CD1' ' A' ' 144' ' ' ILE . . . -53.01 -41.99 65.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.618 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.56 -33.03 72.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.97 -24.98 47.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.869 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.2 t -93.15 -37.99 11.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.752 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.313 179.833 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.839 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.728 0.299 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.756 ' HB1' HD23 ' A' ' 146' ' ' LEU . . . -133.54 162.14 32.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.169 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.0 mtp -86.48 148.63 47.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.091 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.35 -52.04 9.9 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.357 2.038 . . . . 0.0 112.375 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.587 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.09 -34.72 78.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.912 0.386 . . . . 0.0 110.711 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.767 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.0 -50.57 73.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.776 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -58.48 -34.5 70.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.608 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -62.47 -50.0 73.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.284 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -67.01 -25.07 66.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.905 179.556 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.9 -32.6 61.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.005 0.431 . . . . 0.0 110.38 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 -34.97 59.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.394 0.616 . . . . 0.0 109.944 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.07 -47.58 14.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.196 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.807 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.08 -11.81 49.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.713 -179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.54 31.84 55.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.885 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.934 HG13 ' HB2' ' A' ' 167' ' ' ALA . 11.0 mm -87.83 148.7 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.542 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -106.19 100.96 10.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.697 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.756 HD23 ' HB1' ' A' ' 131' ' ' ALA . 1.8 mp -63.65 -20.0 65.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.495 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -19.96 63.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.965 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -107.19 -6.21 17.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.514 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 1.009 HG11 HD13 ' A' ' 158' ' ' ILE . 58.0 t -77.47 146.92 7.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.054 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 111.77 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.362 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.78 122.48 8.34 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.051 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.455 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -138.85 32.69 2.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.291 0.567 . . . . 0.0 110.673 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -124.13 -164.79 12.06 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.865 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -31.69 97.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.781 2.988 . . . . 0.0 114.192 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.36 -18.1 15.79 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.344 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.75 44.43 0.2 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.839 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.4 p -100.32 142.4 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 111.99 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.009 HD13 HG11 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -71.43 124.81 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.306 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.842 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.3 p -107.05 165.14 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.162 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.587 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 21.9 t -50.14 -25.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.676 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.39 -45.68 86.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.699 ' HB2' HD13 ' A' ' 158' ' ' ILE . 5.7 m-20 -74.86 -33.07 62.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.484 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.931 ' CG2' HD11 ' A' ' 158' ' ' ILE . 7.0 t -66.02 -54.6 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -61.6 -36.24 80.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.588 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -70.86 -42.11 70.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.28 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.536 ' CE2' HG23 ' A' ' 144' ' ' ILE . 22.3 t80 -71.62 -49.89 35.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.651 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.934 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.94 -39.76 75.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.496 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.61 -35.32 67.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 110.217 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -77.93 -24.49 48.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.955 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.8 t -89.75 -33.99 16.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.775 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.218 179.874 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.862 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.743 0.306 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.704 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.51 162.15 32.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.184 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -86.27 149.18 49.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.055 179.037 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.456 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 65.7 Cg_exo -50.9 -52.07 9.84 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.366 2.044 . . . . 0.0 112.516 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.651 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -64.04 -35.13 79.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.957 0.408 . . . . 0.0 110.817 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.98 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -59.78 -52.82 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.995 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.728 ' HA ' HD11 ' A' ' 146' ' ' LEU . 4.5 mtt-85 -56.17 -34.98 66.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -61.79 -51.34 68.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.047 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -65.05 -24.19 67.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.77 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.127 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.81 -33.68 62.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.416 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.26 -34.16 59.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.962 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -80.59 -47.57 13.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.225 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.793 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.71 -10.91 49.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.822 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.17 36.17 56.5 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.929 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.921 HG13 ' HB2' ' A' ' 167' ' ' ALA . 11.5 mm -90.69 142.12 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.933 0.397 . . . . 0.0 111.659 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.87 100.78 12.89 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 1.127 HD21 ' HB2' ' A' ' 139' ' ' ALA . 3.9 mt -63.05 -22.13 66.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.349 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.2 p -66.75 -14.96 63.2 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -111.2 5.65 20.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.667 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.828 ' HB ' HD12 ' A' ' 158' ' ' ILE . 87.9 t -90.34 148.1 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.031 0.444 . . . . 0.0 110.97 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -70.87 108.56 4.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.457 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -71.06 123.5 10.64 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.974 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -141.7 34.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.309 0.576 . . . . 0.0 110.746 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -125.34 -164.64 11.9 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.955 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.408 ' N ' HG12 ' A' ' 157' ' ' VAL . 36.6 Cg_exo -31.69 96.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.809 3.006 . . . . 0.0 114.264 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.88 -17.07 17.71 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.389 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.26 43.97 0.22 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.862 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -100.8 143.08 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.208 0.528 . . . . 0.0 111.84 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.836 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -70.42 127.28 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.141 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.3 p -106.43 167.05 10.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.651 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 44.8 t -52.84 -26.87 11.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.125 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -64.77 -44.03 91.35 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.424 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 13.9 m-20 -71.62 -37.35 70.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.653 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.98 HG21 ' HB1' ' A' ' 135' ' ' ALA . 55.2 t -66.87 -54.56 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.406 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -60.87 -33.75 73.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.565 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -43.73 56.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.336 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.713 ' CE2' HG23 ' A' ' 144' ' ' ILE . 7.8 t80 -70.81 -46.75 62.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.465 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.921 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -62.02 -35.58 78.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.629 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.09 -36.29 55.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.088 0.47 . . . . 0.0 110.773 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.25 -21.91 55.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.025 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 167' ' ' ALA . 2.5 t -87.23 -40.52 14.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 110.797 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.168 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.758 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.56 0.219 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.468 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.24 162.1 32.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.949 0.404 . . . . 0.0 111.735 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.0 mtp -84.47 152.06 60.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.651 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.34 -41.9 49.59 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.119 1.88 . . . . 0.0 112.441 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.615 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -74.88 -30.37 61.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.89 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.69 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.95 -50.94 71.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.616 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.98 ' HA ' HD21 ' A' ' 146' ' ' LEU . 56.2 mtm180 -57.03 -34.28 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.304 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.22 -49.01 75.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.264 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 1.019 HD22 HG13 ' A' ' 160' ' ' VAL . 0.8 OUTLIER -65.77 -24.31 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.299 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.708 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -74.12 -36.28 64.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.64 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -76.5 -30.18 57.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.278 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -82.3 -48.99 10.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.858 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -92.33 -7.39 48.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.063 -179.003 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.32 38.97 58.26 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.087 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.809 HG13 ' HB2' ' A' ' 167' ' ' ALA . 12.0 mm -92.22 142.47 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.095 0.474 . . . . 0.0 111.793 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.38 100.73 12.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.98 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -57.88 -25.1 60.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.342 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -14.7 62.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.177 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -112.5 4.93 17.71 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.837 ' CB ' HD12 ' A' ' 158' ' ' ILE . 93.6 t -92.69 150.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.875 0.369 . . . . 0.0 111.021 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -70.89 105.92 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.396 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -73.04 116.84 5.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.841 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.476 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -126.58 31.48 5.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.087 0.47 . . . . 0.0 111.089 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.77 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -132.14 -156.87 8.44 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.363 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.564 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 39.0 Cg_exo -38.18 109.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.235 2.623 . . . . 0.0 114.142 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.66 5.66 25.24 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.592 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.59 39.08 2.11 Favored Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.77 HG12 ' HA3' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -84.63 143.78 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.999 -0.601 . . . . 0.0 111.469 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.065 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -81.16 136.31 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.503 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 163' ' ' VAL . 18.5 p -112.12 165.55 12.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.87 0.367 . . . . 0.0 111.04 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 1.019 HG13 HD22 ' A' ' 138' ' ' LEU . 39.3 t -52.45 -31.1 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.022 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.02 -39.45 93.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.16 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -74.88 -40.14 61.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.542 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.065 HG22 HD11 ' A' ' 158' ' ' ILE . 26.9 t -64.65 -54.75 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.021 0.438 . . . . 0.0 110.263 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -41.51 97.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.414 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.428 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 73.3 mtt-85 -62.65 -47.65 82.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.317 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.734 ' CE2' HG23 ' A' ' 144' ' ' ILE . 0.6 OUTLIER -62.87 -54.65 35.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.021 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.858 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -59.65 -41.85 91.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.841 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -72.91 -31.74 64.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 110.655 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 1.2 tm-20 -77.95 -21.98 50.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.303 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -98.07 -27.95 13.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.881 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 170' ' ' THR . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.921 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.837 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.047 0 CA-C-O 120.821 0.343 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.714 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.4 162.06 32.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.425 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -89.84 147.28 37.11 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.151 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.78 -51.99 9.75 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.282 1.988 . . . . 0.0 112.371 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.634 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.13 -33.69 75.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 110.629 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.673 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -62.06 -52.9 62.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.673 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.62 ' HA ' HD11 ' A' ' 146' ' ' LEU . 83.6 mtt-85 -54.65 -38.24 66.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 110.501 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -60.72 -49.66 76.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.129 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.787 HD22 HG13 ' A' ' 160' ' ' VAL . 1.1 mp -64.15 -24.18 67.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.57 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.077 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.83 -36.16 62.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.943 0.401 . . . . 0.0 110.493 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -76.34 -33.04 58.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.315 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -82.01 -44.74 16.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.092 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.55 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -85.0 -13.3 51.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.294 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.09 39.12 54.31 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.257 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.988 HG13 ' HB2' ' A' ' 167' ' ' ALA . 25.5 mm -100.81 146.36 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.88 100.79 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 1.077 HD21 ' HB2' ' A' ' 139' ' ' ALA . 4.3 mt -61.4 -21.54 64.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.621 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -61.97 -17.67 57.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.001 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -107.66 -8.56 16.08 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.677 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.821 ' CB ' HD12 ' A' ' 158' ' ' ILE . 59.0 t -76.28 146.21 9.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.052 0.454 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -71.46 118.74 14.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.444 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.24 119.28 5.14 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.822 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -135.71 34.27 2.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.343 0.592 . . . . 0.0 110.747 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -127.24 -164.75 11.75 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.989 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -31.66 97.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.911 3.074 . . . . 0.0 114.233 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.52 -17.04 15.7 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.425 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.78 44.32 0.22 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.837 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -100.8 144.31 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.12 0.485 . . . . 0.0 111.77 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.867 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.78 127.73 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.346 179.441 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 3.4 p -104.3 164.22 11.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.322 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.787 HG13 HD22 ' A' ' 138' ' ' LEU . 83.3 t -51.33 -27.63 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.804 0.335 . . . . 0.0 110.999 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -63.05 -42.83 99.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.002 0.429 . . . . 0.0 109.865 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.423 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 14.3 m-20 -72.69 -36.64 67.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.868 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.867 HG22 HD11 ' A' ' 158' ' ' ILE . 79.1 t -66.67 -54.63 23.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.906 0.384 . . . . 0.0 110.143 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -61.0 -36.02 78.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.785 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -71.9 -46.02 59.2 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.705 ' CE2' HG23 ' A' ' 144' ' ' ILE . 18.7 t80 -66.42 -51.1 60.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.52 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.988 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.73 -42.48 79.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.517 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.8 -36.34 70.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.345 0.593 . . . . 0.0 110.24 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -75.63 -21.95 57.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.79 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.3 t -93.92 -34.76 12.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.115 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.886 0.374 . . . . 0.0 111.506 -179.762 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.826 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.692 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.42 162.0 33.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.032 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 36.1 mmm -87.35 152.98 53.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.103 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.12 -52.03 6.59 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.283 1.988 . . . . 0.0 112.026 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.579 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -61.86 -30.06 70.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.66 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.945 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -63.94 -52.8 58.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.607 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.646 ' HA ' HD11 ' A' ' 146' ' ' LEU . 80.6 mtt180 -55.99 -36.16 67.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -62.39 -50.06 73.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.208 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.61 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -64.86 -23.79 67.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.751 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.903 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.46 -38.43 62.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.881 0.372 . . . . 0.0 110.539 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -76.31 -29.41 57.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.292 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -82.37 -45.04 15.38 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.55 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.58 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -97.29 -2.8 41.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.118 -178.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.28 38.91 91.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.712 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.768 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 64.9 mt -87.62 142.71 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.401 . . . . 0.0 111.444 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -94.17 100.46 12.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.903 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.7 mt -72.07 -21.91 61.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.254 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.94 -15.89 62.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -111.72 0.25 16.22 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.834 ' HB ' HD12 ' A' ' 158' ' ' ILE . 57.2 t -81.98 148.82 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.139 0.495 . . . . 0.0 111.185 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.5 OUTLIER -77.27 124.53 27.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.199 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -82.57 121.69 5.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.175 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.448 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -137.49 34.22 2.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -124.19 -164.71 12.03 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.709 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -30.92 95.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.798 2.999 . . . . 0.0 114.301 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.84 -17.62 20.44 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.453 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.77 45.04 0.19 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.826 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.4 p -102.13 144.21 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.162 0.506 . . . . 0.0 111.822 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.834 HD12 ' HB ' ' A' ' 149' ' ' VAL . 0.1 OUTLIER -71.89 126.72 32.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.021 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.6 p -109.37 167.85 9.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.409 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.61 HG13 HD22 ' A' ' 138' ' ' LEU . 21.9 t -52.42 -26.37 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.753 0.311 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 4.1 mt-10 -65.43 -43.2 91.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.85 -43.68 57.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.827 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.945 HG21 ' HB1' ' A' ' 135' ' ' ALA . 20.0 t -57.22 -54.24 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.054 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.524 ' HA ' ' CE ' ' A' ' 164' ' ' LYS . 0.2 OUTLIER -65.29 -46.84 78.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 12.6 mtp180 -52.96 -41.71 64.81 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.053 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.531 ' CE2' HG23 ' A' ' 144' ' ' ILE . 12.3 t80 -73.7 -46.66 44.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.267 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.768 ' HB2' ' CD1' ' A' ' 144' ' ' ILE . . . -59.88 -49.1 79.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.458 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.91 -34.08 76.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.32 0.581 . . . . 0.0 109.981 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.7 OUTLIER -78.13 -30.13 49.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.674 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 167' ' ' ALA . 0.6 OUTLIER -82.12 -37.06 26.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.632 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.4 179.861 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.85 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.705 0.288 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.715 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.45 161.03 35.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.8 mtp -81.5 153.01 70.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.78 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.21 -41.45 75.87 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.203 1.935 . . . . 0.0 111.985 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.715 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -75.1 -27.39 59.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.652 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.759 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -65.21 -50.85 64.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.679 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.852 ' HA ' HD21 ' A' ' 146' ' ' LEU . 3.3 mtt-85 -55.94 -42.68 76.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.124 0.487 . . . . 0.0 110.261 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -57.94 -47.46 82.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.799 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.799 HD22 HG13 ' A' ' 160' ' ' VAL . 0.8 OUTLIER -65.37 -22.96 66.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.148 178.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.591 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -73.29 -37.88 66.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.536 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -76.38 -30.69 57.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.313 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.32 -44.65 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.565 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.884 HD12 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -95.6 -3.95 45.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.743 -179.147 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.46 37.66 92.86 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.478 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.741 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 45.1 mt -89.41 138.52 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.39 100.55 12.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.852 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -61.63 -23.0 65.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.539 -178.116 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 t -66.65 -12.19 57.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.305 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -115.6 4.44 14.15 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.876 ' CB ' HD12 ' A' ' 158' ' ' ILE . 67.3 t -89.2 152.02 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.778 0.323 . . . . 0.0 110.921 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.81 106.48 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.349 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.95 120.41 9.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.914 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -137.82 32.2 2.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 110.796 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.491 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -126.98 -166.38 12.14 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.129 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.406 ' N ' HG12 ' A' ' 157' ' ' VAL . 36.5 Cg_exo -32.26 99.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.86 3.04 . . . . 0.0 114.307 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.26 -17.16 10.48 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.435 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.46 43.19 0.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.85 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -98.51 143.88 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.129 0.49 . . . . 0.0 111.523 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.059 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -72.31 127.61 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.69 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 163' ' ' VAL . 11.4 p -100.67 165.83 11.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.207 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.799 HG13 HD22 ' A' ' 138' ' ' LEU . 67.9 t -54.96 -30.53 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.701 0.286 . . . . 0.0 111.142 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -61.77 -39.77 92.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.009 0.433 . . . . 0.0 109.85 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 10.8 m-20 -74.85 -37.61 62.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.416 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.059 HG22 HD11 ' A' ' 158' ' ' ILE . 42.1 t -64.12 -54.84 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.591 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -61.64 -42.44 98.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.618 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 2.0 mtt180 -64.57 -45.2 88.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 111.054 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.713 ' CE2' HG23 ' A' ' 144' ' ' ILE . 3.7 t80 -67.21 -49.46 64.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.884 ' HB1' HD12 ' A' ' 142' ' ' LEU . . . -63.38 -34.5 77.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.958 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 6.3 pt-20 -74.28 -38.03 63.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.0 110.562 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.72 -21.91 57.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.984 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.6 t -91.93 -36.7 13.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.247 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 0.0 111.591 -179.835 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.77 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.762 0.315 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.528 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.23 162.03 32.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.639 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -88.24 157.65 50.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.718 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.64 -52.02 7.03 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.157 1.904 . . . . 0.0 112.224 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.576 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.05 -32.71 74.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.943 0.402 . . . . 0.0 110.601 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.727 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -63.45 -52.83 59.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.644 ' HA ' HD11 ' A' ' 146' ' ' LEU . 1.1 mtm105 -56.44 -34.41 66.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.135 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -62.25 -50.99 69.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.964 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.691 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -63.96 -24.03 67.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.382 179.186 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.781 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -71.33 -40.76 70.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 110.617 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -76.32 -29.2 57.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.701 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -82.2 -44.17 16.72 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.576 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.805 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -99.61 -2.22 36.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.061 -178.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.53 39.13 93.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.588 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.775 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 67.2 mt -87.63 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.971 0.415 . . . . 0.0 111.712 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.26 100.48 12.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.811 ' HB3' HD13 ' A' ' 158' ' ' ILE . 5.6 mt -70.52 -18.83 62.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.278 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.57 -15.0 62.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.994 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -114.58 3.17 14.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.708 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.822 ' CB ' HD12 ' A' ' 158' ' ' ILE . 84.3 t -83.96 144.45 9.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.947 0.403 . . . . 0.0 110.809 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 111.45 6.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.413 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -76.44 120.22 5.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.979 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -122.83 18.96 10.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 0.0 111.235 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.716 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -123.86 -154.21 8.87 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.587 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 26.6 Cg_exo -34.73 109.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.553 2.835 . . . . 0.0 114.467 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.27 8.53 6.71 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.518 -0.764 . . . . 0.0 113.806 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.95 41.37 1.7 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.77 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -85.54 145.03 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.054 -0.573 . . . . 0.0 111.433 -178.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.93 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -83.87 132.47 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 163' ' ' VAL . 7.3 p -112.07 166.82 10.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.932 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.691 HG13 HD22 ' A' ' 138' ' ' LEU . 19.2 t -53.27 -27.74 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.293 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 4.4 pt-20 -64.12 -42.97 96.64 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -75.09 -38.12 61.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.93 HG22 HD11 ' A' ' 158' ' ' ILE . 58.3 t -62.59 -54.54 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.907 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -60.73 -41.38 95.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.022 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -68.79 -37.52 79.33 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.689 0.28 . . . . 0.0 111.491 -179.484 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.665 ' CE2' HG23 ' A' ' 144' ' ' ILE . 7.2 t80 -74.01 -54.1 8.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.805 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -52.7 -41.08 63.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.551 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 10.4 pt-20 -71.12 -39.39 72.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.153 0.502 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 6.9 tt0 -70.1 -21.96 63.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.501 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -97.8 -34.27 10.94 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.114 -179.883 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.843 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.719 0.295 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.71 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.38 162.05 32.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.2 mtp -82.61 146.33 53.02 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.87 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.45 -39.21 22.02 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.19 1.926 . . . . 0.0 112.349 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.751 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -77.71 -28.18 50.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.613 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -64.01 -50.89 66.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.66 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.726 ' HA ' HD21 ' A' ' 146' ' ' LEU . 73.6 mtt180 -58.3 -35.51 71.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.334 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -62.25 -50.39 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.124 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.473 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -65.86 -23.05 66.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.561 179.239 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.711 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -73.21 -38.62 66.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.646 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -32.24 58.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.482 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -82.11 -42.71 18.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.616 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.826 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -99.47 -2.9 34.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.962 -178.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.82 39.21 95.01 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.197 -1.002 . . . . 0.0 111.618 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.745 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 68.6 mt -87.55 143.34 11.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.031 0.443 . . . . 0.0 111.811 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -95.38 100.61 12.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.726 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER -68.46 -24.1 64.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.088 -178.775 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -65.44 -14.77 61.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.038 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -110.92 -2.2 16.12 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.761 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.892 ' CB ' HD12 ' A' ' 158' ' ' ILE . 62.1 t -82.49 148.48 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.966 0.412 . . . . 0.0 111.109 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.99 110.3 5.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.487 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.63 120.4 7.49 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.907 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -135.7 32.94 2.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.344 0.593 . . . . 0.0 110.726 -179.574 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.485 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -127.73 -165.73 11.92 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.189 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.413 ' N ' HG12 ' A' ' 157' ' ' VAL . 35.2 Cg_exo -32.22 99.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.82 3.014 . . . . 0.0 114.33 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.73 -16.64 10.64 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.46 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.09 43.01 0.26 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.843 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.6 p -98.47 144.46 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.314 -0.443 . . . . 0.0 111.536 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.021 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.75 128.33 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 110.924 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 p -101.02 168.6 9.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.144 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.751 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 46.5 t -56.21 -30.22 29.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.712 0.291 . . . . 0.0 110.991 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.75 -39.04 90.18 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.495 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 12.1 m-20 -75.05 -38.32 61.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.615 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.021 HG22 HD11 ' A' ' 158' ' ' ILE . 52.5 t -64.47 -54.74 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.097 0.475 . . . . 0.0 110.313 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -60.51 -41.36 94.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.792 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -68.23 -40.15 82.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.425 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.655 ' CE2' HG23 ' A' ' 144' ' ' ILE . 6.8 t80 -72.29 -52.67 15.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.921 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.826 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -55.66 -39.73 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.381 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 8.8 pt-20 -72.21 -38.15 69.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.35 0.595 . . . . 0.0 110.04 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.416 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 1.7 tp10 -73.13 -21.97 60.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.733 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.1 t -96.58 -41.06 8.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.428 179.966 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.829 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.697 0.284 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.709 ' HB1' HD23 ' A' ' 146' ' ' LEU . . . -133.47 162.01 33.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.233 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.413 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 5.7 mmm -85.05 152.48 58.85 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.988 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.29 -52.06 9.14 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.324 2.016 . . . . 0.0 112.092 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.645 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -62.07 -39.81 93.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 110.531 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.816 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -54.18 -46.05 72.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.695 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -62.22 -33.93 75.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.573 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.81 ' HG2' HD13 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -59.5 -54.35 47.61 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 110.195 179.629 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.81 HD13 ' HG2' ' A' ' 137' ' ' ARG . 4.7 mp -68.06 -24.2 65.05 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.547 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.69 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . . . -74.64 -39.09 62.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.034 0.445 . . . . 0.0 109.947 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -76.44 -30.26 57.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.378 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -82.35 -49.25 10.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.094 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.774 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -85.08 -12.91 51.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.472 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.51 29.5 48.65 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.178 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.873 HG13 ' HB2' ' A' ' 167' ' ' ALA . 14.5 mm -87.73 147.91 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 111.476 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.96 100.93 10.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.678 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.709 HD23 ' HB1' ' A' ' 131' ' ' ALA . 2.0 mp -63.59 -20.08 65.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.255 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 m -63.02 -19.79 64.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.85 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -107.08 -3.91 19.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.495 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.983 HG11 HD13 ' A' ' 158' ' ' ILE . 58.3 t -79.92 147.47 6.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.081 0.467 . . . . 0.0 111.025 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 110.75 5.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.261 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.64 123.64 10.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.194 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.73 33.8 1.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.357 0.599 . . . . 0.0 110.649 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.57 -165.17 12.36 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.777 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -31.46 96.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.73 2.953 . . . . 0.0 114.157 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.26 -18.51 17.44 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.309 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.07 46.52 0.17 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.829 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.2 p -104.54 142.29 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 112.082 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.983 HD13 HG11 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -69.15 123.35 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.036 179.348 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.835 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.3 p -106.74 165.95 10.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.163 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.645 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 21.6 t -50.21 -25.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.603 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.5 -45.57 86.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.703 ' HB2' HD13 ' A' ' 158' ' ' ILE . 8.1 m-20 -74.91 -33.3 61.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.493 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.934 ' CG2' HD11 ' A' ' 158' ' ' ILE . 9.8 t -66.02 -54.59 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -61.72 -35.69 78.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.514 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -43.31 68.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.324 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.585 ' CE2' HG23 ' A' ' 144' ' ' ILE . 19.7 t80 -72.29 -46.51 55.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.818 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.873 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -59.74 -39.77 85.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.602 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -73.25 -36.97 66.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.13 0.491 . . . . 0.0 110.307 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -21.9 50.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.989 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.7 t -91.34 -35.08 14.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.095 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.294 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.72 0.295 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.486 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.32 162.13 32.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.962 0.41 . . . . 0.0 111.658 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.39 149.08 41.97 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.927 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.42 -51.99 9.24 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.27 1.98 . . . . 0.0 112.704 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.612 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -61.14 -36.93 81.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 111.012 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.859 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.1 -52.92 62.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.124 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.713 ' HA ' HD11 ' A' ' 146' ' ' LEU . 1.3 mtt180 -55.6 -37.43 68.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.76 -52.33 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -64.57 -23.15 67.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.86 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.081 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.71 -36.92 62.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.96 0.41 . . . . 0.0 110.434 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -76.38 -29.39 57.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.125 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.2 -48.56 11.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.2 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.621 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -88.97 -8.96 53.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.825 -179.273 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.4 35.78 55.83 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.102 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.858 HG13 ' HB2' ' A' ' 167' ' ' ALA . 14.0 mm -90.17 140.68 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.972 0.415 . . . . 0.0 111.522 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.23 100.78 13.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 1.081 HD21 ' HB2' ' A' ' 139' ' ' ALA . 4.9 mt -64.51 -19.64 65.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.334 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.2 p -66.12 -15.36 63.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.196 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -113.45 6.82 17.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.651 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.791 ' CB ' HD12 ' A' ' 158' ' ' ILE . 87.5 t -90.69 144.13 9.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.888 0.375 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -70.98 113.52 8.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.347 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -77.56 120.55 5.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.921 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.486 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -123.53 24.89 8.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.026 0.441 . . . . 0.0 111.325 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.724 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -129.7 -154.92 8.27 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.592 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 30.6 Cg_exo -35.53 108.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.436 2.758 . . . . 0.0 114.445 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.98 8.0 14.89 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.616 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.84 40.71 1.81 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.811 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -85.74 142.4 13.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.99 -0.605 . . . . 0.0 111.401 -178.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.823 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -82.55 131.01 34.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 p -110.66 170.98 7.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.217 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.612 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 15.2 t -54.92 -23.89 13.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.088 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.44 -41.49 76.2 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.406 ' CB ' ' CG1' ' A' ' 149' ' ' VAL . 0.7 OUTLIER -73.64 -38.72 64.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.306 179.227 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.859 HG21 ' HB1' ' A' ' 135' ' ' ALA . 48.5 t -68.53 -51.96 41.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.259 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -62.09 -34.11 75.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.439 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -75.43 -42.17 54.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.367 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.746 ' CE2' HG23 ' A' ' 144' ' ' ILE . 10.8 t80 -71.95 -48.37 45.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.069 0.462 . . . . 0.0 110.436 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.858 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -59.57 -38.83 82.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.325 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 11.6 pt-20 -74.77 -38.77 62.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.296 0.569 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 17.8 tt0 -73.04 -22.01 60.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.3 t -92.12 -41.06 10.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.948 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.473 -179.9 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.3 p -80.79 90.29 5.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 110.981 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -105.38 -168.54 1.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 129' ' ' VAL . 6.2 mt-10 -99.36 164.37 12.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.034 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.773 HG22 ' H ' ' A' ' 130' ' ' ALA . 1.7 p 44.94 -168.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.468 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.855 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -123.18 143.06 50.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.696 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.73 162.09 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.337 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.418 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 7.4 mtp -86.97 150.16 49.39 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.962 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -50.57 -52.02 9.88 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.168 1.912 . . . . 0.0 112.504 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.712 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.98 -34.96 79.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 110.61 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.654 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.65 -52.9 63.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.79 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.599 ' HA ' HD11 ' A' ' 146' ' ' LEU . 87.6 mtt-85 -56.0 -33.76 65.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.623 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -53.1 56.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.53 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -62.84 -25.4 68.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.783 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.077 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -73.88 -36.89 64.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.984 0.421 . . . . 0.0 110.352 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -76.34 -29.36 57.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.301 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -82.04 -49.04 10.67 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.148 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.541 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.59 -10.21 52.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.71 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 33.23 55.46 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.956 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.865 HG13 ' HB2' ' A' ' 167' ' ' ALA . 17.3 mm -87.81 142.88 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.93 0.395 . . . . 0.0 111.522 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.84 100.79 12.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.077 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.1 mt -65.12 -18.67 65.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.286 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -17.27 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.86 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -110.86 5.66 20.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.602 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.814 ' CB ' HD12 ' A' ' 158' ' ' ILE . 61.5 t -87.72 148.27 4.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.087 0.47 . . . . 0.0 111.198 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.95 109.92 5.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.349 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.82 122.2 8.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.919 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.49 HG22 ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -139.32 33.68 2.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.349 0.595 . . . . 0.0 110.661 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -126.96 -165.53 11.95 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.1 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -31.93 98.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.821 3.014 . . . . 0.0 114.285 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.2 -16.89 11.08 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.443 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.58 43.45 0.24 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.855 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -99.68 144.2 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.135 0.493 . . . . 0.0 111.729 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.924 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.6 127.78 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.369 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 31.0 p -102.86 167.94 9.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.797 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.712 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 99.0 t -54.77 -31.61 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 110.873 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.22 -39.39 94.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.49 ' OD2' HG22 ' A' ' 152' ' ' THR . 4.8 m-20 -69.89 -44.25 70.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.397 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.924 HG22 HD11 ' A' ' 158' ' ' ILE . 83.4 t -63.41 -54.64 30.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.292 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -57.65 -34.41 69.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.731 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -72.7 -49.54 30.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.438 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.706 ' CE2' HG23 ' A' ' 144' ' ' ILE . 14.9 t80 -65.99 -47.97 72.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.798 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.865 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.59 -42.01 77.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.403 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 6.9 pt-20 -72.13 -33.08 67.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.048 0.452 . . . . 0.0 110.454 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.418 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 23.0 tt0 -77.99 -24.07 48.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.5 t -89.35 -38.24 14.29 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.648 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -168.02 93.03 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 9.9 ttpt -109.78 -41.32 4.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.755 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -156.66 75.59 0.85 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.008 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.11 48.13 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.976 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 176' ' ' PRO . . . -177.02 -62.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.122 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 175' ' ' ALA . 57.2 Cg_endo -71.09 108.96 2.44 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.552 2.168 . . . . 0.0 112.323 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.763 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . . . -88.23 -52.97 0.38 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.763 ' HD3' ' HB3' ' A' ' 177' ' ' ALA . 50.7 Cg_exo -53.32 115.74 2.49 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.474 2.116 . . . . 0.0 112.24 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -135.73 87.91 24.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.173 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.42 170.49 16.05 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.513 2.142 . . . . 0.0 112.25 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.1 -64.81 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -72.58 139.07 47.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.062 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.42 95.41 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -128.28 -57.28 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -72.64 157.17 38.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.076 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.2 p -76.21 -14.9 60.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.525 0.202 . . . . 0.0 111.289 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.98 42.78 6.64 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.504 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -82.37 147.22 28.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 130' ' ' ALA . 15.2 t -151.52 159.6 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.169 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.823 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -95.91 120.43 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.909 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.739 ' HB1' HD23 ' A' ' 146' ' ' LEU . . . -133.52 161.99 33.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.42 ' HG3' ' HB ' ' A' ' 159' ' ' THR . 35.9 mmm -84.53 155.42 62.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.922 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.92 -52.07 5.78 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.246 1.964 . . . . 0.0 112.247 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.624 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -62.95 -32.54 73.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.986 0.422 . . . . 0.0 110.624 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.809 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.13 -49.86 75.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.72 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.1 mtt85 -58.44 -33.4 69.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.511 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -63.6 -52.7 59.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.226 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -64.48 -24.2 67.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.816 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.73 -35.74 62.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.92 0.391 . . . . 0.0 110.378 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -76.39 -29.38 57.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.186 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -82.37 -48.94 10.55 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.161 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.84 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.97 -9.95 51.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.746 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.52 32.41 54.77 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.047 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.922 HG13 ' HB2' ' A' ' 167' ' ' ALA . 15.1 mm -88.35 148.61 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.132 0.491 . . . . 0.0 111.712 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -106.99 100.89 10.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.486 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.739 HD23 ' HB1' ' A' ' 131' ' ' ALA . 1.7 mp -62.56 -19.53 63.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.336 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.7 m -62.19 -21.05 64.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.924 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -106.32 -4.76 19.69 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.55 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.995 HG11 HD13 ' A' ' 158' ' ' ILE . 58.0 t -79.01 147.36 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -70.98 113.0 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.203 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.93 122.68 7.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.126 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -139.77 33.25 2.0 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.317 0.579 . . . . 0.0 110.661 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.45 -165.29 12.27 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.801 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -31.09 95.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.776 2.984 . . . . 0.0 114.197 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.76 -20.41 12.17 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.188 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 131.04 44.73 0.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.3 p -100.62 142.97 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.252 0.548 . . . . 0.0 111.956 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.995 HD13 HG11 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -71.26 124.61 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.03 179.415 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.83 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.4 p -107.34 165.7 11.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.231 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.624 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 30.0 t -50.16 -26.02 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.593 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -45.58 88.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.669 ' HB2' HD13 ' A' ' 158' ' ' ILE . 6.6 m-20 -74.83 -33.64 62.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.494 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.933 ' CG2' HD11 ' A' ' 158' ' ' ILE . 8.7 t -65.1 -54.53 28.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.6 tptp -61.31 -37.31 82.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.546 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.36 -42.96 74.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.307 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.56 ' CE2' HG23 ' A' ' 144' ' ' ILE . 23.3 t80 -71.45 -50.52 30.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.642 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.922 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -55.89 -39.41 71.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.254 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.619 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 22.6 pt-20 -75.63 -45.72 35.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.155 0.502 . . . . 0.0 109.866 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.2 tp10 -64.4 -21.93 66.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.487 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.1 t -93.71 -33.16 13.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -177.81 96.21 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.634 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.619 ' HB3' ' HA ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -115.49 -177.62 3.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.545 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.62 102.78 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.006 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.503 ' O ' ' HB3' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -162.19 -39.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.997 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 174' ' ' THR . . . 73.52 149.55 0.13 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.44 160.08 50.67 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.55 2.167 . . . . 0.0 112.4 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 61.46 74.33 0.51 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.078 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.63 -170.35 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.584 2.189 . . . . 0.0 112.224 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -169.97 85.84 0.57 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.21 -35.78 8.12 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.523 2.149 . . . . 0.0 112.297 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.05 152.88 0.94 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.804 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -138.13 131.66 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.17 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.45 -60.89 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.29 158.54 43.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 33.4 2.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.07 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -77.85 152.01 33.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.36 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -60.63 149.41 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.957 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 130' ' ' ALA . 43.4 t 57.31 162.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.258 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.849 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -125.32 131.18 53.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.704 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.47 162.02 33.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 10.4 mtp -80.75 146.91 61.24 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.808 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.22 -40.11 21.49 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.249 1.966 . . . . 0.0 112.324 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -77.85 -27.87 49.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.603 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -63.37 -52.56 61.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.617 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.712 ' HA ' HD21 ' A' ' 146' ' ' LEU . 18.6 mtp-105 -56.25 -35.01 66.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.463 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -62.76 -51.56 66.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.25 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -64.21 -23.2 67.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.693 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -72.03 -41.47 67.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.581 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -76.52 -29.03 56.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.569 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.27 -43.62 17.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.652 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.845 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -100.65 -2.28 33.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.178 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.08 39.18 92.83 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.643 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.739 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 66.8 mt -87.54 141.8 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.054 0.454 . . . . 0.0 111.8 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.28 100.58 12.61 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.712 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER -68.29 -22.6 64.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.217 -178.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.5 m -65.19 -13.96 59.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.193 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -114.29 0.02 14.02 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.897 ' CB ' HD12 ' A' ' 158' ' ' ILE . 60.2 t -81.6 149.98 4.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.801 0.334 . . . . 0.0 110.959 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -70.96 108.79 4.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.314 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.67 119.99 7.93 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.808 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -136.88 34.48 2.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.231 0.538 . . . . 0.0 110.895 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.492 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -130.29 -166.25 11.76 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.3 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.426 ' N ' HG12 ' A' ' 157' ' ' VAL . 36.2 Cg_exo -32.53 100.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.864 3.043 . . . . 0.0 114.315 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.2 -16.38 9.5 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.474 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 126.75 42.25 0.29 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.849 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.7 p -97.65 144.4 11.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.197 -0.502 . . . . 0.0 111.35 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.0 129.29 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.791 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.0 p -100.86 168.0 9.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.174 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.765 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 50.4 t -55.64 -31.7 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.337 . . . . 0.0 111.139 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -38.88 84.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.119 0.485 . . . . 0.0 109.909 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.473 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 10.0 m-20 -74.94 -38.67 61.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.725 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.01 HG22 HD11 ' A' ' 158' ' ' ILE . 45.6 t -64.67 -54.71 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.042 0.449 . . . . 0.0 110.362 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -60.4 -40.7 91.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.794 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -69.04 -40.3 78.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.454 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.689 ' CE2' HG23 ' A' ' 144' ' ' ILE . 6.5 t80 -72.13 -52.15 18.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.845 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -57.63 -38.47 75.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.538 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 8.8 pt-20 -71.69 -34.69 69.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.237 0.542 . . . . 0.0 110.481 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -21.94 50.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.087 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.4 t -92.61 -35.13 13.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.652 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 172' ' ' LYS . . . -146.15 -63.61 0.31 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.641 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 21.2 tttp 74.95 -18.23 0.45 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.897 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 174' ' ' THR . . . -167.86 -43.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 111.115 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 173' ' ' ALA . 7.1 p -157.3 -78.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -169.89 153.85 5.01 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.149 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.53 66.17 2.94 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.607 2.205 . . . . 0.0 112.227 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -95.48 139.92 22.15 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.128 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.53 151.5 24.04 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.458 2.105 . . . . 0.0 112.241 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 180' ' ' PRO . . . -90.25 160.73 39.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.062 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 39.5 Cg_endo -67.02 -171.51 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.544 2.163 . . . . 0.0 112.226 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.423 ' HA ' ' CE ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -59.68 161.61 6.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -107.23 178.35 4.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.042 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.2 p -76.62 -40.05 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.74 -75.7 0.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt 60.91 159.65 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.825 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.113 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.551 -0.22 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -82.01 132.96 35.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.74 -44.5 32.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.49 -177.17 3.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 130' ' ' ALA . 10.6 t -131.36 158.03 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.869 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -113.46 127.0 55.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.639 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.672 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.72 162.21 32.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.311 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 4.7 mmm -86.26 150.3 51.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.172 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.59 -51.94 9.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.202 1.934 . . . . 0.0 112.149 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.756 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -59.75 -34.52 73.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.021 0.438 . . . . 0.0 110.637 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 1.011 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -59.98 -51.22 70.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.57 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 84.5 mtt-85 -55.11 -36.41 65.68 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.447 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.3 mtm-85 -61.48 -51.19 69.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.99 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 138' ' ' LEU . 0.9 OUTLIER -62.85 -24.84 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.762 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . . . -70.91 -41.54 71.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.731 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -76.38 -29.05 56.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.768 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -82.16 -43.79 17.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.575 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.618 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -100.67 -1.83 34.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.08 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.31 39.15 94.23 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.645 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.781 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 58.5 mt -87.55 144.99 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 112.002 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.8 100.64 12.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.85 ' HG ' HD11 ' A' ' 158' ' ' ILE . 2.5 mp -74.39 -20.74 59.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.229 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 t -61.93 -17.03 55.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.715 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -109.16 -9.78 15.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.63 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.972 ' HB ' HD12 ' A' ' 158' ' ' ILE . 57.8 t -70.66 146.09 12.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.063 0.459 . . . . 0.0 111.191 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.7 121.15 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.433 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -77.77 123.24 6.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.065 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.431 HG22 ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -143.46 38.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.29 0.567 . . . . 0.0 110.857 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -129.68 -162.65 10.91 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.102 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -31.75 96.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.775 2.983 . . . . 0.0 114.176 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.12 -18.15 14.62 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.277 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.37 44.4 0.19 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.869 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -103.74 141.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.352 0.596 . . . . 0.0 112.01 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.972 HD12 ' HB ' ' A' ' 149' ' ' VAL . 0.1 OUTLIER -67.42 127.93 29.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.5 p -108.07 172.82 6.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.102 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.756 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 53.7 t -54.67 -29.8 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -63.65 -40.78 97.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' OD2' HG22 ' A' ' 152' ' ' THR . 2.0 m-20 -71.81 -42.56 66.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.602 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.011 HG21 ' HB1' ' A' ' 135' ' ' ALA . 80.7 t -64.49 -54.53 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.381 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -58.67 -37.38 75.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -70.81 -46.4 62.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.153 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.576 ' CE2' HG23 ' A' ' 144' ' ' ILE . 16.8 t80 -65.52 -50.55 64.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.451 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.781 ' HB2' ' CD1' ' A' ' 144' ' ' ILE . . . -56.54 -44.61 81.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.547 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.59 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 14.4 pt-20 -71.98 -34.91 69.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.298 0.571 . . . . 0.0 110.405 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -77.42 -21.87 52.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.859 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.4 t -91.32 -41.14 11.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.866 0.365 . . . . 0.0 110.896 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.79 98.56 2.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.218 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 3.6 tttp -155.44 -175.32 5.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.07 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -153.68 -169.09 3.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.962 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.3 p 56.1 36.31 27.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.995 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -101.94 143.45 26.61 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.127 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.91 118.18 4.51 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.48 2.12 . . . . 0.0 112.142 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -147.09 91.66 5.09 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.036 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.33 -36.45 68.55 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.587 2.192 . . . . 0.0 112.339 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -113.73 98.88 48.67 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.135 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.99 170.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.475 2.117 . . . . 0.0 112.36 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 159.29 15.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -125.54 77.61 1.66 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.005 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.02 110.53 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 60.49 -178.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.721 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -116.85 39.16 3.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.031 -179.984 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.8 p -127.78 100.27 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 110.982 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -131.24 32.76 4.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -77.58 -31.45 53.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 130' ' ' ALA . 13.6 t -79.94 159.56 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.204 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.837 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -117.61 131.03 56.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.98 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.662 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.56 162.1 32.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.276 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.1 OUTLIER -83.25 153.77 66.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.41 -52.01 8.69 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.297 1.998 . . . . 0.0 112.344 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.813 ' HB3' HG21 ' A' ' 160' ' ' VAL . . . -64.79 -32.11 73.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.809 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.33 -52.97 62.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.885 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.654 ' HA ' HD11 ' A' ' 146' ' ' LEU . 9.1 mtt-85 -55.65 -36.53 67.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.453 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -61.45 -50.91 70.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.45 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -65.05 -24.67 67.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.89 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.037 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.64 -34.73 62.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.965 0.412 . . . . 0.0 110.537 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -33.63 59.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.362 0.601 . . . . 0.0 109.997 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -79.61 -47.99 14.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.073 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.817 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.23 -10.45 52.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.779 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.22 34.76 57.67 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.832 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.89 HG13 ' HB2' ' A' ' 167' ' ' ALA . 16.2 mm -90.81 141.83 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.015 0.436 . . . . 0.0 111.695 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.19 100.78 12.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.037 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.5 mt -63.5 -20.62 65.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.229 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 79.7 p -64.13 -16.83 62.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.106 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -108.57 -3.77 17.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.726 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.81 ' CB ' HD12 ' A' ' 158' ' ' ILE . 59.8 t -79.94 149.88 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.076 0.465 . . . . 0.0 111.04 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.1 OUTLIER -72.32 121.68 19.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.364 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.07 119.14 4.78 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.003 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -137.92 34.23 2.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.413 0.625 . . . . 0.0 110.678 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.485 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -126.77 -166.3 12.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.095 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -31.64 98.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.867 3.045 . . . . 0.0 114.269 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.77 -18.11 13.34 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.399 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.38 44.53 0.21 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.837 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.3 p -101.08 144.87 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.162 0.506 . . . . 0.0 111.685 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.829 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.1 126.31 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.137 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 23.3 p -102.36 167.13 10.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.62 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.813 HG21 ' HB3' ' A' ' 134' ' ' ALA . 95.4 t -54.78 -36.3 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.384 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 2.5 pt-20 -58.49 -37.05 74.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.606 ' HA ' ' HG2' ' A' ' 165' ' ' ARG . 34.5 m-20 -72.68 -46.89 51.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.355 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.829 HG22 HD11 ' A' ' 158' ' ' ILE . 71.1 t -56.92 -52.8 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 109.858 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -60.35 -37.67 81.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.234 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.606 ' HG2' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -72.29 -36.22 68.91 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.617 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.681 ' HE2' HG23 ' A' ' 144' ' ' ILE . 14.9 t80 -77.12 -50.09 13.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.038 0.447 . . . . 0.0 110.194 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.89 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -57.52 -36.37 71.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.378 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 9.9 pt-20 -75.02 -34.74 61.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.061 0.458 . . . . 0.0 110.443 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -78.05 -22.07 49.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.219 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 167' ' ' ALA . 3.0 t -88.45 -33.42 17.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.805 0.336 . . . . 0.0 111.049 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.31 92.37 0.98 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 0.3 OUTLIER -161.96 161.39 28.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -170.54 100.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.453 HG23 ' CE ' ' A' ' 172' ' ' LYS . 7.3 p -127.2 74.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.009 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 62.85 127.09 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.201 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.06 106.52 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.412 2.075 . . . . 0.0 112.262 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.775 ' HB3' ' HG3' ' A' ' 180' ' ' PRO . . . -160.93 147.82 11.88 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.084 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.53 -28.59 14.31 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.602 2.201 . . . . 0.0 112.396 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -168.96 76.05 0.75 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.134 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.775 ' HG3' ' HB3' ' A' ' 177' ' ' ALA . 50.4 Cg_exo -55.95 -167.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.641 2.227 . . . . 0.0 112.299 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.27 -46.7 8.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 58.23 179.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.41 43.67 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.057 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -58.01 164.42 2.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.031 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.02 120.23 12.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.146 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.84 165.2 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 127.68 54.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.17 159.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 147' ' ' SER . 62.9 t -87.9 -58.9 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . 65.63 120.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.461 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.3 162.14 32.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.641 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.89 151.43 54.91 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.011 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.83 -52.14 9.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.306 2.004 . . . . 0.0 112.511 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.68 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -61.75 -36.05 79.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.008 0.432 . . . . 0.0 110.819 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.94 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.61 -52.81 63.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.912 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.669 ' HA ' HD11 ' A' ' 146' ' ' LEU . 76.8 mtt180 -56.27 -34.76 66.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.749 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -63.02 -52.0 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.252 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -64.66 -23.71 67.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.841 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.032 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.44 -36.8 63.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.016 0.436 . . . . 0.0 110.376 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -76.28 -29.3 57.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.144 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.12 -49.03 10.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.094 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.756 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.41 -10.13 52.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.804 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.12 32.64 55.95 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.946 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.854 HG13 ' HB2' ' A' ' 167' ' ' ALA . 17.8 mm -87.77 140.07 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.918 0.39 . . . . 0.0 111.437 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.48 100.78 13.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.5 mt -64.22 -17.72 63.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.208 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.426 ' HA ' HG11 ' A' ' 129' ' ' VAL . 1.1 t -65.38 -15.62 62.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.199 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -114.03 5.61 16.14 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.73 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.803 ' CB ' HD12 ' A' ' 158' ' ' ILE . 57.4 t -87.62 145.63 7.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.941 0.401 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 111.88 7.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.629 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -75.45 118.28 5.47 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.72 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.459 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -126.83 29.37 5.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.109 0.481 . . . . 0.0 111.295 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.781 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -130.4 -156.6 8.71 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.242 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.564 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 40.5 Cg_exo -38.11 108.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.111 2.541 . . . . 0.0 114.07 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.82 5.81 27.06 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.494 -0.776 . . . . 0.0 113.519 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.5 40.69 1.86 Allowed Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -86.73 140.44 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.039 -0.581 . . . . 0.0 111.617 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.823 HD13 ' HB3' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -79.01 131.35 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.5 p -108.95 167.65 9.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.719 0.295 . . . . 0.0 110.842 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.68 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 47.4 t -54.2 -24.58 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 3.3 tt0 -65.79 -42.95 90.13 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.409 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 11.9 m-20 -74.21 -35.94 63.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.503 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.94 HG21 ' HB1' ' A' ' 135' ' ' ALA . 58.2 t -66.16 -53.69 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.955 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -62.82 -35.71 80.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.715 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 0.6 OUTLIER -71.78 -44.3 64.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.134 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.726 ' CE2' HG23 ' A' ' 144' ' ' ILE . 15.2 t80 -70.11 -47.66 60.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.983 0.42 . . . . 0.0 110.317 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.854 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -58.15 -39.0 77.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.548 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.596 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 14.2 pt-20 -75.27 -45.48 39.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.029 0.442 . . . . 0.0 110.429 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.1 tm-20 -65.19 -23.81 67.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.439 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.1 t -90.54 -37.36 13.91 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.684 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -175.22 94.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.439 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 168' ' ' GLU . 0.3 OUTLIER -107.21 146.66 31.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.619 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -166.79 52.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.23 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 69.3 p -74.04 -31.22 62.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 176' ' ' PRO . . . -90.41 166.08 20.98 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.027 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 175' ' ' ALA . 29.4 Cg_endo -63.03 103.63 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.505 2.137 . . . . 0.0 112.297 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -95.19 148.73 35.13 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.65 177.24 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.502 2.135 . . . . 0.0 112.311 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 58.97 86.12 0.17 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.21 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.44 -35.62 7.95 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.519 2.146 . . . . 0.0 112.33 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -172.36 2.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.045 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -99.7 30.3 3.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 183' ' ' VAL . 29.9 m -73.9 105.21 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.116 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.33 -75.52 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.04 164.68 32.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.074 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.576 -0.21 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.44 136.6 36.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.804 0.335 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -109.19 107.95 18.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.37 167.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 130' ' ' ALA . 2.1 p -164.94 -46.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.777 ' C ' HG23 ' A' ' 157' ' ' VAL . . . 62.97 118.11 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.095 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.66 ' CA ' HG23 ' A' ' 157' ' ' VAL . . . -133.4 162.05 32.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.446 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.5 OUTLIER -93.35 145.71 30.51 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.197 179.299 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.72 -52.04 9.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.406 2.071 . . . . 0.0 112.692 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.637 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -59.74 -37.39 78.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.976 0.417 . . . . 0.0 110.917 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.912 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.2 -52.84 63.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.027 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.624 ' HA ' HD11 ' A' ' 146' ' ' LEU . 14.4 mtm105 -56.86 -33.78 67.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.653 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -63.46 -50.9 67.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -65.77 -23.97 66.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.837 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.993 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.21 -37.05 63.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.013 0.435 . . . . 0.0 110.466 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -76.3 -29.28 57.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.251 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -82.13 -48.44 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.149 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.66 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.95 -10.7 49.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.735 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.5 36.03 45.24 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.842 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.762 HG13 ' HB2' ' A' ' 167' ' ' ALA . 23.3 mm -92.44 139.83 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.995 0.426 . . . . 0.0 111.583 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -93.2 100.75 13.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.993 HD21 ' HB2' ' A' ' 139' ' ' ALA . 6.1 mt -64.88 -16.73 63.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.368 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -15.65 62.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.061 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -112.27 2.71 16.69 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.643 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.781 ' CB ' HD12 ' A' ' 158' ' ' ILE . 47.7 t -86.91 142.23 13.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.094 0.474 . . . . 0.0 111.073 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -70.91 127.7 33.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.979 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.0 118.57 4.97 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.912 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -128.8 22.57 5.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.12 0.485 . . . . 0.0 110.827 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -113.78 -164.34 15.39 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.936 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -31.15 97.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.827 3.018 . . . . 0.0 114.258 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.14 -17.7 16.6 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.408 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.84 45.22 0.21 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.777 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.1 p -100.4 145.66 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.228 0.537 . . . . 0.0 111.781 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.829 HD13 ' HB3' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -72.94 124.85 30.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.155 179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.1 p -108.01 170.35 8.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.61 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.637 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 24.4 t -52.57 -25.7 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -66.21 -43.11 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 152' ' ' THR . 3.3 m-20 -73.08 -40.06 65.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.565 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.912 HG21 ' HB1' ' A' ' 135' ' ' ALA . 44.8 t -65.01 -53.52 40.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.073 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -61.82 -34.9 76.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.016 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -72.86 -47.29 47.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.792 0.33 . . . . 0.0 111.344 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.739 ' HE2' HG23 ' A' ' 144' ' ' ILE . 14.9 t80 -68.87 -41.13 78.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.309 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.762 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -63.71 -38.64 91.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.323 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.457 ' HA ' ' CB ' ' A' ' 172' ' ' LYS . 14.7 pt-20 -77.13 -36.94 54.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.136 0.493 . . . . 0.0 110.471 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.35 -24.51 59.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.935 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 167' ' ' ALA . 3.0 t -83.35 -39.64 20.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.67 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -161.51 94.7 0.98 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.379 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.457 ' CB ' ' HA ' ' A' ' 168' ' ' GLU . 5.5 tmtt? -177.3 -42.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.005 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -157.59 179.51 9.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.22 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.3 p -150.35 -46.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.961 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -139.47 159.73 64.55 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.061 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.26 175.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.539 2.159 . . . . 0.0 112.345 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -174.57 78.6 0.34 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.25 -168.47 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.597 2.198 . . . . 0.0 112.305 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -123.86 86.76 53.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.37 162.78 41.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.524 2.149 . . . . 0.0 112.339 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -99.39 -39.43 8.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -65.0 -27.35 68.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.242 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t 66.67 85.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.081 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -132.54 168.74 17.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.945 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt 60.76 53.2 4.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.071 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.0 p -99.37 150.78 21.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.805 0.336 . . . . 0.0 110.945 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.85 129.6 12.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.74 169.17 17.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.754 HG11 ' HA ' ' A' ' 147' ' ' SER . 41.6 t -60.97 -67.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.155 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . 66.12 122.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.673 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.827 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . . . -133.31 162.11 32.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.567 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.27 159.13 54.18 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.793 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.61 -52.07 3.48 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.122 1.882 . . . . 0.0 112.313 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.527 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -59.42 -35.72 74.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.087 0.47 . . . . 0.0 110.545 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.8 -51.22 70.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.587 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.827 ' CZ ' ' HB3' ' A' ' 131' ' ' ALA . 4.1 mtt85 -57.11 -34.13 68.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.675 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.11 -51.77 65.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.189 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.525 HD22 HG13 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -64.69 -24.22 67.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.765 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.75 -35.54 62.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.392 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -76.37 -29.44 57.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.125 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -82.18 -49.03 10.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.134 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.923 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -87.92 -9.12 54.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.758 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.15 34.76 54.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.148 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.957 HG13 ' HB2' ' A' ' 167' ' ' ALA . 13.1 mm -90.81 150.13 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.132 0.492 . . . . 0.0 111.711 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -107.91 100.98 10.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.473 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.654 HD23 ' HB1' ' A' ' 131' ' ' ALA . 1.4 mp -63.4 -17.65 62.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.422 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.754 ' HA ' HG11 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -62.32 -18.74 62.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.917 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -110.43 -3.04 16.29 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.601 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 1.058 HG11 HD13 ' A' ' 158' ' ' ILE . 75.1 t -80.36 143.27 12.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.003 0.43 . . . . 0.0 111.07 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -71.25 112.74 7.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.206 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -76.29 123.52 6.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.282 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -127.09 15.97 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 0.0 111.367 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.72 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -115.02 -154.3 10.65 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.423 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.571 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 31.1 Cg_exo -36.01 106.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.426 2.751 . . . . 0.0 114.243 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.31 25.14 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.62 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.31 40.11 1.84 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.3 OUTLIER -86.68 142.3 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.086 -0.557 . . . . 0.0 111.241 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.058 HD13 HG11 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -81.14 123.63 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.823 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.2 p -106.66 166.12 10.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.343 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 21.1 t -50.33 -25.4 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.448 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.66 -45.86 84.96 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.724 ' HB2' HD13 ' A' ' 158' ' ' ILE . 4.9 m-20 -74.97 -33.78 61.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.439 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.945 ' CG2' HD11 ' A' ' 158' ' ' ILE . 6.1 t -65.12 -54.57 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -61.91 -35.9 79.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.59 -42.56 74.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.548 ' CE2' HG23 ' A' ' 144' ' ' ILE . 26.8 t80 -71.91 -51.27 23.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.552 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.957 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.82 -37.69 71.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.587 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 9.5 pt-20 -76.84 -42.5 39.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.264 0.554 . . . . 0.0 110.336 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.9 tp10 -70.07 -21.93 63.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.826 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.4 t -89.34 -41.01 12.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.048 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -146.5 -55.72 0.26 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 33.7 tttp 65.34 168.01 0.19 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.534 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.07 58.02 1.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.996 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.23 -31.49 9.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.815 ' HB3' ' HD3' ' A' ' 176' ' ' PRO . . . -178.88 -55.1 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.815 ' HD3' ' HB3' ' A' ' 175' ' ' ALA . 52.0 Cg_exo -53.19 179.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.463 2.109 . . . . 0.0 112.229 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -172.2 78.11 0.46 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.71 -176.75 2.16 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.621 2.214 . . . . 0.0 112.412 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.671 ' HB3' ' HD3' ' A' ' 180' ' ' PRO . . . -170.99 -64.73 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.021 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 17.8 Cg_endo -61.07 -73.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.398 2.065 . . . . 0.0 112.274 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER 179.53 -39.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 62.76 124.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.18 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.4 m -98.28 29.98 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 -43.83 23.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.29 100.94 5.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.095 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -161.31 160.43 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 -122.58 137.81 54.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.57 -179.7 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 130' ' ' ALA . 14.0 t -133.63 159.52 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.842 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -133.62 132.44 40.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.678 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.5 162.11 32.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.437 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -89.06 150.04 44.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.089 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.59 -51.95 9.97 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.198 1.932 . . . . 0.0 112.443 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.658 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -60.2 -37.02 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.03 0.443 . . . . 0.0 110.713 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.821 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -59.62 -48.75 80.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.692 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -59.57 -34.77 73.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.641 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -50.03 72.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.283 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -67.2 -25.23 66.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.919 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.764 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.97 -32.34 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.034 0.445 . . . . 0.0 110.413 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -35.11 58.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.873 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -80.35 -47.5 14.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.207 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.769 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.02 -12.13 48.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.705 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.21 31.44 54.99 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.009 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.857 HG13 ' HB2' ' A' ' 167' ' ' ALA . 13.3 mm -88.46 147.85 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.449 . . . . 0.0 111.602 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.36 100.99 10.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.774 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.637 HD23 ' HB1' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -63.19 -17.8 62.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.549 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.5 m -63.31 -17.75 62.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.009 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -111.36 -1.09 16.11 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.584 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 1.08 HG11 HD13 ' A' ' 158' ' ' ILE . 63.6 t -81.01 148.62 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.004 0.43 . . . . 0.0 110.969 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 111.21 6.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.358 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.09 122.62 9.04 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.074 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -142.46 32.94 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.334 0.588 . . . . 0.0 110.569 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.77 -165.43 12.4 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.819 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -31.04 95.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.831 3.021 . . . . 0.0 114.197 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.56 -18.85 17.12 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.248 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.71 45.19 0.18 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.842 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.3 p -102.35 142.25 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.327 0.584 . . . . 0.0 111.997 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.08 HD13 HG11 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -68.66 124.68 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.868 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.812 ' N ' HD12 ' A' ' 158' ' ' ILE . 20.1 p -106.08 163.65 12.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.207 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.658 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 61.5 t -50.35 -33.28 10.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.467 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -59.16 -41.62 88.81 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.534 ' HB2' HD13 ' A' ' 158' ' ' ILE . 12.2 m-20 -74.97 -35.92 62.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.409 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.916 ' CG2' HD11 ' A' ' 158' ' ' ILE . 19.2 t -63.08 -54.7 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -37.62 84.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.458 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -65.99 -44.68 84.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.057 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.526 ' CE2' HG23 ' A' ' 144' ' ' ILE . 15.5 t80 -72.4 -46.89 53.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.731 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.857 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -57.82 -41.28 81.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.605 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 9.1 pt-20 -71.65 -37.23 70.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.288 0.566 . . . . 0.0 110.063 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -76.02 -21.9 56.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.832 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.5 t -94.64 -32.25 13.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.257 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -148.0 -61.58 0.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.784 0.326 . . . . 0.0 111.737 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 15.4 tttt 67.6 -71.89 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.815 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -121.71 66.68 0.9 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.019 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.03 33.39 2.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.905 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.4 ' HA ' ' HD2' ' A' ' 176' ' ' PRO . . . -126.81 106.36 22.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.079 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 175' ' ' ALA . 42.9 Cg_endo -67.69 161.22 44.66 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.384 2.056 . . . . 0.0 112.35 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.721 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . . . -65.65 -61.42 5.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.145 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.721 ' HD3' ' HB3' ' A' ' 177' ' ' ALA . 50.5 Cg_endo -69.34 140.92 45.52 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.493 2.129 . . . . 0.0 112.276 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.671 ' HB1' ' HD2' ' A' ' 180' ' ' PRO . . . -69.52 164.35 50.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.671 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 53.8 Cg_endo -69.52 -175.89 1.24 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.488 2.126 . . . . 0.0 112.333 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.54 161.24 15.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -84.23 118.65 24.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.044 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 183' ' ' VAL . 15.8 t -103.66 31.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.108 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -142.37 161.15 38.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.878 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -72.04 -33.06 67.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.13 179.936 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.0 p -107.36 75.31 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.909 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -128.21 31.61 5.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.971 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -143.47 165.92 26.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 147' ' ' SER . 46.5 t -96.93 -61.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.766 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . 66.61 120.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.948 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.476 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.28 162.04 32.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.417 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.445 ' HG3' HG22 ' A' ' 159' ' ' THR . 0.0 OUTLIER -85.54 151.25 55.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.838 178.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.16 -50.12 14.92 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.069 1.846 . . . . 0.0 112.31 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.638 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -66.18 -32.89 74.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.845 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.665 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.35 -52.97 62.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.767 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.618 ' HA ' HD11 ' A' ' 146' ' ' LEU . 50.1 mtp180 -56.38 -35.54 67.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.39 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -61.63 -49.51 76.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.176 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.64 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -64.7 -25.52 67.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.504 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.758 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -69.98 -41.93 73.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.021 0.439 . . . . 0.0 110.684 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.5 -29.15 56.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.86 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -82.17 -43.2 18.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.651 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.759 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -101.16 -2.36 31.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.971 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.95 39.03 93.21 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.648 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.764 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 65.5 mt -87.81 141.0 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 111.635 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.0 100.45 13.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.765 ' HB3' HD13 ' A' ' 158' ' ' ILE . 5.9 mt -71.4 -18.19 62.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.432 ' HA ' HG11 ' A' ' 129' ' ' VAL . 0.6 OUTLIER -65.33 -15.9 63.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 179.319 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -113.24 1.52 15.24 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.712 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.818 ' CB ' HD12 ' A' ' 158' ' ' ILE . 58.2 t -82.72 144.59 9.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.993 0.425 . . . . 0.0 110.799 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -70.88 117.73 12.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.625 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 156' ' ' GLY . . . -80.81 114.79 3.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.755 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.47 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -117.33 20.32 13.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.692 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -129.1 -153.86 8.07 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.754 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.52 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 21.2 Cg_exo -32.66 106.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.783 2.989 . . . . 0.0 114.617 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.5 10.58 8.09 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.876 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.412 ' O ' ' HA3' ' A' ' 151' ' ' GLY . . . 107.49 41.73 1.57 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -86.33 145.01 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.033 -0.583 . . . . 0.0 111.157 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.048 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -83.73 136.05 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 163' ' ' VAL . 36.1 p -112.16 166.9 10.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.318 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.64 HG13 HD22 ' A' ' 138' ' ' LEU . 24.3 t -55.18 -29.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.1 -40.12 94.12 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 14.1 m-20 -74.81 -39.12 61.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.389 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.048 HG22 HD11 ' A' ' 158' ' ' ILE . 60.1 t -65.26 -54.66 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.316 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -59.26 -42.5 91.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.837 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -67.65 -43.31 80.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.237 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.654 ' CE2' HG23 ' A' ' 144' ' ' ILE . 9.8 t80 -67.1 -54.41 21.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.491 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.764 ' HB2' ' CD1' ' A' ' 144' ' ' ILE . . . -53.01 -41.99 65.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.618 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 7.5 pt-20 -69.56 -33.03 72.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 0.0 110.263 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.97 -24.98 47.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.869 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.2 t -93.15 -37.99 11.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.752 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.96 79.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.313 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 9.9 tttm -78.26 -37.15 45.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -174.72 41.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.98 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.4 t -56.78 95.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.983 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -163.61 93.99 1.08 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.87 -26.16 52.21 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.478 2.119 . . . . 0.0 112.261 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -143.08 124.6 8.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.039 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.75 -61.42 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.413 2.075 . . . . 0.0 112.31 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -168.39 119.63 0.67 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.988 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.51 160.74 48.62 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.382 2.055 . . . . 0.0 112.247 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.74 -56.26 3.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.943 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 186' ' ' ALA . . . -73.09 129.55 38.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.087 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 184' ' ' GLU . 11.8 p -176.49 -40.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.402 ' N ' HG13 ' A' ' 183' ' ' VAL . 19.4 mm-40 -86.92 -56.43 3.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.76 30.4 1.87 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.412 ' HA ' ' HB1' ' A' ' 182' ' ' ALA . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.224 -0.894 . . . . 0.0 111.073 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.18 61.21 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.9 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.4 84.78 2.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -142.74 140.48 31.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 130' ' ' ALA . 1.9 p -120.79 -47.81 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 0.0 111.09 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.839 ' C ' HG23 ' A' ' 157' ' ' VAL . . . 62.24 133.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.019 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.756 ' HB1' HD23 ' A' ' 146' ' ' LEU . . . -133.54 162.14 32.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.169 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.0 mtp -86.48 148.63 47.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.091 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.35 -52.04 9.9 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.357 2.038 . . . . 0.0 112.375 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.587 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.09 -34.72 78.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.912 0.386 . . . . 0.0 110.711 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.767 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.0 -50.57 73.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.776 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -58.48 -34.5 70.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.608 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -62.47 -50.0 73.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.284 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -67.01 -25.07 66.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.905 179.556 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.9 -32.6 61.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.005 0.431 . . . . 0.0 110.38 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 -34.97 59.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.394 0.616 . . . . 0.0 109.944 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.07 -47.58 14.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.196 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.807 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.08 -11.81 49.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.713 -179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.54 31.84 55.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.885 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.934 HG13 ' HB2' ' A' ' 167' ' ' ALA . 11.0 mm -87.83 148.7 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.542 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -106.19 100.96 10.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.697 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.756 HD23 ' HB1' ' A' ' 131' ' ' ALA . 1.8 mp -63.65 -20.0 65.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.495 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -19.96 63.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.965 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -107.19 -6.21 17.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.514 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 1.009 HG11 HD13 ' A' ' 158' ' ' ILE . 58.0 t -77.47 146.92 7.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.054 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 111.77 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.362 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.78 122.48 8.34 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.051 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.455 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -138.85 32.69 2.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.291 0.567 . . . . 0.0 110.673 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -124.13 -164.79 12.06 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.865 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -31.69 97.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.781 2.988 . . . . 0.0 114.192 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.36 -18.1 15.79 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.344 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.75 44.43 0.2 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.839 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.4 p -100.32 142.4 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 111.99 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.009 HD13 HG11 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -71.43 124.81 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.306 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.842 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.3 p -107.05 165.14 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.162 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.587 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 21.9 t -50.14 -25.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.676 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.39 -45.68 86.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.699 ' HB2' HD13 ' A' ' 158' ' ' ILE . 5.7 m-20 -74.86 -33.07 62.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.484 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.931 ' CG2' HD11 ' A' ' 158' ' ' ILE . 7.0 t -66.02 -54.6 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -61.6 -36.24 80.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.588 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -70.86 -42.11 70.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.28 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.536 ' CE2' HG23 ' A' ' 144' ' ' ILE . 22.3 t80 -71.62 -49.89 35.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.651 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.934 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.94 -39.76 75.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.496 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 11.1 pt-20 -72.61 -35.32 67.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 110.217 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -77.93 -24.49 48.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.955 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.8 t -89.75 -33.99 16.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.775 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -173.94 90.93 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.218 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 11.5 tttt -103.85 -33.63 8.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.841 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.9 134.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 53.0 p -112.08 -34.65 5.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.971 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.42 138.42 91.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.86 112.07 3.45 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.436 2.091 . . . . 0.0 112.292 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -131.9 106.4 13.94 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.123 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.5 -26.85 33.84 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.445 2.096 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -159.14 89.71 2.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -51.34 143.78 33.15 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.49 2.126 . . . . 0.0 112.399 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -117.74 -43.01 2.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.949 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -72.62 169.55 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.094 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.99 -43.78 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.55 157.08 18.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.16 -45.31 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.17 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 p -126.95 -45.01 1.6 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.883 0.373 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -111.41 111.0 21.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.44 149.73 45.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER -168.43 -164.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.943 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.862 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -126.95 139.72 52.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.066 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.704 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.51 162.15 32.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.184 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -86.27 149.18 49.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.055 179.037 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.456 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 65.7 Cg_exo -50.9 -52.07 9.84 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.366 2.044 . . . . 0.0 112.516 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.651 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -64.04 -35.13 79.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.957 0.408 . . . . 0.0 110.817 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.98 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -59.78 -52.82 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.995 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.728 ' HA ' HD11 ' A' ' 146' ' ' LEU . 4.5 mtt-85 -56.17 -34.98 66.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -61.79 -51.34 68.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.047 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -65.05 -24.19 67.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.77 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.127 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.81 -33.68 62.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.416 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.26 -34.16 59.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.962 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -80.59 -47.57 13.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.225 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.793 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.71 -10.91 49.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.822 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.17 36.17 56.5 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.929 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.921 HG13 ' HB2' ' A' ' 167' ' ' ALA . 11.5 mm -90.69 142.12 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.933 0.397 . . . . 0.0 111.659 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.87 100.78 12.89 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.127 HD21 ' HB2' ' A' ' 139' ' ' ALA . 3.9 mt -63.05 -22.13 66.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.349 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.2 p -66.75 -14.96 63.2 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -111.2 5.65 20.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.667 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.828 ' HB ' HD12 ' A' ' 158' ' ' ILE . 87.9 t -90.34 148.1 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.031 0.444 . . . . 0.0 110.97 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -70.87 108.56 4.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.457 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -71.06 123.5 10.64 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.974 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -141.7 34.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.309 0.576 . . . . 0.0 110.746 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -125.34 -164.64 11.9 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.955 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.408 ' N ' HG12 ' A' ' 157' ' ' VAL . 36.6 Cg_exo -31.69 96.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.809 3.006 . . . . 0.0 114.264 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.88 -17.07 17.71 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.389 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.26 43.97 0.22 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.862 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -100.8 143.08 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.208 0.528 . . . . 0.0 111.84 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.836 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -70.42 127.28 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.141 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.3 p -106.43 167.05 10.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.651 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 44.8 t -52.84 -26.87 11.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.125 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -64.77 -44.03 91.35 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.424 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 13.9 m-20 -71.62 -37.35 70.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.653 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.98 HG21 ' HB1' ' A' ' 135' ' ' ALA . 55.2 t -66.87 -54.56 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.406 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -60.87 -33.75 73.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.565 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -43.73 56.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.336 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.713 ' CE2' HG23 ' A' ' 144' ' ' ILE . 7.8 t80 -70.81 -46.75 62.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.465 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.921 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -62.02 -35.58 78.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.629 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 11.1 pt-20 -77.09 -36.29 55.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.088 0.47 . . . . 0.0 110.773 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.25 -21.91 55.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.025 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 167' ' ' ALA . 2.5 t -87.23 -40.52 14.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 110.797 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.74 95.11 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.168 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 4.7 tttm -163.51 163.7 24.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.99 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.02 95.41 4.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.054 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 69.3 p -77.89 -34.32 51.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.965 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 58.77 78.58 0.35 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.63 82.79 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.662 2.241 . . . . 0.0 112.304 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 59.23 89.79 0.1 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.132 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.59 98.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.617 2.212 . . . . 0.0 112.3 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -137.24 96.21 11.32 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.27 141.56 52.3 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.509 2.139 . . . . 0.0 112.226 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -100.43 -51.78 3.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.0 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -114.48 126.61 55.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.093 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.52 30.74 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -106.08 158.96 16.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -128.03 -71.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.108 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.4 p -109.15 -42.61 4.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 60.65 176.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.952 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.99 148.15 40.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.681 HG13 ' N ' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -141.12 -165.48 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.923 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.758 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . -149.06 129.97 14.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.429 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.468 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.24 162.1 32.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.949 0.404 . . . . 0.0 111.735 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.0 mtp -84.47 152.06 60.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.651 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.34 -41.9 49.59 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.119 1.88 . . . . 0.0 112.441 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.615 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -74.88 -30.37 61.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.89 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.69 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.95 -50.94 71.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.616 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.98 ' HA ' HD21 ' A' ' 146' ' ' LEU . 56.2 mtm180 -57.03 -34.28 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.304 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.22 -49.01 75.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.264 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 1.019 HD22 HG13 ' A' ' 160' ' ' VAL . 0.8 OUTLIER -65.77 -24.31 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.299 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.708 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -74.12 -36.28 64.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.64 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -76.5 -30.18 57.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.278 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -82.3 -48.99 10.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.858 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -92.33 -7.39 48.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.063 -179.003 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.32 38.97 58.26 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.087 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.809 HG13 ' HB2' ' A' ' 167' ' ' ALA . 12.0 mm -92.22 142.47 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.095 0.474 . . . . 0.0 111.793 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.38 100.73 12.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.98 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -57.88 -25.1 60.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.342 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.43 ' HA ' HG11 ' A' ' 129' ' ' VAL . 0.3 OUTLIER -66.05 -14.7 62.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.177 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -112.5 4.93 17.71 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.837 ' CB ' HD12 ' A' ' 158' ' ' ILE . 93.6 t -92.69 150.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.875 0.369 . . . . 0.0 111.021 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -70.89 105.92 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.396 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -73.04 116.84 5.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.841 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.476 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -126.58 31.48 5.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.087 0.47 . . . . 0.0 111.089 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.77 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -132.14 -156.87 8.44 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.363 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.564 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 39.0 Cg_exo -38.18 109.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.235 2.623 . . . . 0.0 114.142 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.66 5.66 25.24 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.592 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.59 39.08 2.11 Favored Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.77 HG12 ' HA3' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -84.63 143.78 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.999 -0.601 . . . . 0.0 111.469 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.065 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -81.16 136.31 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.503 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 163' ' ' VAL . 18.5 p -112.12 165.55 12.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.87 0.367 . . . . 0.0 111.04 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 1.019 HG13 HD22 ' A' ' 138' ' ' LEU . 39.3 t -52.45 -31.1 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.022 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.02 -39.45 93.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.16 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -74.88 -40.14 61.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.542 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.065 HG22 HD11 ' A' ' 158' ' ' ILE . 26.9 t -64.65 -54.75 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.021 0.438 . . . . 0.0 110.263 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -41.51 97.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.414 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.428 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 73.3 mtt-85 -62.65 -47.65 82.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.317 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.734 ' CE2' HG23 ' A' ' 144' ' ' ILE . 0.6 OUTLIER -62.87 -54.65 35.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.021 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.858 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -59.65 -41.85 91.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.841 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.64 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 0.0 OUTLIER -72.91 -31.74 64.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 110.655 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 1.2 tm-20 -77.95 -21.98 50.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.303 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -98.07 -27.95 13.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.881 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 170' ' ' THR . . . 175.53 90.48 0.01 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.921 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.64 ' HB3' ' HA ' ' A' ' 168' ' ' GLU . 1.5 ptmm? -95.17 141.45 28.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.65 110.39 14.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.8 p -115.72 32.04 6.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.4 59.43 6.84 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.064 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.95 173.08 11.67 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.801 2.334 . . . . 0.0 112.279 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.792 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . . . -176.85 -53.73 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.111 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 177' ' ' ALA . 33.3 Cg_exo -61.11 101.25 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.477 2.118 . . . . 0.0 112.027 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 62.17 92.69 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.945 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.73 148.2 86.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.578 2.185 . . . . 0.0 112.304 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 169.04 18.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.517 ' HB1' ' OXT' ' A' ' 186' ' ' ALA . . . -69.49 171.6 8.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.02 -42.46 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -136.32 -49.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -137.58 -48.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.976 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.517 ' OXT' ' HB1' ' A' ' 182' ' ' ALA . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.054 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.2 m -115.38 49.22 1.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -173.19 -41.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -56.96 -178.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.011 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.3 t -60.03 -72.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.012 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.837 ' C ' HG23 ' A' ' 157' ' ' VAL . . . 61.96 126.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.2 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.714 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.4 162.06 32.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.425 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -89.84 147.28 37.11 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.151 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.78 -51.99 9.75 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.282 1.988 . . . . 0.0 112.371 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.634 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.13 -33.69 75.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 110.629 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.673 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -62.06 -52.9 62.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.673 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.62 ' HA ' HD11 ' A' ' 146' ' ' LEU . 83.6 mtt-85 -54.65 -38.24 66.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 110.501 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -60.72 -49.66 76.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.129 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.787 HD22 HG13 ' A' ' 160' ' ' VAL . 1.1 mp -64.15 -24.18 67.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.57 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.077 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.83 -36.16 62.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.943 0.401 . . . . 0.0 110.493 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -76.34 -33.04 58.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.315 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -82.01 -44.74 16.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.092 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.55 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -85.0 -13.3 51.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.294 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.09 39.12 54.31 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.257 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.988 HG13 ' HB2' ' A' ' 167' ' ' ALA . 25.5 mm -100.81 146.36 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.88 100.79 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.077 HD21 ' HB2' ' A' ' 139' ' ' ALA . 4.3 mt -61.4 -21.54 64.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.621 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -61.97 -17.67 57.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.001 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -107.66 -8.56 16.08 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.677 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.821 ' CB ' HD12 ' A' ' 158' ' ' ILE . 59.0 t -76.28 146.21 9.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.052 0.454 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -71.46 118.74 14.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.444 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.24 119.28 5.14 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.822 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -135.71 34.27 2.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.343 0.592 . . . . 0.0 110.747 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -127.24 -164.75 11.75 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.989 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -31.66 97.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.911 3.074 . . . . 0.0 114.233 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.52 -17.04 15.7 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.425 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.78 44.32 0.22 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.837 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -100.8 144.31 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.12 0.485 . . . . 0.0 111.77 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.867 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.78 127.73 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.346 179.441 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 3.4 p -104.3 164.22 11.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.322 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.787 HG13 HD22 ' A' ' 138' ' ' LEU . 83.3 t -51.33 -27.63 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.804 0.335 . . . . 0.0 110.999 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -63.05 -42.83 99.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.002 0.429 . . . . 0.0 109.865 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.423 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 14.3 m-20 -72.69 -36.64 67.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.868 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.867 HG22 HD11 ' A' ' 158' ' ' ILE . 79.1 t -66.67 -54.63 23.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.906 0.384 . . . . 0.0 110.143 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -61.0 -36.02 78.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.785 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -71.9 -46.02 59.2 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.705 ' CE2' HG23 ' A' ' 144' ' ' ILE . 18.7 t80 -66.42 -51.1 60.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.52 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.988 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.73 -42.48 79.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.517 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 12.5 pt-20 -71.8 -36.34 70.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.345 0.593 . . . . 0.0 110.24 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -75.63 -21.95 57.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.79 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.3 t -93.92 -34.76 12.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.115 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -161.71 96.27 1.03 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.886 0.374 . . . . 0.0 111.506 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -142.73 -170.2 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.642 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.69 120.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.19 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.06 119.81 32.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 62.77 119.25 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.043 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.25 -27.38 34.86 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.384 2.056 . . . . 0.0 112.33 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 178' ' ' PRO . . . -171.62 164.59 4.54 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.066 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 177' ' ' ALA . 58.9 Cg_endo -71.91 62.48 3.18 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.534 2.156 . . . . 0.0 112.327 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -107.87 152.96 41.85 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.089 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.14 -73.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.6 2.2 . . . . 0.0 112.293 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.73 -175.39 3.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 186' ' ' ALA . . . -149.94 108.41 3.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.8 m -84.45 -31.27 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.101 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.24 -47.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.818 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -106.9 93.05 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.521 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.095 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.29 145.69 24.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.89 97.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.69 172.11 4.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 30.5 m -59.77 -177.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.289 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.826 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -73.51 118.85 16.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.022 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.692 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.42 162.0 33.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.032 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 36.1 mmm -87.35 152.98 53.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.103 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.12 -52.03 6.59 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.283 1.988 . . . . 0.0 112.026 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.579 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -61.86 -30.06 70.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.66 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.945 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -63.94 -52.8 58.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.607 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.646 ' HA ' HD11 ' A' ' 146' ' ' LEU . 80.6 mtt180 -55.99 -36.16 67.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -62.39 -50.06 73.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.208 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.61 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -64.86 -23.79 67.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.751 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.903 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.46 -38.43 62.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.881 0.372 . . . . 0.0 110.539 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -76.31 -29.41 57.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.292 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -82.37 -45.04 15.38 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.55 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.58 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -97.29 -2.8 41.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.118 -178.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.28 38.91 91.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.712 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.768 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 64.9 mt -87.62 142.71 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.401 . . . . 0.0 111.444 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -94.17 100.46 12.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.903 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.7 mt -72.07 -21.91 61.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.254 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.94 -15.89 62.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -111.72 0.25 16.22 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.834 ' HB ' HD12 ' A' ' 158' ' ' ILE . 57.2 t -81.98 148.82 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.139 0.495 . . . . 0.0 111.185 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.5 OUTLIER -77.27 124.53 27.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.199 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -82.57 121.69 5.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.175 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.448 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -137.49 34.22 2.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -124.19 -164.71 12.03 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.709 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -30.92 95.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.798 2.999 . . . . 0.0 114.301 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.84 -17.62 20.44 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.453 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.77 45.04 0.19 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.826 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.4 p -102.13 144.21 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.162 0.506 . . . . 0.0 111.822 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.834 HD12 ' HB ' ' A' ' 149' ' ' VAL . 0.1 OUTLIER -71.89 126.72 32.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.021 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.6 p -109.37 167.85 9.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.409 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.61 HG13 HD22 ' A' ' 138' ' ' LEU . 21.9 t -52.42 -26.37 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.753 0.311 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 4.1 mt-10 -65.43 -43.2 91.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.85 -43.68 57.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.827 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.945 HG21 ' HB1' ' A' ' 135' ' ' ALA . 20.0 t -57.22 -54.24 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.054 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.524 ' HA ' ' CE ' ' A' ' 164' ' ' LYS . 0.2 OUTLIER -65.29 -46.84 78.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 12.6 mtp180 -52.96 -41.71 64.81 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.053 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.531 ' CE2' HG23 ' A' ' 144' ' ' ILE . 12.3 t80 -73.7 -46.66 44.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.267 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.768 ' HB2' ' CD1' ' A' ' 144' ' ' ILE . . . -59.88 -49.1 79.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.458 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 9.7 pt-20 -62.91 -34.08 76.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.32 0.581 . . . . 0.0 109.981 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.7 OUTLIER -78.13 -30.13 49.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.674 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 167' ' ' ALA . 0.6 OUTLIER -82.12 -37.06 26.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.632 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -176.59 94.94 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.4 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 0.1 OUTLIER -100.81 -162.07 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.432 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -132.94 111.89 11.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 111.139 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 16.9 p -104.16 34.19 3.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.795 ' HB1' ' HG2' ' A' ' 178' ' ' PRO . . . -157.15 77.47 3.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.081 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.85 -43.48 48.93 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.638 2.225 . . . . 0.0 112.471 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . . . -85.4 -65.15 0.21 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.647 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.795 ' HG2' ' HB1' ' A' ' 175' ' ' ALA . 44.6 Cg_endo -68.91 158.95 55.85 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.281 1.987 . . . . 0.0 112.567 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -146.93 87.9 6.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.049 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -51.69 -27.13 25.21 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.686 2.257 . . . . 0.0 112.474 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.56 -31.45 8.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 59.91 76.23 0.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.999 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.3 -30.96 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.221 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.37 161.15 16.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.09 -45.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.089 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.3 m -111.95 -38.17 4.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.46 -56.49 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -127.71 150.17 49.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.677 HG13 ' N ' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -122.44 -164.39 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.85 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -98.69 123.82 43.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.098 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.715 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.45 161.03 35.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.8 mtp -81.5 153.01 70.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.78 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.21 -41.45 75.87 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.203 1.935 . . . . 0.0 111.985 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.715 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -75.1 -27.39 59.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.652 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.759 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -65.21 -50.85 64.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.679 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.852 ' HA ' HD21 ' A' ' 146' ' ' LEU . 3.3 mtt-85 -55.94 -42.68 76.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.124 0.487 . . . . 0.0 110.261 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -57.94 -47.46 82.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.799 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.799 HD22 HG13 ' A' ' 160' ' ' VAL . 0.8 OUTLIER -65.37 -22.96 66.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.148 178.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.591 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -73.29 -37.88 66.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.536 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -76.38 -30.69 57.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.313 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.32 -44.65 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.565 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.884 HD12 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -95.6 -3.95 45.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.743 -179.147 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.46 37.66 92.86 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.478 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.741 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 45.1 mt -89.41 138.52 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.39 100.55 12.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.852 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -61.63 -23.0 65.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.539 -178.116 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 t -66.65 -12.19 57.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.305 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -115.6 4.44 14.15 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.876 ' CB ' HD12 ' A' ' 158' ' ' ILE . 67.3 t -89.2 152.02 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.778 0.323 . . . . 0.0 110.921 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.81 106.48 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.349 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.95 120.41 9.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.914 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -137.82 32.2 2.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 110.796 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.491 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -126.98 -166.38 12.14 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.129 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' N ' HG12 ' A' ' 157' ' ' VAL . 36.5 Cg_exo -32.26 99.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.86 3.04 . . . . 0.0 114.307 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.26 -17.16 10.48 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.435 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.46 43.19 0.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.85 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -98.51 143.88 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.129 0.49 . . . . 0.0 111.523 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.059 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -72.31 127.61 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.69 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 163' ' ' VAL . 11.4 p -100.67 165.83 11.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.207 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.799 HG13 HD22 ' A' ' 138' ' ' LEU . 67.9 t -54.96 -30.53 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.701 0.286 . . . . 0.0 111.142 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -61.77 -39.77 92.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.009 0.433 . . . . 0.0 109.85 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 10.8 m-20 -74.85 -37.61 62.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.416 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.059 HG22 HD11 ' A' ' 158' ' ' ILE . 42.1 t -64.12 -54.84 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.591 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -61.64 -42.44 98.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.618 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 2.0 mtt180 -64.57 -45.2 88.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 111.054 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.713 ' CE2' HG23 ' A' ' 144' ' ' ILE . 3.7 t80 -67.21 -49.46 64.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.884 ' HB1' HD12 ' A' ' 142' ' ' LEU . . . -63.38 -34.5 77.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.958 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.556 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 6.3 pt-20 -74.28 -38.03 63.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.0 110.562 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.72 -21.91 57.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.984 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.6 t -91.93 -36.7 13.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.247 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -161.33 96.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 0.0 111.591 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.556 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 0.8 OUTLIER -166.82 -69.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.961 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -171.68 -174.22 1.32 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.173 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.38 132.8 4.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -133.65 120.22 15.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.065 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.62 -39.05 84.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.324 2.016 . . . . 0.0 112.227 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 56.65 86.33 0.17 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.202 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.36 174.29 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.556 2.171 . . . . 0.0 112.288 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.811 ' HB3' ' HD3' ' A' ' 180' ' ' PRO . . . -179.55 -55.55 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.241 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 58.1 Cg_exo -51.68 140.38 46.38 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.437 2.091 . . . . 0.0 112.405 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.455 ' HA ' ' CE ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -164.76 -171.55 2.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.835 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -65.18 -37.98 89.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.0 m 42.39 32.24 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.699 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.18 -60.38 1.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.79 139.74 32.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.016 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.066 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.6 m -142.66 97.96 3.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.839 0.352 . . . . 0.0 110.85 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.62 -32.31 8.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -135.7 -45.78 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 130' ' ' ALA . 14.6 t -109.55 160.25 8.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.027 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.77 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . -127.47 128.17 45.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.528 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.23 162.03 32.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.639 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -88.24 157.65 50.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.718 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.64 -52.02 7.03 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.157 1.904 . . . . 0.0 112.224 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.576 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.05 -32.71 74.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.943 0.402 . . . . 0.0 110.601 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.727 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -63.45 -52.83 59.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.644 ' HA ' HD11 ' A' ' 146' ' ' LEU . 1.1 mtm105 -56.44 -34.41 66.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.135 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -62.25 -50.99 69.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.964 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.691 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -63.96 -24.03 67.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.382 179.186 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.781 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -71.33 -40.76 70.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 110.617 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -76.32 -29.2 57.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.701 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -82.2 -44.17 16.72 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.576 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.805 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -99.61 -2.22 36.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.061 -178.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.53 39.13 93.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.588 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.775 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 67.2 mt -87.63 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.971 0.415 . . . . 0.0 111.712 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.26 100.48 12.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.811 ' HB3' HD13 ' A' ' 158' ' ' ILE . 5.6 mt -70.52 -18.83 62.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.278 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.57 -15.0 62.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.994 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -114.58 3.17 14.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.708 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.822 ' CB ' HD12 ' A' ' 158' ' ' ILE . 84.3 t -83.96 144.45 9.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.947 0.403 . . . . 0.0 110.809 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 111.45 6.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.413 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -76.44 120.22 5.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.979 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -122.83 18.96 10.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 0.0 111.235 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.716 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -123.86 -154.21 8.87 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.587 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 26.6 Cg_exo -34.73 109.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.553 2.835 . . . . 0.0 114.467 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.27 8.53 6.71 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.518 -0.764 . . . . 0.0 113.806 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.95 41.37 1.7 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.77 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -85.54 145.03 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.054 -0.573 . . . . 0.0 111.433 -178.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.93 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -83.87 132.47 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 163' ' ' VAL . 7.3 p -112.07 166.82 10.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.932 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.691 HG13 HD22 ' A' ' 138' ' ' LEU . 19.2 t -53.27 -27.74 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.293 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 4.4 pt-20 -64.12 -42.97 96.64 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -75.09 -38.12 61.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.93 HG22 HD11 ' A' ' 158' ' ' ILE . 58.3 t -62.59 -54.54 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.907 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -60.73 -41.38 95.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.022 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -68.79 -37.52 79.33 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.689 0.28 . . . . 0.0 111.491 -179.484 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.665 ' CE2' HG23 ' A' ' 144' ' ' ILE . 7.2 t80 -74.01 -54.1 8.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.805 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -52.7 -41.08 63.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.551 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.647 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 10.4 pt-20 -71.12 -39.39 72.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.153 0.502 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 6.9 tt0 -70.1 -21.96 63.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.501 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -97.8 -34.27 10.94 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -176.66 93.69 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.114 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.647 ' HB3' ' HA ' ' A' ' 168' ' ' GLU . 6.1 pttt -102.21 138.95 38.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.47 -33.97 10.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.3 p -140.07 -62.12 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.716 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.751 ' HB1' ' HD2' ' A' ' 176' ' ' PRO . . . 57.27 167.04 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.214 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.751 ' HD2' ' HB1' ' A' ' 175' ' ' ALA . 54.9 Cg_endo -69.81 165.92 29.39 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.555 2.17 . . . . 0.0 112.307 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.766 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . . . -178.26 -62.11 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 177' ' ' ALA . 57.7 Cg_endo -71.31 138.58 33.3 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.47 2.113 . . . . 0.0 112.267 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -104.45 88.53 2.18 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.217 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.79 -172.97 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.553 2.169 . . . . 0.0 112.23 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.97 173.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 59.1 77.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.092 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 183' ' ' VAL . 11.3 p -58.59 113.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.46 162.8 24.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.91 177.61 9.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.064 179.975 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.3 m -117.57 73.85 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.862 0.363 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 -160.83 101.72 1.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 129' ' ' VAL . 6.5 tt0 -137.7 -48.22 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.78 HG22 ' H ' ' A' ' 130' ' ' ALA . 1.7 p 44.41 -167.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.843 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -122.66 141.85 51.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.072 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.71 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.38 162.05 32.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.2 mtp -82.61 146.33 53.02 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.87 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.45 -39.21 22.02 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.19 1.926 . . . . 0.0 112.349 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.751 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -77.71 -28.18 50.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.613 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -64.01 -50.89 66.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.66 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.726 ' HA ' HD21 ' A' ' 146' ' ' LEU . 73.6 mtt180 -58.3 -35.51 71.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.334 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -62.25 -50.39 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.124 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.473 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -65.86 -23.05 66.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.561 179.239 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.711 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -73.21 -38.62 66.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.646 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -32.24 58.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.482 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -82.11 -42.71 18.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.616 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.826 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -99.47 -2.9 34.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.962 -178.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.82 39.21 95.01 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.197 -1.002 . . . . 0.0 111.618 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.745 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 68.6 mt -87.55 143.34 11.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.031 0.443 . . . . 0.0 111.811 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -95.38 100.61 12.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.726 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER -68.46 -24.1 64.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.088 -178.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -65.44 -14.77 61.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.038 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -110.92 -2.2 16.12 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.761 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.892 ' CB ' HD12 ' A' ' 158' ' ' ILE . 62.1 t -82.49 148.48 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.966 0.412 . . . . 0.0 111.109 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.99 110.3 5.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.487 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.63 120.4 7.49 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.907 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -135.7 32.94 2.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.344 0.593 . . . . 0.0 110.726 -179.574 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.485 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -127.73 -165.73 11.92 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.189 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.413 ' N ' HG12 ' A' ' 157' ' ' VAL . 35.2 Cg_exo -32.22 99.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.82 3.014 . . . . 0.0 114.33 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.73 -16.64 10.64 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.46 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.09 43.01 0.26 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.843 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.6 p -98.47 144.46 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.314 -0.443 . . . . 0.0 111.536 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.021 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.75 128.33 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 110.924 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 p -101.02 168.6 9.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.144 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.751 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 46.5 t -56.21 -30.22 29.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.712 0.291 . . . . 0.0 110.991 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.75 -39.04 90.18 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.495 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 12.1 m-20 -75.05 -38.32 61.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.615 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.021 HG22 HD11 ' A' ' 158' ' ' ILE . 52.5 t -64.47 -54.74 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.097 0.475 . . . . 0.0 110.313 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -60.51 -41.36 94.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.792 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -68.23 -40.15 82.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.425 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.655 ' CE2' HG23 ' A' ' 144' ' ' ILE . 6.8 t80 -72.29 -52.67 15.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.921 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.826 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -55.66 -39.73 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.381 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 8.8 pt-20 -72.21 -38.15 69.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.35 0.595 . . . . 0.0 110.04 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.416 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 1.7 tp10 -73.13 -21.97 60.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.733 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.1 t -96.58 -41.06 8.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -164.44 88.15 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.428 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.753 ' HB3' HG22 ' A' ' 174' ' ' THR . 4.0 tttm -101.74 161.51 13.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.551 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.53 -18.05 61.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.395 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.753 HG22 ' HB3' ' A' ' 172' ' ' LYS . 9.5 t -54.01 -32.13 53.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.848 0.356 . . . . 0.0 111.071 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' A' ' 176' ' ' PRO . . . -129.07 116.07 18.88 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 177' ' ' ALA . 19.3 Cg_endo -61.12 -78.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.329 2.019 . . . . 0.0 112.388 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 176' ' ' PRO . . . 178.74 91.37 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.063 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.04 157.09 63.32 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.445 2.097 . . . . 0.0 112.31 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.861 ' HB3' ' HD3' ' A' ' 180' ' ' PRO . . . -173.5 -57.35 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.23 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.861 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 52.6 Cg_exo -52.61 152.44 16.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.306 2.004 . . . . 0.0 112.251 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -108.53 147.97 30.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -146.2 29.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.998 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 183' ' ' VAL . 13.7 t -107.23 32.07 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.138 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -91.86 167.53 12.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -43.62 64.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.038 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.555 -0.218 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -84.51 126.18 33.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.814 0.34 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.48 29.97 7.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -131.4 156.96 44.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.679 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 130' ' ' ALA . 14.1 t -150.51 159.46 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.271 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.829 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -137.73 136.47 37.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.715 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.709 ' HB1' HD23 ' A' ' 146' ' ' LEU . . . -133.47 162.01 33.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.233 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.413 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 5.7 mmm -85.05 152.48 58.85 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.988 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.29 -52.06 9.14 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.324 2.016 . . . . 0.0 112.092 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.645 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -62.07 -39.81 93.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 110.531 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.816 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -54.18 -46.05 72.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.695 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -62.22 -33.93 75.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.573 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.81 ' HG2' HD13 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -59.5 -54.35 47.61 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 110.195 179.629 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.81 HD13 ' HG2' ' A' ' 137' ' ' ARG . 4.7 mp -68.06 -24.2 65.05 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.547 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.69 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . . . -74.64 -39.09 62.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.034 0.445 . . . . 0.0 109.947 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -76.44 -30.26 57.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.378 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -82.35 -49.25 10.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.094 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.774 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -85.08 -12.91 51.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.472 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.51 29.5 48.65 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.178 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.873 HG13 ' HB2' ' A' ' 167' ' ' ALA . 14.5 mm -87.73 147.91 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 111.476 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.96 100.93 10.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.678 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.709 HD23 ' HB1' ' A' ' 131' ' ' ALA . 2.0 mp -63.59 -20.08 65.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.255 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 m -63.02 -19.79 64.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.85 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -107.08 -3.91 19.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.495 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.983 HG11 HD13 ' A' ' 158' ' ' ILE . 58.3 t -79.92 147.47 6.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.081 0.467 . . . . 0.0 111.025 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 110.75 5.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.261 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.64 123.64 10.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.194 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.73 33.8 1.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.357 0.599 . . . . 0.0 110.649 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.57 -165.17 12.36 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.777 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -31.46 96.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.73 2.953 . . . . 0.0 114.157 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.26 -18.51 17.44 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.309 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.07 46.52 0.17 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.829 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.2 p -104.54 142.29 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 112.082 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.983 HD13 HG11 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -69.15 123.35 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.036 179.348 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.835 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.3 p -106.74 165.95 10.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.163 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.645 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 21.6 t -50.21 -25.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.603 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.5 -45.57 86.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.703 ' HB2' HD13 ' A' ' 158' ' ' ILE . 8.1 m-20 -74.91 -33.3 61.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.493 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.934 ' CG2' HD11 ' A' ' 158' ' ' ILE . 9.8 t -66.02 -54.59 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -61.72 -35.69 78.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.514 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -43.31 68.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.324 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.585 ' CE2' HG23 ' A' ' 144' ' ' ILE . 19.7 t80 -72.29 -46.51 55.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.818 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.873 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -59.74 -39.77 85.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.602 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 13.8 pt-20 -73.25 -36.97 66.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.13 0.491 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -21.9 50.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.989 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.7 t -91.34 -35.08 14.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.095 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.89 86.31 1.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.294 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -176.68 -73.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.738 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.582 ' O ' HG22 ' A' ' 174' ' ' THR . . . 61.64 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.72 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 173' ' ' ALA . 5.2 t 48.35 27.53 1.39 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.472 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -140.26 148.64 54.97 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.189 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.0 153.16 63.33 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.609 2.206 . . . . 0.0 112.312 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.722 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . . . -72.24 -61.15 1.93 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.197 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.722 ' HD3' ' HB3' ' A' ' 177' ' ' ALA . 56.2 Cg_endo -70.34 129.83 17.64 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.488 2.125 . . . . 0.0 112.377 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.87 109.86 2.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.24 162.36 40.72 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.366 2.044 . . . . 0.0 112.33 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -96.97 -50.04 4.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.47 109.49 11.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.014 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.1 m -118.5 32.16 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.15 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -94.84 -50.52 5.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.12 174.63 11.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.132 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.14 132.27 11.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.885 0.374 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.68 119.2 38.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.23 -30.96 71.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 130' ' ' ALA . 15.7 t -106.14 159.93 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.201 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . -134.55 130.12 36.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.486 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.32 162.13 32.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.962 0.41 . . . . 0.0 111.658 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.39 149.08 41.97 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.927 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.42 -51.99 9.24 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.27 1.98 . . . . 0.0 112.704 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.612 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -61.14 -36.93 81.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 111.012 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.859 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.1 -52.92 62.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.124 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.713 ' HA ' HD11 ' A' ' 146' ' ' LEU . 1.3 mtt180 -55.6 -37.43 68.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.76 -52.33 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -64.57 -23.15 67.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.86 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.081 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.71 -36.92 62.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.96 0.41 . . . . 0.0 110.434 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -76.38 -29.39 57.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.125 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.2 -48.56 11.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.2 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.621 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -88.97 -8.96 53.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.825 -179.273 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.4 35.78 55.83 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.102 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.858 HG13 ' HB2' ' A' ' 167' ' ' ALA . 14.0 mm -90.17 140.68 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.972 0.415 . . . . 0.0 111.522 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.23 100.78 13.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.081 HD21 ' HB2' ' A' ' 139' ' ' ALA . 4.9 mt -64.51 -19.64 65.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.334 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.2 p -66.12 -15.36 63.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.196 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -113.45 6.82 17.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.651 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.791 ' CB ' HD12 ' A' ' 158' ' ' ILE . 87.5 t -90.69 144.13 9.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.888 0.375 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -70.98 113.52 8.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.347 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -77.56 120.55 5.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.921 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.486 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -123.53 24.89 8.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.026 0.441 . . . . 0.0 111.325 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.724 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -129.7 -154.92 8.27 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.592 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 30.6 Cg_exo -35.53 108.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.436 2.758 . . . . 0.0 114.445 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.98 8.0 14.89 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.616 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.84 40.71 1.81 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.811 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -85.74 142.4 13.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.99 -0.605 . . . . 0.0 111.401 -178.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.823 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -82.55 131.01 34.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 p -110.66 170.98 7.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.217 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.612 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 15.2 t -54.92 -23.89 13.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.088 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.44 -41.49 76.2 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.406 ' CB ' ' CG1' ' A' ' 149' ' ' VAL . 0.7 OUTLIER -73.64 -38.72 64.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.306 179.227 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.859 HG21 ' HB1' ' A' ' 135' ' ' ALA . 48.5 t -68.53 -51.96 41.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.259 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -62.09 -34.11 75.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.439 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -75.43 -42.17 54.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.367 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.746 ' CE2' HG23 ' A' ' 144' ' ' ILE . 10.8 t80 -71.95 -48.37 45.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.069 0.462 . . . . 0.0 110.436 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.858 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -59.57 -38.83 82.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.325 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.536 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 11.6 pt-20 -74.77 -38.77 62.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.296 0.569 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 17.8 tt0 -73.04 -22.01 60.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.3 t -92.12 -41.06 10.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.948 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -158.95 99.2 1.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.473 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 0.1 OUTLIER -142.04 -167.91 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.737 179.684 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.0 78.73 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.0 p -115.62 33.62 5.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.827 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.28 115.58 20.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.066 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -86.9 26.48 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.805 2.337 . . . . 0.0 112.936 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.484 ' HB1' ' HD2' ' A' ' 178' ' ' PRO . . . 61.81 158.79 0.11 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.174 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' A' ' 177' ' ' ALA . 52.9 Cg_endo -69.33 115.74 4.18 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.636 2.224 . . . . 0.0 112.305 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -97.71 112.53 61.72 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.151 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -50.98 170.45 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.498 2.132 . . . . 0.0 112.337 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -44.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.869 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -74.48 163.87 27.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.02 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.1 m -132.34 112.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.31 169.26 12.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -96.78 122.18 39.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.142 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.855 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.622 0.249 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.696 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.73 162.09 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.337 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.418 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 7.4 mtp -86.97 150.16 49.39 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.962 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -50.57 -52.02 9.88 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.168 1.912 . . . . 0.0 112.504 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.712 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.98 -34.96 79.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 110.61 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.654 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.65 -52.9 63.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.79 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.599 ' HA ' HD11 ' A' ' 146' ' ' LEU . 87.6 mtt-85 -56.0 -33.76 65.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.623 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -53.1 56.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.53 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -62.84 -25.4 68.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.783 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.077 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -73.88 -36.89 64.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.984 0.421 . . . . 0.0 110.352 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -76.34 -29.36 57.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.301 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -82.04 -49.04 10.67 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.148 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.541 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.59 -10.21 52.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.71 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 33.23 55.46 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.956 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.865 HG13 ' HB2' ' A' ' 167' ' ' ALA . 17.3 mm -87.81 142.88 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.93 0.395 . . . . 0.0 111.522 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.84 100.79 12.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 1.077 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.1 mt -65.12 -18.67 65.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.286 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -17.27 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.86 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -110.86 5.66 20.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.602 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.814 ' CB ' HD12 ' A' ' 158' ' ' ILE . 61.5 t -87.72 148.27 4.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.087 0.47 . . . . 0.0 111.198 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.95 109.92 5.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.349 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.82 122.2 8.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.919 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.49 HG22 ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -139.32 33.68 2.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.349 0.595 . . . . 0.0 110.661 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -126.96 -165.53 11.95 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.1 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -31.93 98.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.821 3.014 . . . . 0.0 114.285 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.2 -16.89 11.08 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.443 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.58 43.45 0.24 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.855 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -99.68 144.2 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.135 0.493 . . . . 0.0 111.729 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.924 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.6 127.78 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.369 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 31.0 p -102.86 167.94 9.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.797 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.712 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 99.0 t -54.77 -31.61 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 110.873 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.22 -39.39 94.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.49 ' OD2' HG22 ' A' ' 152' ' ' THR . 4.8 m-20 -69.89 -44.25 70.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.397 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.924 HG22 HD11 ' A' ' 158' ' ' ILE . 83.4 t -63.41 -54.64 30.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.292 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -57.65 -34.41 69.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.731 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -72.7 -49.54 30.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.438 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.706 ' CE2' HG23 ' A' ' 144' ' ' ILE . 14.9 t80 -65.99 -47.97 72.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.798 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.865 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.59 -42.01 77.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.403 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 6.9 pt-20 -72.13 -33.08 67.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.048 0.452 . . . . 0.0 110.454 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.418 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 23.0 tt0 -77.99 -24.07 48.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.5 t -89.35 -38.24 14.29 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.648 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.213 179.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.823 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.674 0.274 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.739 ' HB1' HD23 ' A' ' 146' ' ' LEU . . . -133.52 161.99 33.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.42 ' HG3' ' HB ' ' A' ' 159' ' ' THR . 35.9 mmm -84.53 155.42 62.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.922 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.92 -52.07 5.78 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.246 1.964 . . . . 0.0 112.247 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.624 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -62.95 -32.54 73.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.986 0.422 . . . . 0.0 110.624 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.809 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.13 -49.86 75.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.72 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.1 mtt85 -58.44 -33.4 69.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.511 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -63.6 -52.7 59.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.226 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -64.48 -24.2 67.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.816 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.73 -35.74 62.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.92 0.391 . . . . 0.0 110.378 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -76.39 -29.38 57.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.186 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -82.37 -48.94 10.55 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.161 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.84 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.97 -9.95 51.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.746 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.52 32.41 54.77 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.047 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.922 HG13 ' HB2' ' A' ' 167' ' ' ALA . 15.1 mm -88.35 148.61 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.132 0.491 . . . . 0.0 111.712 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -106.99 100.89 10.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.486 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.739 HD23 ' HB1' ' A' ' 131' ' ' ALA . 1.7 mp -62.56 -19.53 63.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.336 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.7 m -62.19 -21.05 64.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.924 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -106.32 -4.76 19.69 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.55 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.995 HG11 HD13 ' A' ' 158' ' ' ILE . 58.0 t -79.01 147.36 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -70.98 113.0 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.203 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.93 122.68 7.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.126 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -139.77 33.25 2.0 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.317 0.579 . . . . 0.0 110.661 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.45 -165.29 12.27 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.801 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -31.09 95.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.776 2.984 . . . . 0.0 114.197 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.76 -20.41 12.17 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.188 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 131.04 44.73 0.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.3 p -100.62 142.97 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.252 0.548 . . . . 0.0 111.956 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.995 HD13 HG11 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -71.26 124.61 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.03 179.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.83 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.4 p -107.34 165.7 11.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.231 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.624 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 30.0 t -50.16 -26.02 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.593 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -45.58 88.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.669 ' HB2' HD13 ' A' ' 158' ' ' ILE . 6.6 m-20 -74.83 -33.64 62.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.494 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.933 ' CG2' HD11 ' A' ' 158' ' ' ILE . 8.7 t -65.1 -54.53 28.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.6 tptp -61.31 -37.31 82.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.546 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.36 -42.96 74.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.307 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.56 ' CE2' HG23 ' A' ' 144' ' ' ILE . 23.3 t80 -71.45 -50.52 30.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.642 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.922 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -55.89 -39.41 71.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.254 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 22.6 pt-20 -75.63 -45.72 35.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.155 0.502 . . . . 0.0 109.866 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.2 tp10 -64.4 -21.93 66.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.487 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.1 t -93.71 -33.16 13.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.104 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.634 179.766 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.849 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.707 0.289 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.704 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.47 162.02 33.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 10.4 mtp -80.75 146.91 61.24 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.808 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.22 -40.11 21.49 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.249 1.966 . . . . 0.0 112.324 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -77.85 -27.87 49.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.603 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -63.37 -52.56 61.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.617 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.712 ' HA ' HD21 ' A' ' 146' ' ' LEU . 18.6 mtp-105 -56.25 -35.01 66.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.463 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -62.76 -51.56 66.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.25 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -64.21 -23.2 67.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.693 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -72.03 -41.47 67.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.581 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -76.52 -29.03 56.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.569 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.27 -43.62 17.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.652 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.845 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -100.65 -2.28 33.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.178 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.08 39.18 92.83 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.643 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.739 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 66.8 mt -87.54 141.8 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.054 0.454 . . . . 0.0 111.8 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.28 100.58 12.61 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.712 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER -68.29 -22.6 64.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.217 -178.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.5 m -65.19 -13.96 59.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.193 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -114.29 0.02 14.02 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.897 ' CB ' HD12 ' A' ' 158' ' ' ILE . 60.2 t -81.6 149.98 4.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.801 0.334 . . . . 0.0 110.959 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -70.96 108.79 4.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.314 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.67 119.99 7.93 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.808 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -136.88 34.48 2.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.231 0.538 . . . . 0.0 110.895 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.492 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -130.29 -166.25 11.76 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.3 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.426 ' N ' HG12 ' A' ' 157' ' ' VAL . 36.2 Cg_exo -32.53 100.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.864 3.043 . . . . 0.0 114.315 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.2 -16.38 9.5 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.474 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 126.75 42.25 0.29 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.849 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.7 p -97.65 144.4 11.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.197 -0.502 . . . . 0.0 111.35 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.0 129.29 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.791 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.0 p -100.86 168.0 9.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.174 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.765 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 50.4 t -55.64 -31.7 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.337 . . . . 0.0 111.139 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -38.88 84.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.119 0.485 . . . . 0.0 109.909 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.473 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 10.0 m-20 -74.94 -38.67 61.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.725 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.01 HG22 HD11 ' A' ' 158' ' ' ILE . 45.6 t -64.67 -54.71 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.042 0.449 . . . . 0.0 110.362 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -60.4 -40.7 91.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.794 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -69.04 -40.3 78.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.454 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.689 ' CE2' HG23 ' A' ' 144' ' ' ILE . 6.5 t80 -72.13 -52.15 18.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.845 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -57.63 -38.47 75.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.538 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.69 -34.69 69.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.237 0.542 . . . . 0.0 110.481 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -21.94 50.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.087 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.4 t -92.61 -35.13 13.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.652 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.641 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.869 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.57 0.224 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.672 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.72 162.21 32.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.311 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 4.7 mmm -86.26 150.3 51.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.172 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.59 -51.94 9.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.202 1.934 . . . . 0.0 112.149 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.756 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -59.75 -34.52 73.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.021 0.438 . . . . 0.0 110.637 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 1.011 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -59.98 -51.22 70.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.57 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.415 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 84.5 mtt-85 -55.11 -36.41 65.68 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.447 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.3 mtm-85 -61.48 -51.19 69.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.99 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 138' ' ' LEU . 0.9 OUTLIER -62.85 -24.84 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.762 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . . . -70.91 -41.54 71.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.731 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -76.38 -29.05 56.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.768 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -82.16 -43.79 17.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.575 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.618 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -100.67 -1.83 34.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.08 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.31 39.15 94.23 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.645 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.781 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 58.5 mt -87.55 144.99 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 112.002 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.8 100.64 12.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.85 ' HG ' HD11 ' A' ' 158' ' ' ILE . 2.5 mp -74.39 -20.74 59.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.229 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 t -61.93 -17.03 55.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.715 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -109.16 -9.78 15.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.63 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.972 ' HB ' HD12 ' A' ' 158' ' ' ILE . 57.8 t -70.66 146.09 12.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.063 0.459 . . . . 0.0 111.191 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.7 121.15 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.433 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -77.77 123.24 6.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.065 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.431 HG22 ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -143.46 38.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.29 0.567 . . . . 0.0 110.857 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -129.68 -162.65 10.91 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.102 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -31.75 96.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.775 2.983 . . . . 0.0 114.176 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.12 -18.15 14.62 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.277 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.37 44.4 0.19 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.869 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -103.74 141.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.352 0.596 . . . . 0.0 112.01 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.972 HD12 ' HB ' ' A' ' 149' ' ' VAL . 0.1 OUTLIER -67.42 127.93 29.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.5 p -108.07 172.82 6.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.102 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.756 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 53.7 t -54.67 -29.8 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -63.65 -40.78 97.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' OD2' HG22 ' A' ' 152' ' ' THR . 2.0 m-20 -71.81 -42.56 66.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.602 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.011 HG21 ' HB1' ' A' ' 135' ' ' ALA . 80.7 t -64.49 -54.53 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.381 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -58.67 -37.38 75.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -70.81 -46.4 62.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.153 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.576 ' CE2' HG23 ' A' ' 144' ' ' ILE . 16.8 t80 -65.52 -50.55 64.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.451 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.781 ' HB2' ' CD1' ' A' ' 144' ' ' ILE . . . -56.54 -44.61 81.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.547 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -71.98 -34.91 69.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.298 0.571 . . . . 0.0 110.405 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -77.42 -21.87 52.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.859 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.4 t -91.32 -41.14 11.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.866 0.365 . . . . 0.0 110.896 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.218 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.837 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.73 0.3 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.662 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.56 162.1 32.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.276 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.1 OUTLIER -83.25 153.77 66.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.41 -52.01 8.69 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.297 1.998 . . . . 0.0 112.344 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.813 ' HB3' HG21 ' A' ' 160' ' ' VAL . . . -64.79 -32.11 73.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.809 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.33 -52.97 62.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.885 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.654 ' HA ' HD11 ' A' ' 146' ' ' LEU . 9.1 mtt-85 -55.65 -36.53 67.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.453 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -61.45 -50.91 70.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.45 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -65.05 -24.67 67.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.89 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.037 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.64 -34.73 62.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.965 0.412 . . . . 0.0 110.537 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -33.63 59.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.362 0.601 . . . . 0.0 109.997 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -79.61 -47.99 14.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.073 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.817 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.23 -10.45 52.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.779 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.22 34.76 57.67 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.832 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.89 HG13 ' HB2' ' A' ' 167' ' ' ALA . 16.2 mm -90.81 141.83 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.015 0.436 . . . . 0.0 111.695 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.19 100.78 12.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 1.037 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.5 mt -63.5 -20.62 65.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.229 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 79.7 p -64.13 -16.83 62.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.106 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -108.57 -3.77 17.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.726 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.81 ' CB ' HD12 ' A' ' 158' ' ' ILE . 59.8 t -79.94 149.88 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.076 0.465 . . . . 0.0 111.04 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.1 OUTLIER -72.32 121.68 19.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.364 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.07 119.14 4.78 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.003 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -137.92 34.23 2.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.413 0.625 . . . . 0.0 110.678 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.485 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -126.77 -166.3 12.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.095 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -31.64 98.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.867 3.045 . . . . 0.0 114.269 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.77 -18.11 13.34 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.399 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.38 44.53 0.21 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.837 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.3 p -101.08 144.87 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.162 0.506 . . . . 0.0 111.685 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.829 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.1 126.31 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.137 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 23.3 p -102.36 167.13 10.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.62 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.813 HG21 ' HB3' ' A' ' 134' ' ' ALA . 95.4 t -54.78 -36.3 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.384 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 2.5 pt-20 -58.49 -37.05 74.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.606 ' HA ' ' HG2' ' A' ' 165' ' ' ARG . 34.5 m-20 -72.68 -46.89 51.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.355 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.829 HG22 HD11 ' A' ' 158' ' ' ILE . 71.1 t -56.92 -52.8 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 109.858 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -60.35 -37.67 81.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.234 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.606 ' HG2' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -72.29 -36.22 68.91 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.617 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.681 ' HE2' HG23 ' A' ' 144' ' ' ILE . 14.9 t80 -77.12 -50.09 13.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.038 0.447 . . . . 0.0 110.194 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.89 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -57.52 -36.37 71.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.378 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.02 -34.74 61.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.061 0.458 . . . . 0.0 110.443 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -78.05 -22.07 49.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.219 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 167' ' ' ALA . 3.0 t -88.45 -33.42 17.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.805 0.336 . . . . 0.0 111.049 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 -179.809 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.793 0.33 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.461 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.3 162.14 32.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.641 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.89 151.43 54.91 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.011 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.83 -52.14 9.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.306 2.004 . . . . 0.0 112.511 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.68 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -61.75 -36.05 79.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.008 0.432 . . . . 0.0 110.819 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.94 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.61 -52.81 63.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.912 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.669 ' HA ' HD11 ' A' ' 146' ' ' LEU . 76.8 mtt180 -56.27 -34.76 66.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.749 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -63.02 -52.0 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.252 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -64.66 -23.71 67.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.841 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.032 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.44 -36.8 63.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.016 0.436 . . . . 0.0 110.376 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -76.28 -29.3 57.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.144 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.12 -49.03 10.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.094 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.756 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.41 -10.13 52.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.804 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.12 32.64 55.95 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.946 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.854 HG13 ' HB2' ' A' ' 167' ' ' ALA . 17.8 mm -87.77 140.07 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.918 0.39 . . . . 0.0 111.437 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.48 100.78 13.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.5 mt -64.22 -17.72 63.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.208 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t -65.38 -15.62 62.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.199 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -114.03 5.61 16.14 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.73 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.803 ' CB ' HD12 ' A' ' 158' ' ' ILE . 57.4 t -87.62 145.63 7.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.941 0.401 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 111.88 7.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.629 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -75.45 118.28 5.47 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.72 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.459 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -126.83 29.37 5.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.109 0.481 . . . . 0.0 111.295 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.781 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -130.4 -156.6 8.71 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.242 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.564 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 40.5 Cg_exo -38.11 108.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.111 2.541 . . . . 0.0 114.07 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.82 5.81 27.06 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.494 -0.776 . . . . 0.0 113.519 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.5 40.69 1.86 Allowed Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -86.73 140.44 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.039 -0.581 . . . . 0.0 111.617 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.823 HD13 ' HB3' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -79.01 131.35 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.5 p -108.95 167.65 9.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.719 0.295 . . . . 0.0 110.842 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.68 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 47.4 t -54.2 -24.58 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 3.3 tt0 -65.79 -42.95 90.13 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.409 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 11.9 m-20 -74.21 -35.94 63.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.503 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.94 HG21 ' HB1' ' A' ' 135' ' ' ALA . 58.2 t -66.16 -53.69 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.955 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -62.82 -35.71 80.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.715 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 0.6 OUTLIER -71.78 -44.3 64.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.134 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.726 ' CE2' HG23 ' A' ' 144' ' ' ILE . 15.2 t80 -70.11 -47.66 60.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.983 0.42 . . . . 0.0 110.317 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.854 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -58.15 -39.0 77.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.548 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 14.2 pt-20 -75.27 -45.48 39.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.029 0.442 . . . . 0.0 110.429 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.1 tm-20 -65.19 -23.81 67.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.439 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.1 t -90.54 -37.36 13.91 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.684 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.439 179.88 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.777 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.823 0.345 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.66 ' CA ' HG23 ' A' ' 157' ' ' VAL . . . -133.4 162.05 32.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.446 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.5 OUTLIER -93.35 145.71 30.51 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.197 179.299 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.72 -52.04 9.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.406 2.071 . . . . 0.0 112.692 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.637 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -59.74 -37.39 78.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.976 0.417 . . . . 0.0 110.917 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.912 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.2 -52.84 63.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.027 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.624 ' HA ' HD11 ' A' ' 146' ' ' LEU . 14.4 mtm105 -56.86 -33.78 67.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.653 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -63.46 -50.9 67.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -65.77 -23.97 66.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.837 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.993 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.21 -37.05 63.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.013 0.435 . . . . 0.0 110.466 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -76.3 -29.28 57.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.251 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -82.13 -48.44 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.149 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.66 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.95 -10.7 49.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.735 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.5 36.03 45.24 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.842 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.762 HG13 ' HB2' ' A' ' 167' ' ' ALA . 23.3 mm -92.44 139.83 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.995 0.426 . . . . 0.0 111.583 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -93.2 100.75 13.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.993 HD21 ' HB2' ' A' ' 139' ' ' ALA . 6.1 mt -64.88 -16.73 63.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.368 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -15.65 62.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.061 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -112.27 2.71 16.69 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.643 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.781 ' CB ' HD12 ' A' ' 158' ' ' ILE . 47.7 t -86.91 142.23 13.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.094 0.474 . . . . 0.0 111.073 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -70.91 127.7 33.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.979 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.0 118.57 4.97 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.912 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -128.8 22.57 5.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.12 0.485 . . . . 0.0 110.827 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -113.78 -164.34 15.39 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.936 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -31.15 97.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.827 3.018 . . . . 0.0 114.258 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.14 -17.7 16.6 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.408 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.84 45.22 0.21 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.777 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.1 p -100.4 145.66 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.228 0.537 . . . . 0.0 111.781 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.829 HD13 ' HB3' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -72.94 124.85 30.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.155 179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.1 p -108.01 170.35 8.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.61 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.637 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 24.4 t -52.57 -25.7 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -66.21 -43.11 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 152' ' ' THR . 3.3 m-20 -73.08 -40.06 65.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.565 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.912 HG21 ' HB1' ' A' ' 135' ' ' ALA . 44.8 t -65.01 -53.52 40.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.073 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -61.82 -34.9 76.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.016 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -72.86 -47.29 47.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.792 0.33 . . . . 0.0 111.344 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.739 ' HE2' HG23 ' A' ' 144' ' ' ILE . 14.9 t80 -68.87 -41.13 78.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.309 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.762 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -63.71 -38.64 91.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.323 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -77.13 -36.94 54.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.136 0.493 . . . . 0.0 110.471 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.35 -24.51 59.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.935 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 167' ' ' ALA . 3.0 t -83.35 -39.64 20.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.67 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.379 179.86 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.827 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . . . -133.31 162.11 32.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.567 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.27 159.13 54.18 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.793 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.61 -52.07 3.48 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.122 1.882 . . . . 0.0 112.313 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.527 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -59.42 -35.72 74.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.087 0.47 . . . . 0.0 110.545 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.8 -51.22 70.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.587 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.827 ' CZ ' ' HB3' ' A' ' 131' ' ' ALA . 4.1 mtt85 -57.11 -34.13 68.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.675 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.11 -51.77 65.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.189 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.525 HD22 HG13 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -64.69 -24.22 67.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.765 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.75 -35.54 62.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.392 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -76.37 -29.44 57.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.125 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -82.18 -49.03 10.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.134 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.923 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -87.92 -9.12 54.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.758 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.15 34.76 54.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.148 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.957 HG13 ' HB2' ' A' ' 167' ' ' ALA . 13.1 mm -90.81 150.13 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.132 0.492 . . . . 0.0 111.711 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -107.91 100.98 10.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.473 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.654 HD23 ' HB1' ' A' ' 131' ' ' ALA . 1.4 mp -63.4 -17.65 62.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.422 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -18.74 62.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.917 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -110.43 -3.04 16.29 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.601 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 1.058 HG11 HD13 ' A' ' 158' ' ' ILE . 75.1 t -80.36 143.27 12.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.003 0.43 . . . . 0.0 111.07 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -71.25 112.74 7.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.206 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -76.29 123.52 6.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.282 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -127.09 15.97 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 0.0 111.367 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.72 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -115.02 -154.3 10.65 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.423 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.571 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 31.1 Cg_exo -36.01 106.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.426 2.751 . . . . 0.0 114.243 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.31 25.14 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.62 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.31 40.11 1.84 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.3 OUTLIER -86.68 142.3 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.086 -0.557 . . . . 0.0 111.241 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.058 HD13 HG11 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -81.14 123.63 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.823 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.2 p -106.66 166.12 10.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.343 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 21.1 t -50.33 -25.4 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.448 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.66 -45.86 84.96 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.724 ' HB2' HD13 ' A' ' 158' ' ' ILE . 4.9 m-20 -74.97 -33.78 61.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.439 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.945 ' CG2' HD11 ' A' ' 158' ' ' ILE . 6.1 t -65.12 -54.57 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -61.91 -35.9 79.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.59 -42.56 74.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.548 ' CE2' HG23 ' A' ' 144' ' ' ILE . 26.8 t80 -71.91 -51.27 23.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.552 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.957 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.82 -37.69 71.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.587 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 9.5 pt-20 -76.84 -42.5 39.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.264 0.554 . . . . 0.0 110.336 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.9 tp10 -70.07 -21.93 63.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.826 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.4 t -89.34 -41.01 12.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.048 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.87 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.842 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.68 0.276 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.678 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.5 162.11 32.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.437 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -89.06 150.04 44.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.089 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.59 -51.95 9.97 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.198 1.932 . . . . 0.0 112.443 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.658 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -60.2 -37.02 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.03 0.443 . . . . 0.0 110.713 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.821 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -59.62 -48.75 80.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.692 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -59.57 -34.77 73.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.641 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -50.03 72.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.283 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -67.2 -25.23 66.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.919 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.764 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.97 -32.34 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.034 0.445 . . . . 0.0 110.413 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -35.11 58.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.873 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -80.35 -47.5 14.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.207 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.769 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.02 -12.13 48.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.705 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.21 31.44 54.99 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.009 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.857 HG13 ' HB2' ' A' ' 167' ' ' ALA . 13.3 mm -88.46 147.85 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.449 . . . . 0.0 111.602 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.36 100.99 10.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.774 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.637 HD23 ' HB1' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -63.19 -17.8 62.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.549 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.5 m -63.31 -17.75 62.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.009 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -111.36 -1.09 16.11 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.584 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 1.08 HG11 HD13 ' A' ' 158' ' ' ILE . 63.6 t -81.01 148.62 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.004 0.43 . . . . 0.0 110.969 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 111.21 6.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.358 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.09 122.62 9.04 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.074 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -142.46 32.94 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.334 0.588 . . . . 0.0 110.569 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.77 -165.43 12.4 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.819 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -31.04 95.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.831 3.021 . . . . 0.0 114.197 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.56 -18.85 17.12 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.248 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.71 45.19 0.18 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.842 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.3 p -102.35 142.25 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.327 0.584 . . . . 0.0 111.997 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.08 HD13 HG11 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -68.66 124.68 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.868 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.812 ' N ' HD12 ' A' ' 158' ' ' ILE . 20.1 p -106.08 163.65 12.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.207 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.658 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 61.5 t -50.35 -33.28 10.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.467 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -59.16 -41.62 88.81 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.534 ' HB2' HD13 ' A' ' 158' ' ' ILE . 12.2 m-20 -74.97 -35.92 62.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.409 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.916 ' CG2' HD11 ' A' ' 158' ' ' ILE . 19.2 t -63.08 -54.7 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -37.62 84.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.458 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -65.99 -44.68 84.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.057 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.526 ' CE2' HG23 ' A' ' 144' ' ' ILE . 15.5 t80 -72.4 -46.89 53.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.731 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.857 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -57.82 -41.28 81.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.605 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.65 -37.23 70.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.288 0.566 . . . . 0.0 110.063 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -76.02 -21.9 56.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.832 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.5 t -94.64 -32.25 13.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.257 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.153 0 CA-C-O 120.784 0.326 . . . . 0.0 111.737 -179.772 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.766 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.476 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.28 162.04 32.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.417 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.445 ' HG3' HG22 ' A' ' 159' ' ' THR . 0.0 OUTLIER -85.54 151.25 55.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.838 178.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.16 -50.12 14.92 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.069 1.846 . . . . 0.0 112.31 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.638 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -66.18 -32.89 74.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.845 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.665 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.35 -52.97 62.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.767 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.618 ' HA ' HD11 ' A' ' 146' ' ' LEU . 50.1 mtp180 -56.38 -35.54 67.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.39 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -61.63 -49.51 76.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.176 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.64 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -64.7 -25.52 67.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.504 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.758 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -69.98 -41.93 73.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.021 0.439 . . . . 0.0 110.684 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.5 -29.15 56.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.86 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -82.17 -43.2 18.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.651 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.759 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -101.16 -2.36 31.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.971 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.95 39.03 93.21 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.648 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.764 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 65.5 mt -87.81 141.0 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 111.635 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.0 100.45 13.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.765 ' HB3' HD13 ' A' ' 158' ' ' ILE . 5.9 mt -71.4 -18.19 62.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -15.9 63.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -113.24 1.52 15.24 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.712 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.818 ' CB ' HD12 ' A' ' 158' ' ' ILE . 58.2 t -82.72 144.59 9.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.993 0.425 . . . . 0.0 110.799 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -70.88 117.73 12.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.625 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 156' ' ' GLY . . . -80.81 114.79 3.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.755 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.47 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -117.33 20.32 13.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.692 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -129.1 -153.86 8.07 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.754 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.52 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 21.2 Cg_exo -32.66 106.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.783 2.989 . . . . 0.0 114.617 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.5 10.58 8.09 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.876 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.412 ' O ' ' HA3' ' A' ' 151' ' ' GLY . . . 107.49 41.73 1.57 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -86.33 145.01 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.033 -0.583 . . . . 0.0 111.157 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.048 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -83.73 136.05 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 163' ' ' VAL . 36.1 p -112.16 166.9 10.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.318 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.64 HG13 HD22 ' A' ' 138' ' ' LEU . 24.3 t -55.18 -29.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.1 -40.12 94.12 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 14.1 m-20 -74.81 -39.12 61.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.389 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.048 HG22 HD11 ' A' ' 158' ' ' ILE . 60.1 t -65.26 -54.66 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.316 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -59.26 -42.5 91.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.837 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -67.65 -43.31 80.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.237 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.654 ' CE2' HG23 ' A' ' 144' ' ' ILE . 9.8 t80 -67.1 -54.41 21.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.491 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.764 ' HB2' ' CD1' ' A' ' 144' ' ' ILE . . . -53.01 -41.99 65.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.618 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.56 -33.03 72.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.97 -24.98 47.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.869 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.2 t -93.15 -37.99 11.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.752 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.313 179.833 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.839 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.728 0.299 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.756 ' HB1' HD23 ' A' ' 146' ' ' LEU . . . -133.54 162.14 32.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.169 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.0 mtp -86.48 148.63 47.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.091 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.35 -52.04 9.9 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.357 2.038 . . . . 0.0 112.375 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.587 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.09 -34.72 78.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.912 0.386 . . . . 0.0 110.711 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.767 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.0 -50.57 73.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.776 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -58.48 -34.5 70.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.608 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -62.47 -50.0 73.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.284 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -67.01 -25.07 66.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.905 179.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.9 -32.6 61.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.005 0.431 . . . . 0.0 110.38 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 -34.97 59.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.394 0.616 . . . . 0.0 109.944 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.07 -47.58 14.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.196 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.807 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.08 -11.81 49.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.713 -179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.54 31.84 55.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.885 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.934 HG13 ' HB2' ' A' ' 167' ' ' ALA . 11.0 mm -87.83 148.7 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.542 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -106.19 100.96 10.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.697 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.756 HD23 ' HB1' ' A' ' 131' ' ' ALA . 1.8 mp -63.65 -20.0 65.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.495 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -19.96 63.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.965 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -107.19 -6.21 17.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.514 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 1.009 HG11 HD13 ' A' ' 158' ' ' ILE . 58.0 t -77.47 146.92 7.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.054 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 111.77 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.362 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.78 122.48 8.34 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.051 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.455 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -138.85 32.69 2.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.291 0.567 . . . . 0.0 110.673 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -124.13 -164.79 12.06 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.865 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -31.69 97.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.781 2.988 . . . . 0.0 114.192 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.36 -18.1 15.79 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.344 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.75 44.43 0.2 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.839 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.4 p -100.32 142.4 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 111.99 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.009 HD13 HG11 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -71.43 124.81 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.306 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.842 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.3 p -107.05 165.14 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.162 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.587 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 21.9 t -50.14 -25.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.676 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.39 -45.68 86.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.699 ' HB2' HD13 ' A' ' 158' ' ' ILE . 5.7 m-20 -74.86 -33.07 62.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.484 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.931 ' CG2' HD11 ' A' ' 158' ' ' ILE . 7.0 t -66.02 -54.6 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -61.6 -36.24 80.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.588 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -70.86 -42.11 70.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.28 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.536 ' CE2' HG23 ' A' ' 144' ' ' ILE . 22.3 t80 -71.62 -49.89 35.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.651 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.934 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.94 -39.76 75.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.496 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.61 -35.32 67.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 110.217 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -77.93 -24.49 48.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.955 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.8 t -89.75 -33.99 16.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.775 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.218 179.874 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.862 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.743 0.306 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.704 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.51 162.15 32.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.184 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -86.27 149.18 49.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.055 179.037 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.456 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 65.7 Cg_exo -50.9 -52.07 9.84 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.366 2.044 . . . . 0.0 112.516 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.651 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -64.04 -35.13 79.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.957 0.408 . . . . 0.0 110.817 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.98 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -59.78 -52.82 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.995 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.728 ' HA ' HD11 ' A' ' 146' ' ' LEU . 4.5 mtt-85 -56.17 -34.98 66.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -61.79 -51.34 68.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.047 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -65.05 -24.19 67.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.77 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.127 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.81 -33.68 62.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.416 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.26 -34.16 59.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.962 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -80.59 -47.57 13.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.225 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.793 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.71 -10.91 49.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.822 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.17 36.17 56.5 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.929 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.921 HG13 ' HB2' ' A' ' 167' ' ' ALA . 11.5 mm -90.69 142.12 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.933 0.397 . . . . 0.0 111.659 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.87 100.78 12.89 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 1.127 HD21 ' HB2' ' A' ' 139' ' ' ALA . 3.9 mt -63.05 -22.13 66.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.349 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.2 p -66.75 -14.96 63.2 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -111.2 5.65 20.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.667 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.828 ' HB ' HD12 ' A' ' 158' ' ' ILE . 87.9 t -90.34 148.1 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.031 0.444 . . . . 0.0 110.97 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -70.87 108.56 4.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.457 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -71.06 123.5 10.64 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.974 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -141.7 34.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.309 0.576 . . . . 0.0 110.746 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -125.34 -164.64 11.9 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.955 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.408 ' N ' HG12 ' A' ' 157' ' ' VAL . 36.6 Cg_exo -31.69 96.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.809 3.006 . . . . 0.0 114.264 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.88 -17.07 17.71 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.389 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.26 43.97 0.22 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.862 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -100.8 143.08 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.208 0.528 . . . . 0.0 111.84 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.836 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -70.42 127.28 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.141 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.3 p -106.43 167.05 10.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.651 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 44.8 t -52.84 -26.87 11.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.125 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -64.77 -44.03 91.35 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.424 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 13.9 m-20 -71.62 -37.35 70.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.653 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.98 HG21 ' HB1' ' A' ' 135' ' ' ALA . 55.2 t -66.87 -54.56 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.406 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -60.87 -33.75 73.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.565 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -43.73 56.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.336 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.713 ' CE2' HG23 ' A' ' 144' ' ' ILE . 7.8 t80 -70.81 -46.75 62.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.465 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.921 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -62.02 -35.58 78.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.629 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.09 -36.29 55.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.088 0.47 . . . . 0.0 110.773 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.25 -21.91 55.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.025 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 167' ' ' ALA . 2.5 t -87.23 -40.52 14.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 110.797 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.168 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.758 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.56 0.219 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.468 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.24 162.1 32.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.949 0.404 . . . . 0.0 111.735 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.0 mtp -84.47 152.06 60.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.651 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.34 -41.9 49.59 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.119 1.88 . . . . 0.0 112.441 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.615 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -74.88 -30.37 61.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.89 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.69 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.95 -50.94 71.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.616 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.98 ' HA ' HD21 ' A' ' 146' ' ' LEU . 56.2 mtm180 -57.03 -34.28 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.304 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.22 -49.01 75.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.264 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 1.019 HD22 HG13 ' A' ' 160' ' ' VAL . 0.8 OUTLIER -65.77 -24.31 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.299 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.708 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -74.12 -36.28 64.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.64 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -76.5 -30.18 57.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.278 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -82.3 -48.99 10.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.858 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -92.33 -7.39 48.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.063 -179.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.32 38.97 58.26 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.087 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.809 HG13 ' HB2' ' A' ' 167' ' ' ALA . 12.0 mm -92.22 142.47 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.095 0.474 . . . . 0.0 111.793 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.38 100.73 12.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.98 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -57.88 -25.1 60.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.342 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -14.7 62.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.177 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -112.5 4.93 17.71 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.837 ' CB ' HD12 ' A' ' 158' ' ' ILE . 93.6 t -92.69 150.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.875 0.369 . . . . 0.0 111.021 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -70.89 105.92 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.396 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -73.04 116.84 5.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.841 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.476 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -126.58 31.48 5.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.087 0.47 . . . . 0.0 111.089 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.77 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -132.14 -156.87 8.44 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.363 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.564 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 39.0 Cg_exo -38.18 109.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.235 2.623 . . . . 0.0 114.142 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.66 5.66 25.24 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.592 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.59 39.08 2.11 Favored Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.77 HG12 ' HA3' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -84.63 143.78 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.999 -0.601 . . . . 0.0 111.469 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.065 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -81.16 136.31 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 163' ' ' VAL . 18.5 p -112.12 165.55 12.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.87 0.367 . . . . 0.0 111.04 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 1.019 HG13 HD22 ' A' ' 138' ' ' LEU . 39.3 t -52.45 -31.1 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.022 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.02 -39.45 93.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -74.88 -40.14 61.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.542 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.065 HG22 HD11 ' A' ' 158' ' ' ILE . 26.9 t -64.65 -54.75 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.021 0.438 . . . . 0.0 110.263 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -41.51 97.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.414 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.428 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 73.3 mtt-85 -62.65 -47.65 82.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.317 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.734 ' CE2' HG23 ' A' ' 144' ' ' ILE . 0.6 OUTLIER -62.87 -54.65 35.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.021 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.858 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -59.65 -41.85 91.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.841 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -72.91 -31.74 64.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 110.655 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 1.2 tm-20 -77.95 -21.98 50.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.303 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -98.07 -27.95 13.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.881 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 170' ' ' THR . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.921 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.837 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.047 0 CA-C-O 120.821 0.343 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.714 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.4 162.06 32.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.425 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -89.84 147.28 37.11 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.151 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.78 -51.99 9.75 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.282 1.988 . . . . 0.0 112.371 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.634 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.13 -33.69 75.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 110.629 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.673 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -62.06 -52.9 62.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.673 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.62 ' HA ' HD11 ' A' ' 146' ' ' LEU . 83.6 mtt-85 -54.65 -38.24 66.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 110.501 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -60.72 -49.66 76.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.129 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.787 HD22 HG13 ' A' ' 160' ' ' VAL . 1.1 mp -64.15 -24.18 67.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.57 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.077 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.83 -36.16 62.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.943 0.401 . . . . 0.0 110.493 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -76.34 -33.04 58.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.315 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -82.01 -44.74 16.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.092 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.55 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -85.0 -13.3 51.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.294 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.09 39.12 54.31 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.257 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.988 HG13 ' HB2' ' A' ' 167' ' ' ALA . 25.5 mm -100.81 146.36 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.88 100.79 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 1.077 HD21 ' HB2' ' A' ' 139' ' ' ALA . 4.3 mt -61.4 -21.54 64.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.621 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -61.97 -17.67 57.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.001 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -107.66 -8.56 16.08 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.677 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.821 ' CB ' HD12 ' A' ' 158' ' ' ILE . 59.0 t -76.28 146.21 9.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.052 0.454 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -71.46 118.74 14.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.444 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.24 119.28 5.14 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.822 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -135.71 34.27 2.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.343 0.592 . . . . 0.0 110.747 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -127.24 -164.75 11.75 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.989 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -31.66 97.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.911 3.074 . . . . 0.0 114.233 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.52 -17.04 15.7 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.425 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.78 44.32 0.22 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.837 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -100.8 144.31 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.12 0.485 . . . . 0.0 111.77 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.867 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.78 127.73 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.346 179.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 3.4 p -104.3 164.22 11.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.322 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.787 HG13 HD22 ' A' ' 138' ' ' LEU . 83.3 t -51.33 -27.63 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.804 0.335 . . . . 0.0 110.999 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -63.05 -42.83 99.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.002 0.429 . . . . 0.0 109.865 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.423 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 14.3 m-20 -72.69 -36.64 67.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.868 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.867 HG22 HD11 ' A' ' 158' ' ' ILE . 79.1 t -66.67 -54.63 23.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.906 0.384 . . . . 0.0 110.143 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -61.0 -36.02 78.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.785 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -71.9 -46.02 59.2 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.705 ' CE2' HG23 ' A' ' 144' ' ' ILE . 18.7 t80 -66.42 -51.1 60.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.52 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.988 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.73 -42.48 79.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.517 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.8 -36.34 70.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.345 0.593 . . . . 0.0 110.24 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -75.63 -21.95 57.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.79 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.3 t -93.92 -34.76 12.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.115 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.886 0.374 . . . . 0.0 111.506 -179.762 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.826 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.692 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.42 162.0 33.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.032 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 36.1 mmm -87.35 152.98 53.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.103 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.12 -52.03 6.59 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.283 1.988 . . . . 0.0 112.026 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.579 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -61.86 -30.06 70.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.66 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.945 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -63.94 -52.8 58.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.607 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.646 ' HA ' HD11 ' A' ' 146' ' ' LEU . 80.6 mtt180 -55.99 -36.16 67.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -62.39 -50.06 73.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.208 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.61 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -64.86 -23.79 67.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.751 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.903 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.46 -38.43 62.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.881 0.372 . . . . 0.0 110.539 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -76.31 -29.41 57.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.292 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -82.37 -45.04 15.38 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.55 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.58 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -97.29 -2.8 41.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.118 -178.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.28 38.91 91.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.712 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.768 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 64.9 mt -87.62 142.71 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.401 . . . . 0.0 111.444 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -94.17 100.46 12.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.903 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.7 mt -72.07 -21.91 61.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.254 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.94 -15.89 62.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -111.72 0.25 16.22 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.834 ' HB ' HD12 ' A' ' 158' ' ' ILE . 57.2 t -81.98 148.82 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.139 0.495 . . . . 0.0 111.185 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.5 OUTLIER -77.27 124.53 27.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.199 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -82.57 121.69 5.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.175 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.448 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -137.49 34.22 2.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -124.19 -164.71 12.03 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.709 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -30.92 95.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.798 2.999 . . . . 0.0 114.301 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.84 -17.62 20.44 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.453 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.77 45.04 0.19 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.826 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.4 p -102.13 144.21 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.162 0.506 . . . . 0.0 111.822 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.834 HD12 ' HB ' ' A' ' 149' ' ' VAL . 0.1 OUTLIER -71.89 126.72 32.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.021 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.6 p -109.37 167.85 9.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.409 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.61 HG13 HD22 ' A' ' 138' ' ' LEU . 21.9 t -52.42 -26.37 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.753 0.311 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 4.1 mt-10 -65.43 -43.2 91.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.85 -43.68 57.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.827 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.945 HG21 ' HB1' ' A' ' 135' ' ' ALA . 20.0 t -57.22 -54.24 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.054 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.524 ' HA ' ' CE ' ' A' ' 164' ' ' LYS . 0.2 OUTLIER -65.29 -46.84 78.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 12.6 mtp180 -52.96 -41.71 64.81 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.053 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.531 ' CE2' HG23 ' A' ' 144' ' ' ILE . 12.3 t80 -73.7 -46.66 44.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.267 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.768 ' HB2' ' CD1' ' A' ' 144' ' ' ILE . . . -59.88 -49.1 79.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.458 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.91 -34.08 76.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.32 0.581 . . . . 0.0 109.981 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.7 OUTLIER -78.13 -30.13 49.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.674 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 167' ' ' ALA . 0.6 OUTLIER -82.12 -37.06 26.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.632 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.4 179.861 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.85 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.705 0.288 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.715 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.45 161.03 35.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.8 mtp -81.5 153.01 70.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.78 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.21 -41.45 75.87 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.203 1.935 . . . . 0.0 111.985 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.715 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -75.1 -27.39 59.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.652 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.759 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -65.21 -50.85 64.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.679 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.852 ' HA ' HD21 ' A' ' 146' ' ' LEU . 3.3 mtt-85 -55.94 -42.68 76.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.124 0.487 . . . . 0.0 110.261 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -57.94 -47.46 82.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.799 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.799 HD22 HG13 ' A' ' 160' ' ' VAL . 0.8 OUTLIER -65.37 -22.96 66.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.148 178.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.591 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -73.29 -37.88 66.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.536 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -76.38 -30.69 57.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.313 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.32 -44.65 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.565 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.884 HD12 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -95.6 -3.95 45.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.743 -179.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.46 37.66 92.86 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.478 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.741 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 45.1 mt -89.41 138.52 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.39 100.55 12.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.852 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -61.63 -23.0 65.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.539 -178.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 t -66.65 -12.19 57.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.305 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -115.6 4.44 14.15 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.876 ' CB ' HD12 ' A' ' 158' ' ' ILE . 67.3 t -89.2 152.02 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.778 0.323 . . . . 0.0 110.921 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.81 106.48 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.349 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.95 120.41 9.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.914 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -137.82 32.2 2.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 110.796 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.491 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -126.98 -166.38 12.14 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.129 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.406 ' N ' HG12 ' A' ' 157' ' ' VAL . 36.5 Cg_exo -32.26 99.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.86 3.04 . . . . 0.0 114.307 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.26 -17.16 10.48 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.435 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.46 43.19 0.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.85 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -98.51 143.88 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.129 0.49 . . . . 0.0 111.523 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.059 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -72.31 127.61 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.69 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 163' ' ' VAL . 11.4 p -100.67 165.83 11.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.207 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.799 HG13 HD22 ' A' ' 138' ' ' LEU . 67.9 t -54.96 -30.53 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.701 0.286 . . . . 0.0 111.142 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -61.77 -39.77 92.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.009 0.433 . . . . 0.0 109.85 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 10.8 m-20 -74.85 -37.61 62.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.416 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.059 HG22 HD11 ' A' ' 158' ' ' ILE . 42.1 t -64.12 -54.84 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.591 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -61.64 -42.44 98.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.618 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 2.0 mtt180 -64.57 -45.2 88.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 111.054 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.713 ' CE2' HG23 ' A' ' 144' ' ' ILE . 3.7 t80 -67.21 -49.46 64.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.884 ' HB1' HD12 ' A' ' 142' ' ' LEU . . . -63.38 -34.5 77.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.958 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 6.3 pt-20 -74.28 -38.03 63.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.0 110.562 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.72 -21.91 57.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.984 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.6 t -91.93 -36.7 13.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.247 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 0.0 111.591 -179.835 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.77 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.762 0.315 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.528 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.23 162.03 32.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.639 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -88.24 157.65 50.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.718 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.64 -52.02 7.03 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.157 1.904 . . . . 0.0 112.224 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.576 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.05 -32.71 74.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.943 0.402 . . . . 0.0 110.601 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.727 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -63.45 -52.83 59.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.644 ' HA ' HD11 ' A' ' 146' ' ' LEU . 1.1 mtm105 -56.44 -34.41 66.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.135 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -62.25 -50.99 69.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.964 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.691 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -63.96 -24.03 67.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.382 179.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.781 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -71.33 -40.76 70.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 110.617 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -76.32 -29.2 57.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.701 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -82.2 -44.17 16.72 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.576 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.805 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -99.61 -2.22 36.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.061 -178.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.53 39.13 93.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.588 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.775 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 67.2 mt -87.63 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.971 0.415 . . . . 0.0 111.712 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.26 100.48 12.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.811 ' HB3' HD13 ' A' ' 158' ' ' ILE . 5.6 mt -70.52 -18.83 62.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.278 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.57 -15.0 62.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.994 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -114.58 3.17 14.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.708 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.822 ' CB ' HD12 ' A' ' 158' ' ' ILE . 84.3 t -83.96 144.45 9.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.947 0.403 . . . . 0.0 110.809 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 111.45 6.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.413 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -76.44 120.22 5.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.979 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -122.83 18.96 10.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 0.0 111.235 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.716 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -123.86 -154.21 8.87 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.587 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 26.6 Cg_exo -34.73 109.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.553 2.835 . . . . 0.0 114.467 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.27 8.53 6.71 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.518 -0.764 . . . . 0.0 113.806 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.95 41.37 1.7 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.77 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -85.54 145.03 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.054 -0.573 . . . . 0.0 111.433 -178.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.93 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -83.87 132.47 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 163' ' ' VAL . 7.3 p -112.07 166.82 10.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.932 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.691 HG13 HD22 ' A' ' 138' ' ' LEU . 19.2 t -53.27 -27.74 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.293 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 4.4 pt-20 -64.12 -42.97 96.64 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -75.09 -38.12 61.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.93 HG22 HD11 ' A' ' 158' ' ' ILE . 58.3 t -62.59 -54.54 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.907 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -60.73 -41.38 95.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.022 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -68.79 -37.52 79.33 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.689 0.28 . . . . 0.0 111.491 -179.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.665 ' CE2' HG23 ' A' ' 144' ' ' ILE . 7.2 t80 -74.01 -54.1 8.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.805 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -52.7 -41.08 63.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.551 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 10.4 pt-20 -71.12 -39.39 72.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.153 0.502 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 6.9 tt0 -70.1 -21.96 63.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.501 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -97.8 -34.27 10.94 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.114 -179.883 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.843 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.719 0.295 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.71 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.38 162.05 32.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.2 mtp -82.61 146.33 53.02 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.87 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.45 -39.21 22.02 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.19 1.926 . . . . 0.0 112.349 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.751 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -77.71 -28.18 50.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.613 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -64.01 -50.89 66.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.66 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.726 ' HA ' HD21 ' A' ' 146' ' ' LEU . 73.6 mtt180 -58.3 -35.51 71.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.334 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -62.25 -50.39 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.124 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.473 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -65.86 -23.05 66.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.561 179.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.711 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -73.21 -38.62 66.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.646 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -32.24 58.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.482 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -82.11 -42.71 18.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.616 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.826 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -99.47 -2.9 34.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.962 -178.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.82 39.21 95.01 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.197 -1.002 . . . . 0.0 111.618 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.745 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 68.6 mt -87.55 143.34 11.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.031 0.443 . . . . 0.0 111.811 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -95.38 100.61 12.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.726 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER -68.46 -24.1 64.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.088 -178.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -65.44 -14.77 61.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.038 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -110.92 -2.2 16.12 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.761 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.892 ' CB ' HD12 ' A' ' 158' ' ' ILE . 62.1 t -82.49 148.48 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.966 0.412 . . . . 0.0 111.109 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.99 110.3 5.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.487 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.63 120.4 7.49 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.907 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -135.7 32.94 2.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.344 0.593 . . . . 0.0 110.726 -179.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.485 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -127.73 -165.73 11.92 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.189 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.413 ' N ' HG12 ' A' ' 157' ' ' VAL . 35.2 Cg_exo -32.22 99.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.82 3.014 . . . . 0.0 114.33 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.73 -16.64 10.64 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.46 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.09 43.01 0.26 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.843 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.6 p -98.47 144.46 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.314 -0.443 . . . . 0.0 111.536 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.021 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.75 128.33 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 110.924 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 p -101.02 168.6 9.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.144 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.751 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 46.5 t -56.21 -30.22 29.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.712 0.291 . . . . 0.0 110.991 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.75 -39.04 90.18 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.495 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 12.1 m-20 -75.05 -38.32 61.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.615 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.021 HG22 HD11 ' A' ' 158' ' ' ILE . 52.5 t -64.47 -54.74 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.097 0.475 . . . . 0.0 110.313 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -60.51 -41.36 94.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.792 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -68.23 -40.15 82.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.425 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.655 ' CE2' HG23 ' A' ' 144' ' ' ILE . 6.8 t80 -72.29 -52.67 15.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.921 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.826 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -55.66 -39.73 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.381 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 8.8 pt-20 -72.21 -38.15 69.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.35 0.595 . . . . 0.0 110.04 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.416 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 1.7 tp10 -73.13 -21.97 60.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.733 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.1 t -96.58 -41.06 8.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.428 179.966 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.829 ' C ' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.697 0.284 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.709 ' HB1' HD23 ' A' ' 146' ' ' LEU . . . -133.47 162.01 33.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.233 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.413 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 5.7 mmm -85.05 152.48 58.85 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.988 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.29 -52.06 9.14 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.324 2.016 . . . . 0.0 112.092 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.645 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -62.07 -39.81 93.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 110.531 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.816 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -54.18 -46.05 72.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.695 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -62.22 -33.93 75.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.573 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.81 ' HG2' HD13 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -59.5 -54.35 47.61 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 110.195 179.629 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.81 HD13 ' HG2' ' A' ' 137' ' ' ARG . 4.7 mp -68.06 -24.2 65.05 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.547 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.69 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . . . -74.64 -39.09 62.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.034 0.445 . . . . 0.0 109.947 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -76.44 -30.26 57.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.378 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -82.35 -49.25 10.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.094 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.774 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -85.08 -12.91 51.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.472 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.51 29.5 48.65 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.178 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.873 HG13 ' HB2' ' A' ' 167' ' ' ALA . 14.5 mm -87.73 147.91 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 111.476 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.96 100.93 10.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.678 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.709 HD23 ' HB1' ' A' ' 131' ' ' ALA . 2.0 mp -63.59 -20.08 65.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.255 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 m -63.02 -19.79 64.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.85 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -107.08 -3.91 19.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.495 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.983 HG11 HD13 ' A' ' 158' ' ' ILE . 58.3 t -79.92 147.47 6.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.081 0.467 . . . . 0.0 111.025 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 110.75 5.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.261 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.64 123.64 10.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.194 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.73 33.8 1.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.357 0.599 . . . . 0.0 110.649 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.57 -165.17 12.36 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.777 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -31.46 96.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.73 2.953 . . . . 0.0 114.157 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.26 -18.51 17.44 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.309 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.07 46.52 0.17 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.829 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.2 p -104.54 142.29 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 112.082 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.983 HD13 HG11 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -69.15 123.35 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.036 179.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.835 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.3 p -106.74 165.95 10.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.163 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.645 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 21.6 t -50.21 -25.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.603 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.5 -45.57 86.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.703 ' HB2' HD13 ' A' ' 158' ' ' ILE . 8.1 m-20 -74.91 -33.3 61.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.493 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.934 ' CG2' HD11 ' A' ' 158' ' ' ILE . 9.8 t -66.02 -54.59 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -61.72 -35.69 78.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.514 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -43.31 68.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.324 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.585 ' CE2' HG23 ' A' ' 144' ' ' ILE . 19.7 t80 -72.29 -46.51 55.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.818 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.873 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -59.74 -39.77 85.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.602 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -73.25 -36.97 66.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.13 0.491 . . . . 0.0 110.307 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -21.9 50.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.989 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.7 t -91.34 -35.08 14.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.095 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.294 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.72 0.295 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.486 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.32 162.13 32.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.962 0.41 . . . . 0.0 111.658 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.39 149.08 41.97 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.927 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.42 -51.99 9.24 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.27 1.98 . . . . 0.0 112.704 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.612 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -61.14 -36.93 81.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 111.012 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.859 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.1 -52.92 62.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.124 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.713 ' HA ' HD11 ' A' ' 146' ' ' LEU . 1.3 mtt180 -55.6 -37.43 68.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.76 -52.33 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -64.57 -23.15 67.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.86 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.081 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.71 -36.92 62.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.96 0.41 . . . . 0.0 110.434 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -76.38 -29.39 57.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.125 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.2 -48.56 11.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.2 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.621 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -88.97 -8.96 53.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.825 -179.273 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.4 35.78 55.83 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.102 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.858 HG13 ' HB2' ' A' ' 167' ' ' ALA . 14.0 mm -90.17 140.68 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.972 0.415 . . . . 0.0 111.522 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.23 100.78 13.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 1.081 HD21 ' HB2' ' A' ' 139' ' ' ALA . 4.9 mt -64.51 -19.64 65.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.334 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.2 p -66.12 -15.36 63.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.196 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -113.45 6.82 17.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.651 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.791 ' CB ' HD12 ' A' ' 158' ' ' ILE . 87.5 t -90.69 144.13 9.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.888 0.375 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -70.98 113.52 8.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.347 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -77.56 120.55 5.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.921 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.486 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -123.53 24.89 8.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.026 0.441 . . . . 0.0 111.325 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.724 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -129.7 -154.92 8.27 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.592 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 30.6 Cg_exo -35.53 108.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.436 2.758 . . . . 0.0 114.445 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.98 8.0 14.89 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.616 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.84 40.71 1.81 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.811 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -85.74 142.4 13.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.99 -0.605 . . . . 0.0 111.401 -178.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.823 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -82.55 131.01 34.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 p -110.66 170.98 7.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.217 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.612 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 15.2 t -54.92 -23.89 13.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.088 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.44 -41.49 76.2 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.406 ' CB ' ' CG1' ' A' ' 149' ' ' VAL . 0.7 OUTLIER -73.64 -38.72 64.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.306 179.227 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.859 HG21 ' HB1' ' A' ' 135' ' ' ALA . 48.5 t -68.53 -51.96 41.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.259 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -62.09 -34.11 75.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.439 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -75.43 -42.17 54.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.367 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.746 ' CE2' HG23 ' A' ' 144' ' ' ILE . 10.8 t80 -71.95 -48.37 45.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.069 0.462 . . . . 0.0 110.436 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.858 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -59.57 -38.83 82.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.325 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 11.6 pt-20 -74.77 -38.77 62.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.296 0.569 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 17.8 tt0 -73.04 -22.01 60.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.3 t -92.12 -41.06 10.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.948 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.473 -179.9 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.3 p -80.79 90.29 5.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 110.981 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -105.38 -168.54 1.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 129' ' ' VAL . 6.2 mt-10 -99.36 164.37 12.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.034 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.773 HG22 ' H ' ' A' ' 130' ' ' ALA . 1.7 p 44.94 -168.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.468 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.855 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -123.18 143.06 50.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.696 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.73 162.09 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.337 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.418 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 7.4 mtp -86.97 150.16 49.39 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.962 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -50.57 -52.02 9.88 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.168 1.912 . . . . 0.0 112.504 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.712 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.98 -34.96 79.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 110.61 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.654 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.65 -52.9 63.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.79 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.599 ' HA ' HD11 ' A' ' 146' ' ' LEU . 87.6 mtt-85 -56.0 -33.76 65.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.623 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -53.1 56.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.53 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -62.84 -25.4 68.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.783 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.077 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -73.88 -36.89 64.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.984 0.421 . . . . 0.0 110.352 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -76.34 -29.36 57.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.301 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -82.04 -49.04 10.67 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.148 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.541 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -87.59 -10.21 52.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.71 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 33.23 55.46 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.956 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.865 HG13 ' HB2' ' A' ' 167' ' ' ALA . 17.3 mm -87.81 142.88 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.93 0.395 . . . . 0.0 111.522 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.84 100.79 12.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.077 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.1 mt -65.12 -18.67 65.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.286 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -17.27 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.86 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -110.86 5.66 20.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.602 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.814 ' CB ' HD12 ' A' ' 158' ' ' ILE . 61.5 t -87.72 148.27 4.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.087 0.47 . . . . 0.0 111.198 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.95 109.92 5.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.349 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.82 122.2 8.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.919 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.49 HG22 ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -139.32 33.68 2.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.349 0.595 . . . . 0.0 110.661 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -126.96 -165.53 11.95 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.1 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -31.93 98.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.821 3.014 . . . . 0.0 114.285 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.2 -16.89 11.08 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.443 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.58 43.45 0.24 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.855 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -99.68 144.2 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.135 0.493 . . . . 0.0 111.729 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.924 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.6 127.78 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.369 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 31.0 p -102.86 167.94 9.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.797 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.712 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 99.0 t -54.77 -31.61 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 110.873 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.22 -39.39 94.49 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.49 ' OD2' HG22 ' A' ' 152' ' ' THR . 4.8 m-20 -69.89 -44.25 70.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.397 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.924 HG22 HD11 ' A' ' 158' ' ' ILE . 83.4 t -63.41 -54.64 30.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.961 0.41 . . . . 0.0 110.292 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -57.65 -34.41 69.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.731 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -72.7 -49.54 30.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.438 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.706 ' CE2' HG23 ' A' ' 144' ' ' ILE . 14.9 t80 -65.99 -47.97 72.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.798 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.865 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.59 -42.01 77.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.403 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 6.9 pt-20 -72.13 -33.08 67.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.048 0.452 . . . . 0.0 110.454 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.418 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 23.0 tt0 -77.99 -24.07 48.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.5 t -89.35 -38.24 14.29 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.648 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -168.02 93.03 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 9.9 ttpt -109.78 -41.32 4.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.755 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -156.66 75.59 0.85 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.008 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.11 48.13 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.976 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 176' ' ' PRO . . . -177.02 -62.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.122 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 175' ' ' ALA . 57.2 Cg_endo -71.09 108.96 2.44 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.552 2.168 . . . . 0.0 112.323 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.763 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . . . -88.23 -52.97 0.38 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.763 ' HD3' ' HB3' ' A' ' 177' ' ' ALA . 50.7 Cg_exo -53.32 115.74 2.49 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.474 2.116 . . . . 0.0 112.24 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -135.73 87.91 24.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.173 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.42 170.49 16.05 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.513 2.142 . . . . 0.0 112.25 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.1 -64.81 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -72.58 139.07 47.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.062 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.42 95.41 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -128.28 -57.28 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -72.64 157.17 38.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.076 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.2 p -76.21 -14.9 60.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.525 0.202 . . . . 0.0 111.289 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.98 42.78 6.64 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.504 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -82.37 147.22 28.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 130' ' ' ALA . 15.2 t -151.52 159.6 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.169 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.823 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -95.91 120.43 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.909 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.739 ' HB1' HD23 ' A' ' 146' ' ' LEU . . . -133.52 161.99 33.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.42 ' HG3' ' HB ' ' A' ' 159' ' ' THR . 35.9 mmm -84.53 155.42 62.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.922 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.92 -52.07 5.78 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.246 1.964 . . . . 0.0 112.247 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.624 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -62.95 -32.54 73.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.986 0.422 . . . . 0.0 110.624 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.809 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.13 -49.86 75.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.72 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.1 mtt85 -58.44 -33.4 69.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.511 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -63.6 -52.7 59.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.226 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -64.48 -24.2 67.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.816 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.73 -35.74 62.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.92 0.391 . . . . 0.0 110.378 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -76.39 -29.38 57.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.186 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -82.37 -48.94 10.55 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.161 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.84 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.97 -9.95 51.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.746 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.52 32.41 54.77 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.047 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.922 HG13 ' HB2' ' A' ' 167' ' ' ALA . 15.1 mm -88.35 148.61 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.132 0.491 . . . . 0.0 111.712 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -106.99 100.89 10.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.486 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.739 HD23 ' HB1' ' A' ' 131' ' ' ALA . 1.7 mp -62.56 -19.53 63.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.336 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.7 m -62.19 -21.05 64.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.924 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -106.32 -4.76 19.69 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.55 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.995 HG11 HD13 ' A' ' 158' ' ' ILE . 58.0 t -79.01 147.36 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -70.98 113.0 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.203 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.93 122.68 7.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.126 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -139.77 33.25 2.0 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.317 0.579 . . . . 0.0 110.661 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -123.45 -165.29 12.27 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.801 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -31.09 95.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.776 2.984 . . . . 0.0 114.197 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.76 -20.41 12.17 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.188 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 131.04 44.73 0.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.3 p -100.62 142.97 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.252 0.548 . . . . 0.0 111.956 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.995 HD13 HG11 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -71.26 124.61 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.03 179.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.83 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.4 p -107.34 165.7 11.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.231 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.624 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 30.0 t -50.16 -26.02 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.593 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -45.58 88.38 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.669 ' HB2' HD13 ' A' ' 158' ' ' ILE . 6.6 m-20 -74.83 -33.64 62.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.494 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.933 ' CG2' HD11 ' A' ' 158' ' ' ILE . 8.7 t -65.1 -54.53 28.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.6 tptp -61.31 -37.31 82.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.546 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.36 -42.96 74.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.307 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.56 ' CE2' HG23 ' A' ' 144' ' ' ILE . 23.3 t80 -71.45 -50.52 30.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.642 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.922 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -55.89 -39.41 71.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.254 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.619 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 22.6 pt-20 -75.63 -45.72 35.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.155 0.502 . . . . 0.0 109.866 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.2 tp10 -64.4 -21.93 66.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.487 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.1 t -93.71 -33.16 13.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -177.81 96.21 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.634 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.619 ' HB3' ' HA ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -115.49 -177.62 3.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.545 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.62 102.78 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.006 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.503 ' O ' ' HB3' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -162.19 -39.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.997 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 174' ' ' THR . . . 73.52 149.55 0.13 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.44 160.08 50.67 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.55 2.167 . . . . 0.0 112.4 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 61.46 74.33 0.51 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.078 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.63 -170.35 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.584 2.189 . . . . 0.0 112.224 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -169.97 85.84 0.57 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.21 -35.78 8.12 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.523 2.149 . . . . 0.0 112.297 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.05 152.88 0.94 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.804 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -138.13 131.66 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.17 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.45 -60.89 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.29 158.54 43.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 33.4 2.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.07 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -77.85 152.01 33.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.36 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -60.63 149.41 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.957 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 130' ' ' ALA . 43.4 t 57.31 162.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.258 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.849 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -125.32 131.18 53.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.704 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.47 162.02 33.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 10.4 mtp -80.75 146.91 61.24 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.808 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.22 -40.11 21.49 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.249 1.966 . . . . 0.0 112.324 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -77.85 -27.87 49.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.883 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.603 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -63.37 -52.56 61.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.617 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.712 ' HA ' HD21 ' A' ' 146' ' ' LEU . 18.6 mtp-105 -56.25 -35.01 66.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.463 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -62.76 -51.56 66.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.25 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -64.21 -23.2 67.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.693 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -72.03 -41.47 67.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.581 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -76.52 -29.03 56.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.569 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -82.27 -43.62 17.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.652 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.845 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -100.65 -2.28 33.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.178 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.08 39.18 92.83 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.643 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.739 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 66.8 mt -87.54 141.8 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.054 0.454 . . . . 0.0 111.8 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.28 100.58 12.61 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.712 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER -68.29 -22.6 64.72 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.217 -178.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.5 m -65.19 -13.96 59.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.193 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -114.29 0.02 14.02 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.897 ' CB ' HD12 ' A' ' 158' ' ' ILE . 60.2 t -81.6 149.98 4.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.801 0.334 . . . . 0.0 110.959 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -70.96 108.79 4.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.314 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.67 119.99 7.93 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.808 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -136.88 34.48 2.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.231 0.538 . . . . 0.0 110.895 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.492 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -130.29 -166.25 11.76 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.3 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.426 ' N ' HG12 ' A' ' 157' ' ' VAL . 36.2 Cg_exo -32.53 100.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.864 3.043 . . . . 0.0 114.315 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.2 -16.38 9.5 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.474 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 126.75 42.25 0.29 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.849 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.7 p -97.65 144.4 11.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.197 -0.502 . . . . 0.0 111.35 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.0 129.29 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.791 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.0 p -100.86 168.0 9.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.174 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.765 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 50.4 t -55.64 -31.7 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.337 . . . . 0.0 111.139 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -38.88 84.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.119 0.485 . . . . 0.0 109.909 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.473 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 10.0 m-20 -74.94 -38.67 61.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.725 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.01 HG22 HD11 ' A' ' 158' ' ' ILE . 45.6 t -64.67 -54.71 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.042 0.449 . . . . 0.0 110.362 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -60.4 -40.7 91.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.794 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -69.04 -40.3 78.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.454 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.689 ' CE2' HG23 ' A' ' 144' ' ' ILE . 6.5 t80 -72.13 -52.15 18.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.845 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -57.63 -38.47 75.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.538 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 8.8 pt-20 -71.69 -34.69 69.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.237 0.542 . . . . 0.0 110.481 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -21.94 50.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.087 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.4 t -92.61 -35.13 13.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.652 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 172' ' ' LYS . . . -146.15 -63.61 0.31 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.641 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 21.2 tttp 74.95 -18.23 0.45 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.897 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 174' ' ' THR . . . -167.86 -43.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 111.115 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 173' ' ' ALA . 7.1 p -157.3 -78.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -169.89 153.85 5.01 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.149 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.53 66.17 2.94 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.607 2.205 . . . . 0.0 112.227 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -95.48 139.92 22.15 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.128 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.53 151.5 24.04 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.458 2.105 . . . . 0.0 112.241 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 180' ' ' PRO . . . -90.25 160.73 39.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.062 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 39.5 Cg_endo -67.02 -171.51 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.544 2.163 . . . . 0.0 112.226 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.423 ' HA ' ' CE ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -59.68 161.61 6.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -107.23 178.35 4.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.042 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.2 p -76.62 -40.05 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.74 -75.7 0.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt 60.91 159.65 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.825 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.113 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.551 -0.22 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -82.01 132.96 35.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.74 -44.5 32.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.49 -177.17 3.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 130' ' ' ALA . 10.6 t -131.36 158.03 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.869 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -113.46 127.0 55.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.639 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.672 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.72 162.21 32.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.311 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 4.7 mmm -86.26 150.3 51.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.172 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.59 -51.94 9.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.202 1.934 . . . . 0.0 112.149 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.756 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -59.75 -34.52 73.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.021 0.438 . . . . 0.0 110.637 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 1.011 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -59.98 -51.22 70.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.57 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 84.5 mtt-85 -55.11 -36.41 65.68 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.447 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.3 mtm-85 -61.48 -51.19 69.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.99 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 138' ' ' LEU . 0.9 OUTLIER -62.85 -24.84 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.762 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . . . -70.91 -41.54 71.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.731 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -76.38 -29.05 56.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.768 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -82.16 -43.79 17.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.575 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.618 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -100.67 -1.83 34.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.08 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.31 39.15 94.23 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.645 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.781 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 58.5 mt -87.55 144.99 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 112.002 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.8 100.64 12.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.85 ' HG ' HD11 ' A' ' 158' ' ' ILE . 2.5 mp -74.39 -20.74 59.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.229 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 t -61.93 -17.03 55.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.715 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -109.16 -9.78 15.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.63 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.972 ' HB ' HD12 ' A' ' 158' ' ' ILE . 57.8 t -70.66 146.09 12.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.063 0.459 . . . . 0.0 111.191 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.7 121.15 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.433 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -77.77 123.24 6.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.065 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.431 HG22 ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -143.46 38.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.29 0.567 . . . . 0.0 110.857 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -129.68 -162.65 10.91 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.102 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -31.75 96.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.775 2.983 . . . . 0.0 114.176 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.12 -18.15 14.62 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.277 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.37 44.4 0.19 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.869 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -103.74 141.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.352 0.596 . . . . 0.0 112.01 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.972 HD12 ' HB ' ' A' ' 149' ' ' VAL . 0.1 OUTLIER -67.42 127.93 29.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.5 p -108.07 172.82 6.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.102 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.756 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 53.7 t -54.67 -29.8 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -63.65 -40.78 97.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' OD2' HG22 ' A' ' 152' ' ' THR . 2.0 m-20 -71.81 -42.56 66.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.602 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.011 HG21 ' HB1' ' A' ' 135' ' ' ALA . 80.7 t -64.49 -54.53 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.381 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -58.67 -37.38 75.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -70.81 -46.4 62.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.153 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.576 ' CE2' HG23 ' A' ' 144' ' ' ILE . 16.8 t80 -65.52 -50.55 64.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.451 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.781 ' HB2' ' CD1' ' A' ' 144' ' ' ILE . . . -56.54 -44.61 81.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.547 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.59 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 14.4 pt-20 -71.98 -34.91 69.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.298 0.571 . . . . 0.0 110.405 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -77.42 -21.87 52.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.859 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.4 t -91.32 -41.14 11.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.866 0.365 . . . . 0.0 110.896 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.79 98.56 2.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.218 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 3.6 tttp -155.44 -175.32 5.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.07 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -153.68 -169.09 3.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.962 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.3 p 56.1 36.31 27.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.995 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -101.94 143.45 26.61 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.127 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.91 118.18 4.51 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.48 2.12 . . . . 0.0 112.142 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -147.09 91.66 5.09 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.036 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.33 -36.45 68.55 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.587 2.192 . . . . 0.0 112.339 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -113.73 98.88 48.67 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.135 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.99 170.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.475 2.117 . . . . 0.0 112.36 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 159.29 15.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -125.54 77.61 1.66 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.005 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.02 110.53 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 60.49 -178.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.721 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -116.85 39.16 3.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.031 -179.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 52.8 p -127.78 100.27 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 110.982 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -131.24 32.76 4.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -77.58 -31.45 53.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 130' ' ' ALA . 13.6 t -79.94 159.56 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.204 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.837 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -117.61 131.03 56.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.98 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.662 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.56 162.1 32.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.276 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.1 OUTLIER -83.25 153.77 66.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.41 -52.01 8.69 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.297 1.998 . . . . 0.0 112.344 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.813 ' HB3' HG21 ' A' ' 160' ' ' VAL . . . -64.79 -32.11 73.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.809 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.33 -52.97 62.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.885 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.654 ' HA ' HD11 ' A' ' 146' ' ' LEU . 9.1 mtt-85 -55.65 -36.53 67.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.453 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -61.45 -50.91 70.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.45 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -65.05 -24.67 67.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.89 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.037 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.64 -34.73 62.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.965 0.412 . . . . 0.0 110.537 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -33.63 59.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.362 0.601 . . . . 0.0 109.997 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -79.61 -47.99 14.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.073 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.817 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.23 -10.45 52.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.779 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.22 34.76 57.67 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.832 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.89 HG13 ' HB2' ' A' ' 167' ' ' ALA . 16.2 mm -90.81 141.83 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.015 0.436 . . . . 0.0 111.695 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.19 100.78 12.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.037 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.5 mt -63.5 -20.62 65.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.229 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 79.7 p -64.13 -16.83 62.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.106 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -108.57 -3.77 17.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.726 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.81 ' CB ' HD12 ' A' ' 158' ' ' ILE . 59.8 t -79.94 149.88 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.076 0.465 . . . . 0.0 111.04 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.1 OUTLIER -72.32 121.68 19.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.364 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.07 119.14 4.78 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.003 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -137.92 34.23 2.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.413 0.625 . . . . 0.0 110.678 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.485 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -126.77 -166.3 12.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.095 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -31.64 98.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.867 3.045 . . . . 0.0 114.269 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.77 -18.11 13.34 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.399 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.38 44.53 0.21 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.837 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.3 p -101.08 144.87 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.162 0.506 . . . . 0.0 111.685 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.829 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.1 126.31 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.137 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 23.3 p -102.36 167.13 10.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.62 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.813 HG21 ' HB3' ' A' ' 134' ' ' ALA . 95.4 t -54.78 -36.3 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.384 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 2.5 pt-20 -58.49 -37.05 74.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.606 ' HA ' ' HG2' ' A' ' 165' ' ' ARG . 34.5 m-20 -72.68 -46.89 51.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.355 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.829 HG22 HD11 ' A' ' 158' ' ' ILE . 71.1 t -56.92 -52.8 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 109.858 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -60.35 -37.67 81.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.234 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.606 ' HG2' ' HA ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -72.29 -36.22 68.91 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.617 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.681 ' HE2' HG23 ' A' ' 144' ' ' ILE . 14.9 t80 -77.12 -50.09 13.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.038 0.447 . . . . 0.0 110.194 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.89 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -57.52 -36.37 71.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.378 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 9.9 pt-20 -75.02 -34.74 61.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.061 0.458 . . . . 0.0 110.443 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -78.05 -22.07 49.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.219 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 167' ' ' ALA . 3.0 t -88.45 -33.42 17.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.805 0.336 . . . . 0.0 111.049 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.31 92.37 0.98 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 0.3 OUTLIER -161.96 161.39 28.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -170.54 100.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.453 HG23 ' CE ' ' A' ' 172' ' ' LYS . 7.3 p -127.2 74.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.009 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 62.85 127.09 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.201 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.06 106.52 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.412 2.075 . . . . 0.0 112.262 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.775 ' HB3' ' HG3' ' A' ' 180' ' ' PRO . . . -160.93 147.82 11.88 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.084 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.53 -28.59 14.31 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.602 2.201 . . . . 0.0 112.396 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -168.96 76.05 0.75 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.134 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.775 ' HG3' ' HB3' ' A' ' 177' ' ' ALA . 50.4 Cg_exo -55.95 -167.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.641 2.227 . . . . 0.0 112.299 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.27 -46.7 8.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 58.23 179.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.41 43.67 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.057 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -58.01 164.42 2.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.031 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.02 120.23 12.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.146 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.84 165.2 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 127.68 54.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.17 159.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.935 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 147' ' ' SER . 62.9 t -87.9 -58.9 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . 65.63 120.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.461 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.3 162.14 32.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.641 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.89 151.43 54.91 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.011 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.83 -52.14 9.14 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.306 2.004 . . . . 0.0 112.511 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.68 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -61.75 -36.05 79.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.008 0.432 . . . . 0.0 110.819 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.94 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.61 -52.81 63.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.912 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.669 ' HA ' HD11 ' A' ' 146' ' ' LEU . 76.8 mtt180 -56.27 -34.76 66.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.749 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -63.02 -52.0 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.252 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -64.66 -23.71 67.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.841 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.032 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.44 -36.8 63.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.016 0.436 . . . . 0.0 110.376 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -76.28 -29.3 57.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.144 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.12 -49.03 10.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.094 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.756 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.41 -10.13 52.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.804 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.12 32.64 55.95 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.946 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.854 HG13 ' HB2' ' A' ' 167' ' ' ALA . 17.8 mm -87.77 140.07 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.918 0.39 . . . . 0.0 111.437 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.48 100.78 13.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.5 mt -64.22 -17.72 63.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.208 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.426 ' HA ' HG11 ' A' ' 129' ' ' VAL . 1.1 t -65.38 -15.62 62.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.199 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -114.03 5.61 16.14 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.73 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.803 ' CB ' HD12 ' A' ' 158' ' ' ILE . 57.4 t -87.62 145.63 7.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.941 0.401 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 111.88 7.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.629 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -75.45 118.28 5.47 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.72 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.459 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -126.83 29.37 5.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.109 0.481 . . . . 0.0 111.295 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.781 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -130.4 -156.6 8.71 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.242 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.564 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 40.5 Cg_exo -38.11 108.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.111 2.541 . . . . 0.0 114.07 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.82 5.81 27.06 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.494 -0.776 . . . . 0.0 113.519 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.5 40.69 1.86 Allowed Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -86.73 140.44 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.039 -0.581 . . . . 0.0 111.617 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.823 HD13 ' HB3' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -79.01 131.35 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.5 p -108.95 167.65 9.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.719 0.295 . . . . 0.0 110.842 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.68 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 47.4 t -54.2 -24.58 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 3.3 tt0 -65.79 -42.95 90.13 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.409 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 11.9 m-20 -74.21 -35.94 63.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.503 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.94 HG21 ' HB1' ' A' ' 135' ' ' ALA . 58.2 t -66.16 -53.69 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.955 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -62.82 -35.71 80.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.715 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 0.6 OUTLIER -71.78 -44.3 64.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.134 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.726 ' CE2' HG23 ' A' ' 144' ' ' ILE . 15.2 t80 -70.11 -47.66 60.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.983 0.42 . . . . 0.0 110.317 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.854 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -58.15 -39.0 77.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.548 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.596 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 14.2 pt-20 -75.27 -45.48 39.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.029 0.442 . . . . 0.0 110.429 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.1 tm-20 -65.19 -23.81 67.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.439 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.1 t -90.54 -37.36 13.91 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.684 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -175.22 94.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.439 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 168' ' ' GLU . 0.3 OUTLIER -107.21 146.66 31.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.619 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -166.79 52.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.23 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 69.3 p -74.04 -31.22 62.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 176' ' ' PRO . . . -90.41 166.08 20.98 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.027 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 175' ' ' ALA . 29.4 Cg_endo -63.03 103.63 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.505 2.137 . . . . 0.0 112.297 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -95.19 148.73 35.13 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.65 177.24 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.502 2.135 . . . . 0.0 112.311 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 58.97 86.12 0.17 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.21 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.44 -35.62 7.95 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.519 2.146 . . . . 0.0 112.33 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -172.36 2.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.045 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -99.7 30.3 3.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 183' ' ' VAL . 29.9 m -73.9 105.21 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.116 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.33 -75.52 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.04 164.68 32.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.074 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.576 -0.21 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.44 136.6 36.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.804 0.335 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -109.19 107.95 18.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.37 167.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 130' ' ' ALA . 2.1 p -164.94 -46.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.777 ' C ' HG23 ' A' ' 157' ' ' VAL . . . 62.97 118.11 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.095 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.66 ' CA ' HG23 ' A' ' 157' ' ' VAL . . . -133.4 162.05 32.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.446 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.5 OUTLIER -93.35 145.71 30.51 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.197 179.299 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.72 -52.04 9.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.406 2.071 . . . . 0.0 112.692 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.637 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -59.74 -37.39 78.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.976 0.417 . . . . 0.0 110.917 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.912 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.2 -52.84 63.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.027 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.624 ' HA ' HD11 ' A' ' 146' ' ' LEU . 14.4 mtm105 -56.86 -33.78 67.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.653 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -63.46 -50.9 67.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -65.77 -23.97 66.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.837 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.993 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.21 -37.05 63.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.013 0.435 . . . . 0.0 110.466 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -76.3 -29.28 57.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.251 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -82.13 -48.44 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.149 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.66 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.95 -10.7 49.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.735 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.5 36.03 45.24 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.842 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.762 HG13 ' HB2' ' A' ' 167' ' ' ALA . 23.3 mm -92.44 139.83 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.995 0.426 . . . . 0.0 111.583 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -93.2 100.75 13.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.993 HD21 ' HB2' ' A' ' 139' ' ' ALA . 6.1 mt -64.88 -16.73 63.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.368 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -15.65 62.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.061 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -112.27 2.71 16.69 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.643 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.781 ' CB ' HD12 ' A' ' 158' ' ' ILE . 47.7 t -86.91 142.23 13.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.094 0.474 . . . . 0.0 111.073 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -70.91 127.7 33.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.979 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.0 118.57 4.97 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.912 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -128.8 22.57 5.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.12 0.485 . . . . 0.0 110.827 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -113.78 -164.34 15.39 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.936 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -31.15 97.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.827 3.018 . . . . 0.0 114.258 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.14 -17.7 16.6 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.408 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.84 45.22 0.21 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.777 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.1 p -100.4 145.66 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.228 0.537 . . . . 0.0 111.781 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.829 HD13 ' HB3' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -72.94 124.85 30.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.155 179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.1 p -108.01 170.35 8.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.61 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.637 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 24.4 t -52.57 -25.7 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -66.21 -43.11 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 152' ' ' THR . 3.3 m-20 -73.08 -40.06 65.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.565 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.912 HG21 ' HB1' ' A' ' 135' ' ' ALA . 44.8 t -65.01 -53.52 40.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.073 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -61.82 -34.9 76.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.016 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -72.86 -47.29 47.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.792 0.33 . . . . 0.0 111.344 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.739 ' HE2' HG23 ' A' ' 144' ' ' ILE . 14.9 t80 -68.87 -41.13 78.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.309 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.762 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -63.71 -38.64 91.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.323 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.457 ' HA ' ' CB ' ' A' ' 172' ' ' LYS . 14.7 pt-20 -77.13 -36.94 54.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.136 0.493 . . . . 0.0 110.471 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -74.35 -24.51 59.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.935 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 167' ' ' ALA . 3.0 t -83.35 -39.64 20.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.67 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -161.51 94.7 0.98 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.379 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.457 ' CB ' ' HA ' ' A' ' 168' ' ' GLU . 5.5 tmtt? -177.3 -42.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.005 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -157.59 179.51 9.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.22 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.3 p -150.35 -46.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.961 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -139.47 159.73 64.55 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.061 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.26 175.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.539 2.159 . . . . 0.0 112.345 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -174.57 78.6 0.34 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.25 -168.47 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.597 2.198 . . . . 0.0 112.305 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -123.86 86.76 53.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.37 162.78 41.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.524 2.149 . . . . 0.0 112.339 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -99.39 -39.43 8.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -65.0 -27.35 68.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.242 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t 66.67 85.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.081 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -132.54 168.74 17.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.945 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt 60.76 53.2 4.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.071 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.0 p -99.37 150.78 21.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.805 0.336 . . . . 0.0 110.945 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.85 129.6 12.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.74 169.17 17.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.754 HG11 ' HA ' ' A' ' 147' ' ' SER . 41.6 t -60.97 -67.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.155 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . 66.12 122.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.673 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.827 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . . . -133.31 162.11 32.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.567 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.27 159.13 54.18 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.793 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.61 -52.07 3.48 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.122 1.882 . . . . 0.0 112.313 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.527 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -59.42 -35.72 74.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.087 0.47 . . . . 0.0 110.545 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.8 -51.22 70.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.587 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.827 ' CZ ' ' HB3' ' A' ' 131' ' ' ALA . 4.1 mtt85 -57.11 -34.13 68.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.675 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -63.11 -51.77 65.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.189 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.525 HD22 HG13 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -64.69 -24.22 67.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.765 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.75 -35.54 62.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.392 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -76.37 -29.44 57.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.125 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -82.18 -49.03 10.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.134 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.923 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -87.92 -9.12 54.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.758 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.15 34.76 54.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.148 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.957 HG13 ' HB2' ' A' ' 167' ' ' ALA . 13.1 mm -90.81 150.13 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.132 0.492 . . . . 0.0 111.711 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -107.91 100.98 10.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.473 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.654 HD23 ' HB1' ' A' ' 131' ' ' ALA . 1.4 mp -63.4 -17.65 62.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.422 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.754 ' HA ' HG11 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -62.32 -18.74 62.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.917 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -110.43 -3.04 16.29 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.601 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 1.058 HG11 HD13 ' A' ' 158' ' ' ILE . 75.1 t -80.36 143.27 12.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.003 0.43 . . . . 0.0 111.07 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -71.25 112.74 7.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.206 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -76.29 123.52 6.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.282 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -127.09 15.97 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 0.0 111.367 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.72 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -115.02 -154.3 10.65 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.423 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.571 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 31.1 Cg_exo -36.01 106.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.426 2.751 . . . . 0.0 114.243 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.31 25.14 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.62 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.31 40.11 1.84 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.3 OUTLIER -86.68 142.3 13.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.086 -0.557 . . . . 0.0 111.241 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.058 HD13 HG11 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -81.14 123.63 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.823 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.2 p -106.66 166.12 10.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.343 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 21.1 t -50.33 -25.4 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.448 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.66 -45.86 84.96 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.724 ' HB2' HD13 ' A' ' 158' ' ' ILE . 4.9 m-20 -74.97 -33.78 61.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.439 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.945 ' CG2' HD11 ' A' ' 158' ' ' ILE . 6.1 t -65.12 -54.57 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -61.91 -35.9 79.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.59 -42.56 74.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.548 ' CE2' HG23 ' A' ' 144' ' ' ILE . 26.8 t80 -71.91 -51.27 23.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.552 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.957 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.82 -37.69 71.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.587 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 9.5 pt-20 -76.84 -42.5 39.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.264 0.554 . . . . 0.0 110.336 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.42 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 2.9 tp10 -70.07 -21.93 63.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.826 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.4 t -89.34 -41.01 12.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.048 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -146.5 -55.72 0.26 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 33.7 tttp 65.34 168.01 0.19 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.534 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.07 58.02 1.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.996 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.23 -31.49 9.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.815 ' HB3' ' HD3' ' A' ' 176' ' ' PRO . . . -178.88 -55.1 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.815 ' HD3' ' HB3' ' A' ' 175' ' ' ALA . 52.0 Cg_exo -53.19 179.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.463 2.109 . . . . 0.0 112.229 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -172.2 78.11 0.46 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.71 -176.75 2.16 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.621 2.214 . . . . 0.0 112.412 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.671 ' HB3' ' HD3' ' A' ' 180' ' ' PRO . . . -170.99 -64.73 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.021 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 17.8 Cg_endo -61.07 -73.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.398 2.065 . . . . 0.0 112.274 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER 179.53 -39.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 62.76 124.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.18 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.4 m -98.28 29.98 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 -43.83 23.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.29 100.94 5.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.095 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -161.31 160.43 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 -122.58 137.81 54.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.57 -179.7 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 130' ' ' ALA . 14.0 t -133.63 159.52 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.842 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -133.62 132.44 40.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.678 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.5 162.11 32.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.437 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -89.06 150.04 44.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.089 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.59 -51.95 9.97 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.198 1.932 . . . . 0.0 112.443 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.658 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -60.2 -37.02 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.03 0.443 . . . . 0.0 110.713 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.821 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -59.62 -48.75 80.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.692 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -59.57 -34.77 73.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.641 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -50.03 72.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.283 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -67.2 -25.23 66.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.919 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.764 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.97 -32.34 61.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.034 0.445 . . . . 0.0 110.413 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.4 -35.11 58.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.873 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -80.35 -47.5 14.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.207 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.769 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.02 -12.13 48.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.705 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.21 31.44 54.99 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.009 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.857 HG13 ' HB2' ' A' ' 167' ' ' ALA . 13.3 mm -88.46 147.85 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.449 . . . . 0.0 111.602 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.36 100.99 10.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.774 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.637 HD23 ' HB1' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -63.19 -17.8 62.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.549 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.5 m -63.31 -17.75 62.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.009 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -111.36 -1.09 16.11 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.584 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 1.08 HG11 HD13 ' A' ' 158' ' ' ILE . 63.6 t -81.01 148.62 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.004 0.43 . . . . 0.0 110.969 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 111.21 6.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.358 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.09 122.62 9.04 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.074 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -142.46 32.94 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.334 0.588 . . . . 0.0 110.569 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.77 -165.43 12.4 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.819 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -31.04 95.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.831 3.021 . . . . 0.0 114.197 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.56 -18.85 17.12 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.248 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.71 45.19 0.18 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.842 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.3 p -102.35 142.25 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.327 0.584 . . . . 0.0 111.997 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.08 HD13 HG11 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -68.66 124.68 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.868 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.812 ' N ' HD12 ' A' ' 158' ' ' ILE . 20.1 p -106.08 163.65 12.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.207 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.658 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 61.5 t -50.35 -33.28 10.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.467 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -59.16 -41.62 88.81 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.534 ' HB2' HD13 ' A' ' 158' ' ' ILE . 12.2 m-20 -74.97 -35.92 62.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.409 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.916 ' CG2' HD11 ' A' ' 158' ' ' ILE . 19.2 t -63.08 -54.7 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -37.62 84.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.458 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -65.99 -44.68 84.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.057 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.526 ' CE2' HG23 ' A' ' 144' ' ' ILE . 15.5 t80 -72.4 -46.89 53.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.731 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.857 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -57.82 -41.28 81.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.605 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 9.1 pt-20 -71.65 -37.23 70.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.288 0.566 . . . . 0.0 110.063 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -76.02 -21.9 56.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.832 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.5 t -94.64 -32.25 13.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.257 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -148.0 -61.58 0.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.784 0.326 . . . . 0.0 111.737 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 15.4 tttt 67.6 -71.89 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.815 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -121.71 66.68 0.9 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.019 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.03 33.39 2.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.905 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.4 ' HA ' ' HD2' ' A' ' 176' ' ' PRO . . . -126.81 106.36 22.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.079 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 175' ' ' ALA . 42.9 Cg_endo -67.69 161.22 44.66 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.384 2.056 . . . . 0.0 112.35 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.721 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . . . -65.65 -61.42 5.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.145 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.721 ' HD3' ' HB3' ' A' ' 177' ' ' ALA . 50.5 Cg_endo -69.34 140.92 45.52 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.493 2.129 . . . . 0.0 112.276 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.671 ' HB1' ' HD2' ' A' ' 180' ' ' PRO . . . -69.52 164.35 50.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.671 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 53.8 Cg_endo -69.52 -175.89 1.24 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.488 2.126 . . . . 0.0 112.333 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.54 161.24 15.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -84.23 118.65 24.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.044 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 183' ' ' VAL . 15.8 t -103.66 31.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.108 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -142.37 161.15 38.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.878 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -72.04 -33.06 67.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.13 179.936 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.0 p -107.36 75.31 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.909 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -128.21 31.61 5.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.971 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -143.47 165.92 26.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 147' ' ' SER . 46.5 t -96.93 -61.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.766 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . 66.61 120.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.948 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.476 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.28 162.04 32.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.417 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.445 ' HG3' HG22 ' A' ' 159' ' ' THR . 0.0 OUTLIER -85.54 151.25 55.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.838 178.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.16 -50.12 14.92 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.069 1.846 . . . . 0.0 112.31 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.638 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -66.18 -32.89 74.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.845 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.665 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.35 -52.97 62.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.767 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.618 ' HA ' HD11 ' A' ' 146' ' ' LEU . 50.1 mtp180 -56.38 -35.54 67.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.39 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -61.63 -49.51 76.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.176 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.64 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -64.7 -25.52 67.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.504 179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.758 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -69.98 -41.93 73.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.021 0.439 . . . . 0.0 110.684 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.5 -29.15 56.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.86 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -82.17 -43.2 18.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.651 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.759 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -101.16 -2.36 31.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.971 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.95 39.03 93.21 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.648 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.764 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 65.5 mt -87.81 141.0 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 111.635 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.0 100.45 13.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.765 ' HB3' HD13 ' A' ' 158' ' ' ILE . 5.9 mt -71.4 -18.19 62.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.432 ' HA ' HG11 ' A' ' 129' ' ' VAL . 0.6 OUTLIER -65.33 -15.9 63.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 179.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -113.24 1.52 15.24 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.712 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.818 ' CB ' HD12 ' A' ' 158' ' ' ILE . 58.2 t -82.72 144.59 9.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.993 0.425 . . . . 0.0 110.799 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -70.88 117.73 12.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.625 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 156' ' ' GLY . . . -80.81 114.79 3.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.755 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.47 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -117.33 20.32 13.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.692 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -129.1 -153.86 8.07 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.754 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.52 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 21.2 Cg_exo -32.66 106.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.783 2.989 . . . . 0.0 114.617 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.5 10.58 8.09 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.876 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.412 ' O ' ' HA3' ' A' ' 151' ' ' GLY . . . 107.49 41.73 1.57 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -86.33 145.01 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.033 -0.583 . . . . 0.0 111.157 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.048 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -83.73 136.05 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 163' ' ' VAL . 36.1 p -112.16 166.9 10.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.318 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.64 HG13 HD22 ' A' ' 138' ' ' LEU . 24.3 t -55.18 -29.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.1 -40.12 94.12 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 14.1 m-20 -74.81 -39.12 61.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.389 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.048 HG22 HD11 ' A' ' 158' ' ' ILE . 60.1 t -65.26 -54.66 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.316 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -59.26 -42.5 91.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.837 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -67.65 -43.31 80.59 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.237 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.654 ' CE2' HG23 ' A' ' 144' ' ' ILE . 9.8 t80 -67.1 -54.41 21.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.491 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.764 ' HB2' ' CD1' ' A' ' 144' ' ' ILE . . . -53.01 -41.99 65.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.618 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 7.5 pt-20 -69.56 -33.03 72.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 0.0 110.263 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.97 -24.98 47.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.869 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.2 t -93.15 -37.99 11.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.752 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.96 79.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.313 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 9.9 tttm -78.26 -37.15 45.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -174.72 41.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.98 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.4 t -56.78 95.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.983 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -163.61 93.99 1.08 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.87 -26.16 52.21 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.478 2.119 . . . . 0.0 112.261 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -143.08 124.6 8.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.039 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.75 -61.42 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.413 2.075 . . . . 0.0 112.31 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -168.39 119.63 0.67 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.988 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.51 160.74 48.62 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.382 2.055 . . . . 0.0 112.247 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.74 -56.26 3.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.943 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 186' ' ' ALA . . . -73.09 129.55 38.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.087 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 184' ' ' GLU . 11.8 p -176.49 -40.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.402 ' N ' HG13 ' A' ' 183' ' ' VAL . 19.4 mm-40 -86.92 -56.43 3.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.76 30.4 1.87 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.412 ' HA ' ' HB1' ' A' ' 182' ' ' ALA . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.224 -0.894 . . . . 0.0 111.073 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.18 61.21 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.9 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.4 84.78 2.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -142.74 140.48 31.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 130' ' ' ALA . 1.9 p -120.79 -47.81 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.997 0.427 . . . . 0.0 111.09 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.839 ' C ' HG23 ' A' ' 157' ' ' VAL . . . 62.24 133.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.019 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.756 ' HB1' HD23 ' A' ' 146' ' ' LEU . . . -133.54 162.14 32.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.169 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.0 mtp -86.48 148.63 47.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.091 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.35 -52.04 9.9 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.357 2.038 . . . . 0.0 112.375 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.587 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.09 -34.72 78.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.912 0.386 . . . . 0.0 110.711 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.767 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.0 -50.57 73.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.776 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -58.48 -34.5 70.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.608 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -62.47 -50.0 73.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.284 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -67.01 -25.07 66.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.905 179.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 144' ' ' ILE . . . -74.9 -32.6 61.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.005 0.431 . . . . 0.0 110.38 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 -34.97 59.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.394 0.616 . . . . 0.0 109.944 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.07 -47.58 14.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.196 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.807 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.08 -11.81 49.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.713 -179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.54 31.84 55.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.885 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.934 HG13 ' HB2' ' A' ' 167' ' ' ALA . 11.0 mm -87.83 148.7 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.542 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -106.19 100.96 10.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.697 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.756 HD23 ' HB1' ' A' ' 131' ' ' ALA . 1.8 mp -63.65 -20.0 65.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.495 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -19.96 63.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.965 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -107.19 -6.21 17.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.514 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 1.009 HG11 HD13 ' A' ' 158' ' ' ILE . 58.0 t -77.47 146.92 7.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.054 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 111.77 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.362 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.78 122.48 8.34 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.051 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.455 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -138.85 32.69 2.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.291 0.567 . . . . 0.0 110.673 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -124.13 -164.79 12.06 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.865 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -31.69 97.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.781 2.988 . . . . 0.0 114.192 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.36 -18.1 15.79 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.344 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.75 44.43 0.2 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.839 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.4 p -100.32 142.4 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 111.99 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.009 HD13 HG11 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -71.43 124.81 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.306 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.842 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.3 p -107.05 165.14 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.162 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.587 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 21.9 t -50.14 -25.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.676 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.39 -45.68 86.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.699 ' HB2' HD13 ' A' ' 158' ' ' ILE . 5.7 m-20 -74.86 -33.07 62.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.484 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.931 ' CG2' HD11 ' A' ' 158' ' ' ILE . 7.0 t -66.02 -54.6 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -61.6 -36.24 80.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.588 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -70.86 -42.11 70.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.28 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.536 ' CE2' HG23 ' A' ' 144' ' ' ILE . 22.3 t80 -71.62 -49.89 35.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.651 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.934 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.94 -39.76 75.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.496 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 11.1 pt-20 -72.61 -35.32 67.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 0.0 110.217 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -77.93 -24.49 48.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.955 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.8 t -89.75 -33.99 16.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.775 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -173.94 90.93 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.218 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 11.5 tttt -103.85 -33.63 8.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.841 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.9 134.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 53.0 p -112.08 -34.65 5.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.971 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.42 138.42 91.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.86 112.07 3.45 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.436 2.091 . . . . 0.0 112.292 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -131.9 106.4 13.94 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.123 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.5 -26.85 33.84 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.445 2.096 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -159.14 89.71 2.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -51.34 143.78 33.15 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.49 2.126 . . . . 0.0 112.399 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -117.74 -43.01 2.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.949 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -72.62 169.55 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.094 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.99 -43.78 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.55 157.08 18.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.16 -45.31 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.17 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 p -126.95 -45.01 1.6 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.883 0.373 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -111.41 111.0 21.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.44 149.73 45.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER -168.43 -164.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.943 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.862 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -126.95 139.72 52.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.066 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.704 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.51 162.15 32.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.184 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -86.27 149.18 49.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.055 179.037 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.456 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 65.7 Cg_exo -50.9 -52.07 9.84 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.366 2.044 . . . . 0.0 112.516 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.651 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -64.04 -35.13 79.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.957 0.408 . . . . 0.0 110.817 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.98 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -59.78 -52.82 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.995 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.728 ' HA ' HD11 ' A' ' 146' ' ' LEU . 4.5 mtt-85 -56.17 -34.98 66.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -61.79 -51.34 68.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.047 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -65.05 -24.19 67.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.77 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.127 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.81 -33.68 62.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.416 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.26 -34.16 59.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.962 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -80.59 -47.57 13.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.225 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.793 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -87.71 -10.91 49.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.822 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.17 36.17 56.5 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.929 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.921 HG13 ' HB2' ' A' ' 167' ' ' ALA . 11.5 mm -90.69 142.12 13.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.933 0.397 . . . . 0.0 111.659 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.87 100.78 12.89 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.127 HD21 ' HB2' ' A' ' 139' ' ' ALA . 3.9 mt -63.05 -22.13 66.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.349 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.2 p -66.75 -14.96 63.2 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -111.2 5.65 20.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.667 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.828 ' HB ' HD12 ' A' ' 158' ' ' ILE . 87.9 t -90.34 148.1 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.031 0.444 . . . . 0.0 110.97 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -70.87 108.56 4.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.457 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -71.06 123.5 10.64 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.974 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -141.7 34.0 1.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.309 0.576 . . . . 0.0 110.746 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -125.34 -164.64 11.9 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.955 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.408 ' N ' HG12 ' A' ' 157' ' ' VAL . 36.6 Cg_exo -31.69 96.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.809 3.006 . . . . 0.0 114.264 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.88 -17.07 17.71 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.389 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.26 43.97 0.22 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.862 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -100.8 143.08 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.208 0.528 . . . . 0.0 111.84 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.836 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -70.42 127.28 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.141 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.3 p -106.43 167.05 10.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.651 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 44.8 t -52.84 -26.87 11.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.125 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -64.77 -44.03 91.35 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.424 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 13.9 m-20 -71.62 -37.35 70.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.653 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.98 HG21 ' HB1' ' A' ' 135' ' ' ALA . 55.2 t -66.87 -54.56 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.406 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -60.87 -33.75 73.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.565 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -43.73 56.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.336 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.713 ' CE2' HG23 ' A' ' 144' ' ' ILE . 7.8 t80 -70.81 -46.75 62.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.465 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.921 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -62.02 -35.58 78.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.629 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 11.1 pt-20 -77.09 -36.29 55.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.088 0.47 . . . . 0.0 110.773 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.25 -21.91 55.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.025 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 167' ' ' ALA . 2.5 t -87.23 -40.52 14.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 110.797 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.74 95.11 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.168 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 4.7 tttm -163.51 163.7 24.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.99 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.02 95.41 4.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.054 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 69.3 p -77.89 -34.32 51.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.965 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 58.77 78.58 0.35 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.63 82.79 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.662 2.241 . . . . 0.0 112.304 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 59.23 89.79 0.1 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.132 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.59 98.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.617 2.212 . . . . 0.0 112.3 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -137.24 96.21 11.32 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.27 141.56 52.3 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.509 2.139 . . . . 0.0 112.226 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -100.43 -51.78 3.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.0 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -114.48 126.61 55.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.093 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.52 30.74 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -106.08 158.96 16.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -128.03 -71.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.108 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.4 p -109.15 -42.61 4.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 60.65 176.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.952 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.99 148.15 40.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.681 HG13 ' N ' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -141.12 -165.48 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.923 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.758 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . -149.06 129.97 14.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.429 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.468 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.24 162.1 32.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.949 0.404 . . . . 0.0 111.735 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.0 mtp -84.47 152.06 60.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.651 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.34 -41.9 49.59 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.119 1.88 . . . . 0.0 112.441 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.615 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -74.88 -30.37 61.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.89 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.69 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -60.95 -50.94 71.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.616 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.98 ' HA ' HD21 ' A' ' 146' ' ' LEU . 56.2 mtm180 -57.03 -34.28 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.304 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.22 -49.01 75.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.264 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 1.019 HD22 HG13 ' A' ' 160' ' ' VAL . 0.8 OUTLIER -65.77 -24.31 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.299 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.708 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -74.12 -36.28 64.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.64 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -76.5 -30.18 57.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.278 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -82.3 -48.99 10.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.858 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -92.33 -7.39 48.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.063 -179.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.32 38.97 58.26 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.087 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.809 HG13 ' HB2' ' A' ' 167' ' ' ALA . 12.0 mm -92.22 142.47 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.095 0.474 . . . . 0.0 111.793 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.38 100.73 12.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.98 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -57.88 -25.1 60.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.342 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.43 ' HA ' HG11 ' A' ' 129' ' ' VAL . 0.3 OUTLIER -66.05 -14.7 62.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.177 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -112.5 4.93 17.71 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.837 ' CB ' HD12 ' A' ' 158' ' ' ILE . 93.6 t -92.69 150.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.875 0.369 . . . . 0.0 111.021 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -70.89 105.92 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.396 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -73.04 116.84 5.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.841 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.476 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -126.58 31.48 5.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.087 0.47 . . . . 0.0 111.089 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.77 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -132.14 -156.87 8.44 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.363 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.564 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 39.0 Cg_exo -38.18 109.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.235 2.623 . . . . 0.0 114.142 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.66 5.66 25.24 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.592 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.59 39.08 2.11 Favored Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.77 HG12 ' HA3' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -84.63 143.78 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.999 -0.601 . . . . 0.0 111.469 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.065 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -81.16 136.31 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 163' ' ' VAL . 18.5 p -112.12 165.55 12.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.87 0.367 . . . . 0.0 111.04 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 1.019 HG13 HD22 ' A' ' 138' ' ' LEU . 39.3 t -52.45 -31.1 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.022 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.02 -39.45 93.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -74.88 -40.14 61.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.542 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.065 HG22 HD11 ' A' ' 158' ' ' ILE . 26.9 t -64.65 -54.75 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.021 0.438 . . . . 0.0 110.263 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -41.51 97.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.414 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.428 ' HA ' ' HG2' ' A' ' 168' ' ' GLU . 73.3 mtt-85 -62.65 -47.65 82.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.317 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.734 ' CE2' HG23 ' A' ' 144' ' ' ILE . 0.6 OUTLIER -62.87 -54.65 35.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.021 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.858 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -59.65 -41.85 91.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.841 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.64 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 0.0 OUTLIER -72.91 -31.74 64.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 110.655 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 1.2 tm-20 -77.95 -21.98 50.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.303 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -98.07 -27.95 13.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.881 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 170' ' ' THR . . . 175.53 90.48 0.01 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.921 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.64 ' HB3' ' HA ' ' A' ' 168' ' ' GLU . 1.5 ptmm? -95.17 141.45 28.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.65 110.39 14.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.8 p -115.72 32.04 6.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.4 59.43 6.84 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.064 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.95 173.08 11.67 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.801 2.334 . . . . 0.0 112.279 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.792 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . . . -176.85 -53.73 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.111 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 177' ' ' ALA . 33.3 Cg_exo -61.11 101.25 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.477 2.118 . . . . 0.0 112.027 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 62.17 92.69 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.945 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.73 148.2 86.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.578 2.185 . . . . 0.0 112.304 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 169.04 18.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.517 ' HB1' ' OXT' ' A' ' 186' ' ' ALA . . . -69.49 171.6 8.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.02 -42.46 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -136.32 -49.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -137.58 -48.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.976 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.517 ' OXT' ' HB1' ' A' ' 182' ' ' ALA . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.054 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.2 m -115.38 49.22 1.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -173.19 -41.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -56.96 -178.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.011 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.3 t -60.03 -72.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.012 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.837 ' C ' HG23 ' A' ' 157' ' ' VAL . . . 61.96 126.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.2 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.714 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.4 162.06 32.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.425 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 0.0 OUTLIER -89.84 147.28 37.11 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.151 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.78 -51.99 9.75 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.282 1.988 . . . . 0.0 112.371 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.634 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.13 -33.69 75.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 110.629 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.673 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -62.06 -52.9 62.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.673 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.62 ' HA ' HD11 ' A' ' 146' ' ' LEU . 83.6 mtt-85 -54.65 -38.24 66.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 110.501 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -60.72 -49.66 76.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.129 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.787 HD22 HG13 ' A' ' 160' ' ' VAL . 1.1 mp -64.15 -24.18 67.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.57 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.077 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.83 -36.16 62.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.943 0.401 . . . . 0.0 110.493 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -76.34 -33.04 58.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.315 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -82.01 -44.74 16.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.092 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.55 ' HB3' HG12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -85.0 -13.3 51.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.294 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.09 39.12 54.31 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.257 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.988 HG13 ' HB2' ' A' ' 167' ' ' ALA . 25.5 mm -100.81 146.36 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.88 100.79 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.077 HD21 ' HB2' ' A' ' 139' ' ' ALA . 4.3 mt -61.4 -21.54 64.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.621 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -61.97 -17.67 57.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.001 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -107.66 -8.56 16.08 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.677 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.821 ' CB ' HD12 ' A' ' 158' ' ' ILE . 59.0 t -76.28 146.21 9.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.052 0.454 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -71.46 118.74 14.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.444 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.24 119.28 5.14 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.822 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -135.71 34.27 2.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.343 0.592 . . . . 0.0 110.747 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -127.24 -164.75 11.75 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.989 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -31.66 97.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.911 3.074 . . . . 0.0 114.233 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.52 -17.04 15.7 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.425 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.78 44.32 0.22 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.837 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -100.8 144.31 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.12 0.485 . . . . 0.0 111.77 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.867 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.78 127.73 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.346 179.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 3.4 p -104.3 164.22 11.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.322 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.787 HG13 HD22 ' A' ' 138' ' ' LEU . 83.3 t -51.33 -27.63 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.804 0.335 . . . . 0.0 110.999 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -63.05 -42.83 99.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.002 0.429 . . . . 0.0 109.865 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.423 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 14.3 m-20 -72.69 -36.64 67.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.868 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.867 HG22 HD11 ' A' ' 158' ' ' ILE . 79.1 t -66.67 -54.63 23.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.906 0.384 . . . . 0.0 110.143 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -61.0 -36.02 78.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.785 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -71.9 -46.02 59.2 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.705 ' CE2' HG23 ' A' ' 144' ' ' ILE . 18.7 t80 -66.42 -51.1 60.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.52 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.988 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -56.73 -42.48 79.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.517 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 12.5 pt-20 -71.8 -36.34 70.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.345 0.593 . . . . 0.0 110.24 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -75.63 -21.95 57.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.79 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.3 t -93.92 -34.76 12.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.115 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -161.71 96.27 1.03 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.886 0.374 . . . . 0.0 111.506 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -142.73 -170.2 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.642 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.69 120.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.19 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.06 119.81 32.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 62.77 119.25 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.043 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.25 -27.38 34.86 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.384 2.056 . . . . 0.0 112.33 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 178' ' ' PRO . . . -171.62 164.59 4.54 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.066 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 177' ' ' ALA . 58.9 Cg_endo -71.91 62.48 3.18 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.534 2.156 . . . . 0.0 112.327 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -107.87 152.96 41.85 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.089 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.14 -73.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.6 2.2 . . . . 0.0 112.293 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.73 -175.39 3.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 186' ' ' ALA . . . -149.94 108.41 3.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.8 m -84.45 -31.27 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.101 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.24 -47.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.818 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -106.9 93.05 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.521 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.095 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.29 145.69 24.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.89 97.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.69 172.11 4.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 30.5 m -59.77 -177.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.289 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.826 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -73.51 118.85 16.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.022 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.692 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.42 162.0 33.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.032 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 36.1 mmm -87.35 152.98 53.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.103 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.12 -52.03 6.59 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.283 1.988 . . . . 0.0 112.026 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.579 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -61.86 -30.06 70.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.66 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.945 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -63.94 -52.8 58.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.607 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.646 ' HA ' HD11 ' A' ' 146' ' ' LEU . 80.6 mtt180 -55.99 -36.16 67.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -62.39 -50.06 73.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.208 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.61 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -64.86 -23.79 67.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.751 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.903 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.46 -38.43 62.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.881 0.372 . . . . 0.0 110.539 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -76.31 -29.41 57.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.292 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -82.37 -45.04 15.38 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.55 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.58 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -97.29 -2.8 41.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.118 -178.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.28 38.91 91.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.712 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.768 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 64.9 mt -87.62 142.71 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.401 . . . . 0.0 111.444 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -94.17 100.46 12.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.903 HD21 ' HB2' ' A' ' 139' ' ' ALA . 5.7 mt -72.07 -21.91 61.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.254 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.94 -15.89 62.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -111.72 0.25 16.22 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.834 ' HB ' HD12 ' A' ' 158' ' ' ILE . 57.2 t -81.98 148.82 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.139 0.495 . . . . 0.0 111.185 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.5 OUTLIER -77.27 124.53 27.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.199 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -82.57 121.69 5.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.175 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.448 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -137.49 34.22 2.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -124.19 -164.71 12.03 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.709 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -30.92 95.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.798 2.999 . . . . 0.0 114.301 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.84 -17.62 20.44 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.453 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 128.77 45.04 0.19 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.826 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.4 p -102.13 144.21 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.162 0.506 . . . . 0.0 111.822 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.834 HD12 ' HB ' ' A' ' 149' ' ' VAL . 0.1 OUTLIER -71.89 126.72 32.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.021 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 132' ' ' MET . 2.6 p -109.37 167.85 9.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.409 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.61 HG13 HD22 ' A' ' 138' ' ' LEU . 21.9 t -52.42 -26.37 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.753 0.311 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 4.1 mt-10 -65.43 -43.2 91.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.85 -43.68 57.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.827 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.945 HG21 ' HB1' ' A' ' 135' ' ' ALA . 20.0 t -57.22 -54.24 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.054 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.524 ' HA ' ' CE ' ' A' ' 164' ' ' LYS . 0.2 OUTLIER -65.29 -46.84 78.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.842 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 12.6 mtp180 -52.96 -41.71 64.81 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.053 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.531 ' CE2' HG23 ' A' ' 144' ' ' ILE . 12.3 t80 -73.7 -46.66 44.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.267 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.768 ' HB2' ' CD1' ' A' ' 144' ' ' ILE . . . -59.88 -49.1 79.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.458 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 9.7 pt-20 -62.91 -34.08 76.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.32 0.581 . . . . 0.0 109.981 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.7 OUTLIER -78.13 -30.13 49.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.674 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 167' ' ' ALA . 0.6 OUTLIER -82.12 -37.06 26.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.632 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -176.59 94.94 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.4 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 0.1 OUTLIER -100.81 -162.07 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.432 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -132.94 111.89 11.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 111.139 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 16.9 p -104.16 34.19 3.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.795 ' HB1' ' HG2' ' A' ' 178' ' ' PRO . . . -157.15 77.47 3.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.081 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.85 -43.48 48.93 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.638 2.225 . . . . 0.0 112.471 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . . . -85.4 -65.15 0.21 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.647 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.795 ' HG2' ' HB1' ' A' ' 175' ' ' ALA . 44.6 Cg_endo -68.91 158.95 55.85 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.281 1.987 . . . . 0.0 112.567 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -146.93 87.9 6.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.049 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -51.69 -27.13 25.21 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.686 2.257 . . . . 0.0 112.474 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.56 -31.45 8.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 59.91 76.23 0.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.999 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.3 -30.96 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.221 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.37 161.15 16.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.09 -45.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.089 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.3 m -111.95 -38.17 4.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.46 -56.49 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -127.71 150.17 49.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.677 HG13 ' N ' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -122.44 -164.39 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.85 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -98.69 123.82 43.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.098 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.715 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.45 161.03 35.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.8 mtp -81.5 153.01 70.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.78 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.21 -41.45 75.87 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.203 1.935 . . . . 0.0 111.985 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.715 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -75.1 -27.39 59.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.652 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.759 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -65.21 -50.85 64.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.679 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.852 ' HA ' HD21 ' A' ' 146' ' ' LEU . 3.3 mtt-85 -55.94 -42.68 76.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.124 0.487 . . . . 0.0 110.261 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -57.94 -47.46 82.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.799 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.799 HD22 HG13 ' A' ' 160' ' ' VAL . 0.8 OUTLIER -65.37 -22.96 66.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.148 178.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.591 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . . . -73.29 -37.88 66.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.536 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -76.38 -30.69 57.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.313 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.32 -44.65 15.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.565 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.884 HD12 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -95.6 -3.95 45.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.743 -179.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.46 37.66 92.86 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.478 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.741 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 45.1 mt -89.41 138.52 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.39 100.55 12.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.852 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -61.63 -23.0 65.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.539 -178.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 t -66.65 -12.19 57.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.305 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -115.6 4.44 14.15 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.876 ' CB ' HD12 ' A' ' 158' ' ' ILE . 67.3 t -89.2 152.02 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.778 0.323 . . . . 0.0 110.921 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.81 106.48 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.349 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.95 120.41 9.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.914 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -137.82 32.2 2.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 110.796 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.491 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -126.98 -166.38 12.14 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.129 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' N ' HG12 ' A' ' 157' ' ' VAL . 36.5 Cg_exo -32.26 99.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.86 3.04 . . . . 0.0 114.307 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.26 -17.16 10.48 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.435 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.46 43.19 0.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.85 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.5 p -98.51 143.88 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.129 0.49 . . . . 0.0 111.523 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.059 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -72.31 127.61 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.69 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 163' ' ' VAL . 11.4 p -100.67 165.83 11.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.207 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.799 HG13 HD22 ' A' ' 138' ' ' LEU . 67.9 t -54.96 -30.53 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.701 0.286 . . . . 0.0 111.142 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -61.77 -39.77 92.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.009 0.433 . . . . 0.0 109.85 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 10.8 m-20 -74.85 -37.61 62.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.416 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.059 HG22 HD11 ' A' ' 158' ' ' ILE . 42.1 t -64.12 -54.84 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.591 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -61.64 -42.44 98.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.618 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 2.0 mtt180 -64.57 -45.2 88.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 111.054 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.713 ' CE2' HG23 ' A' ' 144' ' ' ILE . 3.7 t80 -67.21 -49.46 64.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.884 ' HB1' HD12 ' A' ' 142' ' ' LEU . . . -63.38 -34.5 77.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.958 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.556 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 6.3 pt-20 -74.28 -38.03 63.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.0 110.562 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.72 -21.91 57.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.984 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.6 t -91.93 -36.7 13.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.247 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -161.33 96.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 0.0 111.591 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.556 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 0.8 OUTLIER -166.82 -69.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.961 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -171.68 -174.22 1.32 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.173 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.38 132.8 4.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -133.65 120.22 15.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.065 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.62 -39.05 84.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.324 2.016 . . . . 0.0 112.227 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 56.65 86.33 0.17 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.202 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.36 174.29 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.556 2.171 . . . . 0.0 112.288 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.811 ' HB3' ' HD3' ' A' ' 180' ' ' PRO . . . -179.55 -55.55 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.241 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 58.1 Cg_exo -51.68 140.38 46.38 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.437 2.091 . . . . 0.0 112.405 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.455 ' HA ' ' CE ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -164.76 -171.55 2.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.835 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -65.18 -37.98 89.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.0 m 42.39 32.24 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.699 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.18 -60.38 1.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.79 139.74 32.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.016 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.066 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.6 m -142.66 97.96 3.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.839 0.352 . . . . 0.0 110.85 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.62 -32.31 8.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -135.7 -45.78 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 130' ' ' ALA . 14.6 t -109.55 160.25 8.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.027 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.77 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . -127.47 128.17 45.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.528 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.23 162.03 32.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.639 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -88.24 157.65 50.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.718 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.64 -52.02 7.03 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.157 1.904 . . . . 0.0 112.224 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.576 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -63.05 -32.71 74.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.943 0.402 . . . . 0.0 110.601 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.727 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -63.45 -52.83 59.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.644 ' HA ' HD11 ' A' ' 146' ' ' LEU . 1.1 mtm105 -56.44 -34.41 66.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.135 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -62.25 -50.99 69.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.964 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.691 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -63.96 -24.03 67.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.382 179.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.781 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -71.33 -40.76 70.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 110.617 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -76.32 -29.2 57.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.701 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -82.2 -44.17 16.72 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.576 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.805 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -99.61 -2.22 36.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.061 -178.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.53 39.13 93.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.588 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.775 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 67.2 mt -87.63 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.971 0.415 . . . . 0.0 111.712 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.26 100.48 12.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.811 ' HB3' HD13 ' A' ' 158' ' ' ILE . 5.6 mt -70.52 -18.83 62.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.278 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.57 -15.0 62.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.994 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -114.58 3.17 14.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.708 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.822 ' CB ' HD12 ' A' ' 158' ' ' ILE . 84.3 t -83.96 144.45 9.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.947 0.403 . . . . 0.0 110.809 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 111.45 6.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.413 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -76.44 120.22 5.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.979 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -122.83 18.96 10.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 0.0 111.235 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.716 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -123.86 -154.21 8.87 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.587 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 26.6 Cg_exo -34.73 109.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.553 2.835 . . . . 0.0 114.467 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.27 8.53 6.71 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.518 -0.764 . . . . 0.0 113.806 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.95 41.37 1.7 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.77 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -85.54 145.03 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.054 -0.573 . . . . 0.0 111.433 -178.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.93 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -83.87 132.47 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 163' ' ' VAL . 7.3 p -112.07 166.82 10.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.932 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.691 HG13 HD22 ' A' ' 138' ' ' LEU . 19.2 t -53.27 -27.74 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.293 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 4.4 pt-20 -64.12 -42.97 96.64 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -75.09 -38.12 61.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.93 HG22 HD11 ' A' ' 158' ' ' ILE . 58.3 t -62.59 -54.54 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.907 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -60.73 -41.38 95.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.022 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -68.79 -37.52 79.33 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.689 0.28 . . . . 0.0 111.491 -179.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.665 ' CE2' HG23 ' A' ' 144' ' ' ILE . 7.2 t80 -74.01 -54.1 8.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.805 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -52.7 -41.08 63.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.551 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.647 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 10.4 pt-20 -71.12 -39.39 72.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.153 0.502 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 6.9 tt0 -70.1 -21.96 63.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.501 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 167' ' ' ALA . 0.9 OUTLIER -97.8 -34.27 10.94 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -176.66 93.69 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.114 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.647 ' HB3' ' HA ' ' A' ' 168' ' ' GLU . 6.1 pttt -102.21 138.95 38.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.47 -33.97 10.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.3 p -140.07 -62.12 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.716 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.751 ' HB1' ' HD2' ' A' ' 176' ' ' PRO . . . 57.27 167.04 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.214 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.751 ' HD2' ' HB1' ' A' ' 175' ' ' ALA . 54.9 Cg_endo -69.81 165.92 29.39 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.555 2.17 . . . . 0.0 112.307 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.766 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . . . -178.26 -62.11 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.016 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 177' ' ' ALA . 57.7 Cg_endo -71.31 138.58 33.3 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.47 2.113 . . . . 0.0 112.267 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -104.45 88.53 2.18 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.217 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.79 -172.97 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.553 2.169 . . . . 0.0 112.23 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.97 173.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 59.1 77.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.092 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 183' ' ' VAL . 11.3 p -58.59 113.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.46 162.8 24.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.91 177.61 9.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.064 179.975 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.3 m -117.57 73.85 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.862 0.363 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 -160.83 101.72 1.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 129' ' ' VAL . 6.5 tt0 -137.7 -48.22 0.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.78 HG22 ' H ' ' A' ' 130' ' ' ALA . 1.7 p 44.41 -167.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.843 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -122.66 141.85 51.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.072 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.71 ' N ' HG23 ' A' ' 157' ' ' VAL . . . -133.38 162.05 32.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.2 mtp -82.61 146.33 53.02 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.87 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.45 -39.21 22.02 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.19 1.926 . . . . 0.0 112.349 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.751 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -77.71 -28.18 50.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.613 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -64.01 -50.89 66.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.66 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.726 ' HA ' HD21 ' A' ' 146' ' ' LEU . 73.6 mtt180 -58.3 -35.51 71.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.334 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -62.25 -50.39 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.124 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.473 HD22 HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -65.86 -23.05 66.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.561 179.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.711 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -73.21 -38.62 66.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.646 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -32.24 58.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.482 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -82.11 -42.71 18.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.616 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.826 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -99.47 -2.9 34.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.962 -178.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.82 39.21 95.01 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.197 -1.002 . . . . 0.0 111.618 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.745 ' CD1' ' HB2' ' A' ' 167' ' ' ALA . 68.6 mt -87.55 143.34 11.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.031 0.443 . . . . 0.0 111.811 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -95.38 100.61 12.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.726 HD21 ' HA ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER -68.46 -24.1 64.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.088 -178.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -65.44 -14.77 61.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.038 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -110.92 -2.2 16.12 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.761 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.892 ' CB ' HD12 ' A' ' 158' ' ' ILE . 62.1 t -82.49 148.48 5.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.966 0.412 . . . . 0.0 111.109 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.99 110.3 5.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.487 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -72.63 120.4 7.49 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.907 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -135.7 32.94 2.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.344 0.593 . . . . 0.0 110.726 -179.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.485 ' HA3' HG13 ' A' ' 157' ' ' VAL . . . -127.73 -165.73 11.92 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.189 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.413 ' N ' HG12 ' A' ' 157' ' ' VAL . 35.2 Cg_exo -32.22 99.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.82 3.014 . . . . 0.0 114.33 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.73 -16.64 10.64 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.46 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 127.09 43.01 0.26 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.843 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.6 p -98.47 144.46 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.314 -0.443 . . . . 0.0 111.536 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.021 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.75 128.33 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 110.924 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.4 p -101.02 168.6 9.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.144 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.751 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 46.5 t -56.21 -30.22 29.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.712 0.291 . . . . 0.0 110.991 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.75 -39.04 90.18 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.495 ' HB3' ' CG1' ' A' ' 149' ' ' VAL . 12.1 m-20 -75.05 -38.32 61.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.615 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.021 HG22 HD11 ' A' ' 158' ' ' ILE . 52.5 t -64.47 -54.74 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.097 0.475 . . . . 0.0 110.313 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -60.51 -41.36 94.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.792 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -68.23 -40.15 82.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.425 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.655 ' CE2' HG23 ' A' ' 144' ' ' ILE . 6.8 t80 -72.29 -52.67 15.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.921 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.826 ' HB1' HD22 ' A' ' 142' ' ' LEU . . . -55.66 -39.73 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.381 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 8.8 pt-20 -72.21 -38.15 69.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.35 0.595 . . . . 0.0 110.04 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.416 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 1.7 tp10 -73.13 -21.97 60.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.733 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.1 t -96.58 -41.06 8.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -164.44 88.15 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.428 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.753 ' HB3' HG22 ' A' ' 174' ' ' THR . 4.0 tttm -101.74 161.51 13.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.551 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.53 -18.05 61.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.395 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.753 HG22 ' HB3' ' A' ' 172' ' ' LYS . 9.5 t -54.01 -32.13 53.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.848 0.356 . . . . 0.0 111.071 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' A' ' 176' ' ' PRO . . . -129.07 116.07 18.88 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 177' ' ' ALA . 19.3 Cg_endo -61.12 -78.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.329 2.019 . . . . 0.0 112.388 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 176' ' ' PRO . . . 178.74 91.37 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.063 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.04 157.09 63.32 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.445 2.097 . . . . 0.0 112.31 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.861 ' HB3' ' HD3' ' A' ' 180' ' ' PRO . . . -173.5 -57.35 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.23 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.861 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 52.6 Cg_exo -52.61 152.44 16.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.306 2.004 . . . . 0.0 112.251 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -108.53 147.97 30.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -146.2 29.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.998 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 183' ' ' VAL . 13.7 t -107.23 32.07 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.138 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -91.86 167.53 12.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -43.62 64.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.004 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.038 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.555 -0.218 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -84.51 126.18 33.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.814 0.34 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.48 29.97 7.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -131.4 156.96 44.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.679 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 130' ' ' ALA . 14.1 t -150.51 159.46 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.271 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.829 ' C ' HG23 ' A' ' 157' ' ' VAL . . . -137.73 136.47 37.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.715 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.709 ' HB1' HD23 ' A' ' 146' ' ' LEU . . . -133.47 162.01 33.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.233 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.413 ' HB2' ' HA ' ' A' ' 159' ' ' THR . 5.7 mmm -85.05 152.48 58.85 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.988 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.29 -52.06 9.14 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.324 2.016 . . . . 0.0 112.092 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.645 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -62.07 -39.81 93.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 110.531 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.816 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -54.18 -46.05 72.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.695 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -62.22 -33.93 75.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.573 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.81 ' HG2' HD13 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -59.5 -54.35 47.61 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 110.195 179.629 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.81 HD13 ' HG2' ' A' ' 137' ' ' ARG . 4.7 mp -68.06 -24.2 65.05 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.547 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.69 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . . . -74.64 -39.09 62.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.034 0.445 . . . . 0.0 109.947 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -76.44 -30.26 57.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.378 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -82.35 -49.25 10.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.094 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.774 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -85.08 -12.91 51.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.472 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.51 29.5 48.65 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.178 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.873 HG13 ' HB2' ' A' ' 167' ' ' ALA . 14.5 mm -87.73 147.91 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 111.476 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.96 100.93 10.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.678 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.709 HD23 ' HB1' ' A' ' 131' ' ' ALA . 2.0 mp -63.59 -20.08 65.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.255 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 m -63.02 -19.79 64.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.85 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -107.08 -3.91 19.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.495 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.983 HG11 HD13 ' A' ' 158' ' ' ILE . 58.3 t -79.92 147.47 6.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.081 0.467 . . . . 0.0 111.025 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 110.75 5.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.261 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -71.64 123.64 10.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.194 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.73 33.8 1.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.357 0.599 . . . . 0.0 110.649 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -122.57 -165.17 12.36 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.777 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -31.46 96.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.73 2.953 . . . . 0.0 114.157 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.26 -18.51 17.44 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.309 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 153' ' ' GLY . . . 129.07 46.52 0.17 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.829 HG23 ' C ' ' A' ' 130' ' ' ALA . 1.2 p -104.54 142.29 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 112.082 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.983 HD13 HG11 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -69.15 123.35 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.036 179.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.835 ' N ' HD12 ' A' ' 158' ' ' ILE . 1.3 p -106.74 165.95 10.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.163 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.645 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 21.6 t -50.21 -25.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.603 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.5 -45.57 86.7 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.703 ' HB2' HD13 ' A' ' 158' ' ' ILE . 8.1 m-20 -74.91 -33.3 61.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.493 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.934 ' CG2' HD11 ' A' ' 158' ' ' ILE . 9.8 t -66.02 -54.59 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -61.72 -35.69 78.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.514 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -43.31 68.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.324 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.585 ' CE2' HG23 ' A' ' 144' ' ' ILE . 19.7 t80 -72.29 -46.51 55.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.818 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.873 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -59.74 -39.77 85.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.602 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 13.8 pt-20 -73.25 -36.97 66.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.13 0.491 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -21.9 50.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.989 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 167' ' ' ALA . 1.7 t -91.34 -35.08 14.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.095 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.89 86.31 1.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.294 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -176.68 -73.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.738 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.582 ' O ' HG22 ' A' ' 174' ' ' THR . . . 61.64 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.72 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 173' ' ' ALA . 5.2 t 48.35 27.53 1.39 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.472 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -140.26 148.64 54.97 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.189 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.0 153.16 63.33 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.609 2.206 . . . . 0.0 112.312 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.722 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . . . -72.24 -61.15 1.93 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.197 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.722 ' HD3' ' HB3' ' A' ' 177' ' ' ALA . 56.2 Cg_endo -70.34 129.83 17.64 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.488 2.125 . . . . 0.0 112.377 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.87 109.86 2.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.24 162.36 40.72 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.366 2.044 . . . . 0.0 112.33 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -96.97 -50.04 4.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.47 109.49 11.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.014 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.1 m -118.5 32.16 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.15 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -94.84 -50.52 5.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.12 174.63 11.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.132 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.14 132.27 11.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.885 0.374 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.68 119.2 38.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.23 -30.96 71.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 130' ' ' ALA . 15.7 t -106.14 159.93 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.201 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 157' ' ' VAL . . . -134.55 130.12 36.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.486 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -133.32 162.13 32.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.962 0.41 . . . . 0.0 111.658 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.39 149.08 41.97 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.927 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.42 -51.99 9.24 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.27 1.98 . . . . 0.0 112.704 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.612 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . . . -61.14 -36.93 81.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 111.012 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.859 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -61.1 -52.92 62.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.124 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.713 ' HA ' HD11 ' A' ' 146' ' ' LEU . 1.3 mtt180 -55.6 -37.43 68.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.76 -52.33 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -64.57 -23.15 67.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.86 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.081 ' HB2' HD21 ' A' ' 146' ' ' LEU . . . -74.71 -36.92 62.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.96 0.41 . . . . 0.0 110.434 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -76.38 -29.39 57.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.125 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.2 -48.56 11.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.2 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.621 HD22 ' HB1' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -88.97 -8.96 53.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.825 -179.273 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.4 35.78 55.83 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.102 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.858 HG13 ' HB2' ' A' ' 167' ' ' ALA . 14.0 mm -90.17 140.68 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.972 0.415 . . . . 0.0 111.522 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.23 100.78 13.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.081 HD21 ' HB2' ' A' ' 139' ' ' ALA . 4.9 mt -64.51 -19.64 65.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.334 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.2 p -66.12 -15.36 63.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.196 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -113.45 6.82 17.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.651 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.791 ' CB ' HD12 ' A' ' 158' ' ' ILE . 87.5 t -90.69 144.13 9.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.888 0.375 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -70.98 113.52 8.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.347 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -77.56 120.55 5.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.921 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.486 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.3 OUTLIER -123.53 24.89 8.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.026 0.441 . . . . 0.0 111.325 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.724 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -129.7 -154.92 8.27 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.592 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 157' ' ' VAL . 30.6 Cg_exo -35.53 108.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.436 2.758 . . . . 0.0 114.445 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.98 8.0 14.89 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.616 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.84 40.71 1.81 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.811 HG23 ' HB1' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -85.74 142.4 13.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.99 -0.605 . . . . 0.0 111.401 -178.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.823 HD11 HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -82.55 131.01 34.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.0 p -110.66 170.98 7.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.217 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.612 ' CG2' ' HB3' ' A' ' 134' ' ' ALA . 15.2 t -54.92 -23.89 13.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.088 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.44 -41.49 76.2 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.406 ' CB ' ' CG1' ' A' ' 149' ' ' VAL . 0.7 OUTLIER -73.64 -38.72 64.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.306 179.227 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.859 HG21 ' HB1' ' A' ' 135' ' ' ALA . 48.5 t -68.53 -51.96 41.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.259 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -62.09 -34.11 75.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.439 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -75.43 -42.17 54.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.367 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.746 ' CE2' HG23 ' A' ' 144' ' ' ILE . 10.8 t80 -71.95 -48.37 45.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.069 0.462 . . . . 0.0 110.436 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.858 ' HB2' HG13 ' A' ' 144' ' ' ILE . . . -59.57 -38.83 82.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.325 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.536 ' O ' ' HB2' ' A' ' 172' ' ' LYS . 11.6 pt-20 -74.77 -38.77 62.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.296 0.569 . . . . 0.0 110.367 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 17.8 tt0 -73.04 -22.01 60.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 167' ' ' ALA . 1.3 t -92.12 -41.06 10.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.948 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -158.95 99.2 1.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.473 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 168' ' ' GLU . 0.1 OUTLIER -142.04 -167.91 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.737 179.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.0 78.73 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.0 p -115.62 33.62 5.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.827 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.28 115.58 20.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.066 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -86.9 26.48 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.805 2.337 . . . . 0.0 112.936 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.484 ' HB1' ' HD2' ' A' ' 178' ' ' PRO . . . 61.81 158.79 0.11 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.174 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' A' ' 177' ' ' ALA . 52.9 Cg_endo -69.33 115.74 4.18 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.636 2.224 . . . . 0.0 112.305 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -97.71 112.53 61.72 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.151 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -50.98 170.45 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.498 2.132 . . . . 0.0 112.337 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -44.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.869 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -74.48 163.87 27.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.02 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.1 m -132.34 112.21 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.31 169.26 12.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -96.78 122.18 39.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.142 179.944 . . . . . . . . 0 0 . 1 stop_ save_